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Abstract 
 
Although bacteria do not contain ubiquitin or ubiquitin homologues, the 
accurate proteolytic processing of ubiquitin precursors and ubiquitin 
fusion proteins in lab strains of Escherichia coli has previously been 
noted3, 4. We provide evidence that a novel ubiquitin-fusion processing 
activity in E. coli substrain RosettaTM2(DE3) represents a specific DUB 
activity against linear (peptide-linked) ubiquitin fusions. Fusions of 
ubiquitin linked to an ATP-binding cassette protein (LmrC) or to 
enhanced green fluorescent protein (EGFP), expressed in 
RosettaTM2(DE3) were cleaved precisely after the C-terminal Gly76 of 
ubiquitin. The use of gene knock-out showed that the source of the 
ubiquitin-fusion processing activity in RosettaTM2(DE3) is the ubiquitin-
like protease, elaD; as specific ubiquitin-fusion processing was ablated 
by the inactivation of the elaD gene. Whilst this study was in progress, 
Catic et al. showed that elaD is present in the commensal E. coli strain 
K12 and intestinal pathogenic strains, but absent from extraintestinal 
pathogenic strains, and exhibits deubiquitinating activity in vitro against 
the generic substrate ubiquitin-AMC14. Our study has demonstrated that 
elaD not only exhibits deubiquitinating activity against linear ubiquitin 
fusions, but also possesses isopeptidase activity, with a preference for 
unanchored Lys63-linked poly-ubiquitin chains over Lys48-linked forms. 
GST-elaD has also been shown in this study to bind specifically to 
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immobilised mammalian ubiquitin in pull-down assays. Thus, elaD is a 
bacterial enzyme which has the ability to functionally interact with the 
highly conserved eukaryotic ubiquitin protein and indicate that elaD may 
have a role in regulating host-microbe interactions. 
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1 Introduction 
Introduction 
The focus of this chapter is to introduce key topics, appropriate to this 
study as well as the main aims and objectives of this work. The areas 
encompassed include protein processing systems in eukaryotes and 
prokaryotes, modes of attack by pathogenic eubacteria and the findings 
in the literature of deubiquitinating enzyme (DUB) activities in non 
pathogenic E. coli. 
 
 
1.2 Comparison of the eukaryotic-ubiquitin mediated 
system with prokaryotic systems 
Ubiquitin is a small (76 amino acid residues), highly conserved protein 
which is covalently linked to target proteins for proteolysis or to alter the 
activity of the target protein. Ubiquitin is expressed as precursor 
ubiquitin either as repeat units of ubiquitin or as fusion proteins to 
ribosomal units. Cells need systems by which proteins are targeted for 
their disposal either to maintain a balance between protein translation 
and proteolysis as well as for protein quality control. Additionally cells 
need to control the activities of key proteins for control over signalling 
pathways. Therefore the proteins of signalling pathways are more likely 
to be targeted to change their interactions with other proteins rather 
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than for proteolysis. There are many different cellular systems which 
serve these protein degradation and signalling functions, however in 
this chapter attention will be restricted to the main system used in 
eukaryotes, the ubiquitin-mediated system. When used in this text, the 
ubiquitin-mediated system is used to include signalling systems, protein 
transport and protein degradation, which use ubiquitin. The area 
covered will include ubiquitin-like proteins (UBLs). More particularly the 
focus will be on the components of the eukaryotic ubiquitin-mediated 
system compared with what is known of prokaryotic systems with 
related functions. 
 
Three scientists, Aaron Ciechanover, Avram Hershko and Irwin Rose, 
were crucial to the discovery of ubiquitin-mediated proteolysis and 
consequently were awarded the Nobel Prize in Chemistry for 200423, 24. 
The small eukaryotic ubiquitin protein is now known to play a key role in 
many of the cell systems for example: signalling pathways, quality 
control of proteins, the cell cycle and cell differentiation. This 
involvement of ubiquitin in such diverse cell systems means that many 
disease states involve altered function of the ubiquitin-mediated system. 
Consequently the ubiquitin-mediated system and its target proteins are 
an area of intensive investigation, with the aim of using the components 
of the ubiquitin-mediated system as potential therapeutic targets. An 
increasing amount of information is being revealed of the ubiquitin-
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mediated system and disease states and is covered in a recent review 
by T. Jung25. The next section will begin with the components of the 
eukaryotic ubiquitin-mediated system and their associated functions will 
be introduced briefly. This will then be followed by sections detailing 
each component of the eukaryotic ubiquitin-mediated system, 
compared with any prokaryotic systems or proteins with a similar 
structure or function. 
 
 
1.2.1 Ubiquitin and UBLs 
Ubiquitin is found in all eukaryotes and an archaebacterium, 
Thermoplasma acidophilium expresses ubiquitin as well as a 20S 
proteasome26,27. However, to date there is no functional evidence to 
describe ubiquitin tagging in the archaea. Curiously, one group also 
describes the purification of ubiquitin from the eubacterium Anabena 
variabilis  which contradicts the current belief that eubacteria lack the 
gene for ubiquitin28. Interestingly, recent findings have revealed that the 
eubacterium, Mycobacterium tuberculosis has a ubiquitin analogue, 
prokaryotic ubiquitin like protein (Pup) which is 64 amino acid residues 
compared with ubiquitin which is 76 amino acid residues29. Pup is used 
for protein modification in a similar way to ubiquitin but is thought to use 
a different mechanism for attachment to the target protein compared 
with ubiquitin30-32. 
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Ubiquitin and UBLs have a ubiquitin superfold and a flexible glycine, 
glycine C-terminus33. Ubiquitin and UBLs are involved in a variety of 
eukaryotic cell signalling processes rather than just as part of a 
protein quality control system. The main UBLs are small Ubiquitin-
related Modifier (SUMO) in humans; interferon stimulated gene 15 
(ISG15) in humans; neural precursor cell expressed developmentally 
down-regulated protein 8 (NEDD8) in humans, autophagy associated 
protein (Atg8) in Saccharomyces cerevisiae and ubiquitin-related 
modifier 1 (Urm1) in Saccharomyces cerevisiae. All UBLs, apart from 
Atg8 are synthesised as inactive precursors, comparable to ubiquitin; 
therefore they have to be specifically cleaved by an enzyme. For 
ubiquitin, this is a DUB and for UBLs the enzymes are referred to as 
UBL specific proteases (ULPs). SUMO is involved in nuclear 
localisation and transcriptional regulation34, as well as in the 
regulation of circadian rhythms35. ISG15 could be involved in 
transcription and pre-mRNA splicing during IFN response36, 37. 
NEDD8 is associated with transcriptional regulation18, 38; Atg8 is 
involved in autophagy and nutrient recycling in yeast39, 40 and Urm1 is 
reported to be involved in budding, nutrient sensing and the oxidative 
stress response in Saccharomyces cerevisiae41, 42.  
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1.2.2 The eukaryotic ubiquitin-mediated system 
 
1,2,2,1 Four areas of protein targeting in a ubiquitin-mediated system 
A simplified version of the eukaryotic ubiquitin-mediated system and 
key components are shown in Fig. 1.1. Many chaperone proteins and 
facilitative proteins are also involved in the eukaryotic ubiquitin-
mediated system, however only the key proteins have been included. 
This is a system which targets proteins as part of a signalling 
mechanism or for disposal as part of a protein quality control or as part 
of autophagy. In all of these cases a protein is ubiquitinated with a 
particular type of ubiquitin tag, deubiquitinated or disposed of. 
 
The targeting of proteins within the eukaryotic ubiquitin-mediated 
system can be broken down in to four main areas, first, the targeting of 
the protein for ubiquitination. This involves particular signals which a 
protein carries singling it out as a target for ubiquitination (not shown in 
Fig.1.1). The second main area of the eukaryotic ubiquitin-mediated 
system is the ubiquitination of the target protein. This involves three 
(sometimes four) enzymes which have a role in the eventual 
ubiquitination of a target protein; The activation enzyme (E1); 
conjugation enzyme (E2); ligation enzyme (E3) and in some cases 
another ligation enzyme, E4. There is a hierarchy of these enzymes as 
there are only two types of E1s, over thirty types of E2s and hundred of 
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different E3s which adds to the selectivity of these enzymes for their 
target proteins43-45. E1, a homodimer, uses ATP to activate ubiquitin 
and passes the ubiquitin to E2, which then works with E3 (and 
sometimes E4) to ubiquitinate a target protein. E3 ligases can be of two 
main types, each with a slightly different method of ubiquitination; the 
HECT (homologous to E6 carboxyl terminus) E3 and the RING (really 
interesting new gene) -type E3. A HECT E3 receives ubiquitin from an 
E2 and subsequently ubiquitinates the target protein. Alternatively, a 
RING E3 serves more as a scaffolding protein while the E2 
ubiquitinates the target protein. There are many different E2 and HECT 
or RING-type E3 enzymes which lead to a variety of types of 
ubiquitination (Fig.1.1 A±G). As will be seen later, UBLs can also be 
ubiquitinated (Fig.1.1 F). 
 
The third area of the eukaryotic ubiquitin-mediated system is the 
deubiquitination by DUBs for removing ubiquitin tags, editing ubiquitin 
tags or cleaving ubiquitin from ubiquitin precursors. Ubiquitin is 
expressed either as a peptide-linked ubiquitin chain precursor or fused 
to a carboxyl extension protein (CEP) for example the human 
HUBCEPs, CEP80 and CEP5246-48. This area that has only recently 
become the focus in studies due to the realisation that DUBs could 
make excellent therapeutic targets due to their ability to alter the 
activities of target proteins49. Within the fourth area of the eukaryotic 
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ubiquitin-mediated system is the disposal of target proteins by the 
proteasome, a complex structure consisting mainly of proteases. Target 
proteins are recognised by their ubiquitin tag, which the proteasome 
cleaves for recycling and the target protein is processed.  
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Fig. 1.1 A cartoon to show the main components of the eukaryotic ubiquitin-mediated 
system with ubiquitin shown as a yellow sphere, target proteins shown as red ovals and 
cleaved proteins shown by a dashed line. First the activating enzyme (E1) activates ubiquitin 
using ATP and passes the ubiquitin to a conjugation enzyme (E2), which in turn works with a 
ligation enzyme (E3) to ubiquitinate a target protein. There are two types of E3 ligases, the 
HECT (homologous to E6 carboxyl terminus) E3 and the RING (really interesting new gene) 
-type E3. If the E2 works with a HECT E3, then the E2 passes ubiquitin to the E3 and the 
target protein is ubiquitinated by the E3. However, if the E2 works with a RING-type E3 then 
it is the E2 which ubiquitinates the target protein. There are mainly different E2 and HECT or 
RING-type E3 enzymes which leads to a variety of types of ubiquitination (A±G), including 
ubiquitinated ubiquitin like proteins (UBLs), dark blue circles (F). This variety of types of 
ubiquitination adds to the specificity in the targeting of proteins for modulation of cell 
signalling pathways. The ubiquitin tag on proteins for disposal will then be recognised by the 
proteasome, a self compartmentalised protease which deubiquitinates the ubiquitin tag, then 
processes the target protein. The ubiqitin tags liberated by the proteasome will then form 
part of the ubiquitin pool as a chain or is cleaved by a DUB and enters the ubiquitin pool as 
monomers. Alternatively, DUBs also remove ubiquitin tags from ubiquitin precursors or 
target proteins from signalling pathways to be recycled. 
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1,2,2,2 The ubiquitin-mediated system in signalling pathways 
Proteins can be targeted for activation or for the activation of a 
neighbouring protein or deactivation by the eukaryotic ubiquitin-
mediated system as part of a control over cell signalling or in protein 
transport. The tumour necrosis factor (TNF) receptor associated factor 
six (TRAF6) is an example of a protein which once ubiquitinated leads 
to activation of a neighbouring protein within a complex. The inhibitory 
protein NB (INB) is an example of a protein which once ubiquitinated 
becomes inactivated, leading to the activation of the immune response. 
 
TRAF6 and INB are targeted as a control over the nuclear factor NB 
(NF-NB) signalling pathway, in this case the interleukin-NF-NB signalling 
pathway. Fig. 1.2 is a schematic view of the interleukin-NF-kB signalling 
pathway taken from a review by Chen11. NF-NB is a transcription factor 
which is inactive when bound to an inhibitory protein, INB and is found 
in the cytosol. When pathogenic microbes are detected by the host cell 
surveillance systems, as part of an immune response, pro-inflammatory 
cytokines (for example interleukins) bind to toll like receptors (TLRs). 
This triggers a chain of events leading to many key proteins forming 
complexes with the TLRs (in the cytosol). TRAF6 is an E3 which binds 
to this protein complex and becomes self-ubiquitinated with a poly-
ubiquitin chain. This poly-ubiquitin chain binds and activates a kinase 
within a neighbouring protein complex, the transforming growth factor  
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(TGF)-E activated kinase known as the Tak1 kinase complex. The Tak1 
kinase complex is made up of TAK1 binding protein 2 (TAB2) and Tak1 
kinase. The poly-ubiquitin chain binds to TAB2 which leads to the 
activation of Tak1 kinase which phosphorylates the inhibitor of NB 
kinase E (IKKE). This then leads to the targeting of the second example 
of a target protein (INB) mediated by ubiquitination but this time 
resulting in inactivating the protein. Phosphorylated IKKE adds to the 
complex and eventually IKK phosphorylates INB which is then targeted 
for ubiquitination and consequently INB undergoes proteolysis in the 
proteasome. The disposal of INB leaves NF-NB free to move to the 
nucleus resulting eventually in the expression of inflammatory proteins 
used to attack pathogens as part of the immune response.  
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Fig.1.2 A schematic view of the interleukin-NF-NB signalling pathway taken 
from a review by Z.J. Chen and L.J. Sun, to illustrate how ubiquitination and 
deubiquitination exerts controls over a signalling pathway11. In this case the 
NF-NB proteins are p65 and p50. The NF-NB signalling pathway is activated 
by pro-inflammatory cytokines released as part of the immune response. A 
protein complex forms with the TLR. TRAF6, an E3 becomes self-
ubiquitinated with a poly-ubiquitin chain. It is this poly-ubiquitin chain that 
binds to the TAK1 kinase complex leading to the activation of TAK1 kinase 
which in turn phosphorylates IKKE. After IKKE becomes incorporated within 
the protein complex, IKK then phosphorylates INBD which is bound to NF-NB. 
Phosphorylation of INBDtargets it for ubiquitination and consequently 
inactivation as it is then disposed of by the proteasome. The loss of INBD 
allows NF-NB to enter the nucleus and to take part in the transcription of 
genes involved in the immune response for example inflammatory proteins.  
 
Cell 
membrane
Nucleus
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UBLs are also modulators of the activities of targeted proteins in the 
same way as ubiquitin, sometimes with similar or opposing roles to 
ubiquitin. For example, NEDD8 increases the ubiquitinating activity of a 
RING E3, cullin1 (Cul1)50, 51. Cul1 forms a protein complex within the, 
SKP1-CUL1-F-box protein (SCF) E3 ubiquitin ligase complex, E3-
SCFETrCP within the interleukin-NF-Nb pathway. This increased E3 ligase 
activity results in the ubiquitination of INB leaving NF-kB to move to the 
nucleus and transcribe genes associated with inflammatory protein 
expression. 
 
NEDD8 and SUMO-1 are found in a signalling pathway which responds 
to DNA damaged proteins, hypoxia or abnormal proteins by activating a 
tumour suppressor, p53. Activated p53 increases transcription of genes 
associated with cell cycle arrest or apoptosis. This protects the body 
from the proliferation of cells containing mutations, thus preventing 
tumour formation. In a normal cell p53 is tagged with ubiquitin by a 
RING E3, Mdm2 and the E2, Ubc5 to keep p53 inactive or at low levels 
in the cell. There are six lysine residues on p53 available for 
ubiquitination, K370, K372, K373, K381, K382 and K386. At low levels 
of Mdm2 in the cell p53 is mono-ubiquitinated, keeping the tumour 
suppressor inactive. When Mdm2 is at high levels in the cell p53 is poly-
ubiquitinated and undergoes proteolysis by the proteasome (Fig.1.3 A). 
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As part of an extra control over the pathway Mdm2 can also self-
ubiquitinate and be directed to the proteasome for proteolysis93.  
 
NEDD8 affects the activity of p53 within the p53 signalling pathway with 
the same result as ubiquitinating p53. Mdm2 can self-NEDDylate and 
NEDDylate p53, this time using E2, Ubc12 (Fig.1.3 B)18. The NEDD8 
tag on p53 has the same result as a ubiquitin tag, as they both result in 
the inactivation of p53. There is limited information regarding the reason 
p53 has an extra controlling tag (NEDD8) to modulate activity as well as 
ubiquitin.  
 
The SUMOylation of p53 was first demonstrated by M. Gostissa et al 
but this time with the opposite effect of both ubiquitin and NEDD8, 
resulting in activated p53 (Fig.1.3 C)22. Mdm2 was not the SUMOylating 
enzyme, instead the E2, hUbc9 was responsible for the ligation of 
SUMO-1 to p53 in the absence of an E3. Other researchers, L. Chen 
and J. Chen reported that the tumour suppressor, a protein, transcribed 
from an alternate reading frame of the INK4a/ARF locus (ARF) 
regulates p53 SUMOylation52. ARF forms a complex with Mdm2 and 
p53, inhibiting the E3 ligase activity of Mdm2, consequently stabilising 
p53. The ARF-Mdm2-p53 complex is then relocated from the cytosol to 
the nucleolus where p53 is SUMOylated. The details of how p53 is 
SUMOylated and the final effects have yet to be ascertained. There 
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have been reports from other groups which did not see the increased 
activity of p53 with SUMOylation53, 54. However, this was thought to 
have arisen from different assay conditions52. 
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Fig.1.3 A schematic view to show the effects of tagging the tumour suppressor, 
p53 with ubiquitin, NEDD8 or SUMO-1. In a normal cell p53 is continuously 
ubiquitinated on the six available lysine (K) residues shown in (A), by an E3, Mdm2. 
The type of ubiquitination tag depends upon the levels of Mdm2, as indicated but 
both tag types result in the inhibition of p53 transcription activity. This prevents the 
cell from going in to cell cycle arrest or entering apoptosis13. NEDD8 has also been 
demonstrated to modify p53 at K370, K372 and K373 and the effect is the same as 
ubiquitin, to keep p53 inactive18. It is possible that the three sites which are not 
modified by NEDD8 can be ubiquitinated resulting in p53 having a two types of tags 
at the same time. However, there is limited information regarding the significance of 
p53 also having a NEDD8 modification. SUMO-1 has been shown to tag p53 with 
the opposite effect of ubiquitin and NEDD8 tags resulting in the cell entering either 
cell cycle arrest or apoptosis22. There is limited knowledge of the details associated 
with SUMOylation of p53 and the outcomes. 
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1.2.3 The signals which identify the target proteins 
There are three main types of signals which single out proteins to be 
targeted for signalling, transport or disposal: a sequence in the primary 
structure or a domain, a polyphosphate (polyP) tag or an Ssra tag. 
 
The first type of signal, a protein sequence within the primary structure, 
or a domain, is recognised in eukaryotes by an E3, which ubiquitinates 
the protein, targeting it either for proteolysis by the proteasome or for 
modification as part of cell signalling. One example of this is a system 
called the N-end rule, which targets misfolded proteins for proteolysis, 
first described by A. Bachmair, D. Finley and A. Varshavsky55, 56. A 
polypeptide expressed with a degron at the N-terminus is referred to as 
having a secondary destabilising N-terminal residue (Nds). In some 
situations the Nds requires another amino acid residue added by a 
transferase. This amino acid is termed a primary destabilising N-
terminal residue (Ndp). In eukaryotes addition of a Ndp is carried out by 
ATE1-encoded arginyl-transferase (RD,E,C*-transferase) or by aat-
encoded Leu/phe-transferase (L/FK,R-transferase) in prokaryotes5, 57-59.  
Fig. 1.4 summarises the main degrons which target proteins for 
proteolysis in mammals and E. coli. After ubiquitination, N-recognin 
then binds directly to the 19S region of the 26S proteasome and the 
targeted protein undergoes proteolysis. This process was first described 
in yeast60. Another example of a degron in eukaryotes, is the domain 
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rich in proline (P), glutamate (E), serine (S) and threonine (T), the 
(PEST) domain, found in INB, important for degradion by P-calpain 
rather than the proteasome61. There is also the phosphorylation 
dependent degron, DSGXXS, where X = any amino acid (found in INB 
andE-catenin). Both serines in DSGXXS are phosphorylated targeting 
the protein for interaction with ETrCP of SCFETrCP, the protein complex 
reponsible for ubiquitinating proteins targeted for proteolysis62. The 
destruction box (D-box), RXXL (X = any amino acid) is a degron 
recognised by either APC/C-Cdc20 or APC/C-Cdh1 for ubiquitination 
and degradation by the proteasome63. 
 
In E. coli an E3-like protein, ClpS was originally thought to be essential 
for targeting proteins in the N-end rule pathway for proteolysis by ClpAP 
in a way similar to that of E3 recognins1, 64. However later research 
revealed that ClpS was not essential for degradation by ClpAP, as 
ClpAP recognises N-end rule substrates. Instead ClpS was shown to be 
important for modulating proteolysis as ClpS raises the rate of 
proteolysis of N-end rule substrates and can also inhibit this 
proteolysis57.  
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Fig.1.4 N-terminal degradation signals in eukaryotes (mammals) and 
prokaryotes (E. coli). A protein is translated with a secondary destabilising N-
terminal residue (Nds), shown in red. In mammals some tertiary signals (shown 
in black) first have to be modified or converted to an Nds. In some occasions 
another amino acid residue, R is added by a transferase to form a primary 
destabilising N-terminal residue (Ndp), shown in blue. Red ovals represent 
target proteins and coloured boxes contain the amino acid degradation signal. 
Numbers 1 and 2 refer to the substrate binding site within N-recognins which 
bind to the N-degrons shown5-10. Cysteine (C), Asparagine (N), Glutamine (Q), 
Aspartate (D), Glutamate (E), Arginine (R), Lysine (K), Histidine (H), Leucine 
(L), Phenylalanine (F), Tryptophan (W), Tyrosine (Y), Isoleucine (I). 
 Mammals
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In E. coli the second type of signal is the polyP tag used for signalling 
and to target proteins for disposal. The polyP tag is a linear polymer of 
many hundreds of phosphate residues which is attached to target 
proteins by polyP (PPKs). The first reported polyP tags were formed 
part of a stress response in E. coli but now it is generally known that 
polyP tags are also important for their growth and survival65. In E. coli 
the polyP tag becomes attached to a target protein labelling it for 
proteolysis by the Lon protease in response to starvation66, 67. In 
eukaryotes there are many polyP tagged proteins yet little is known of 
their function68. However, there is evidence that polyP plays a role in 
cell growth and proliferation in mammals by targeting a key enzyme, 
mammalian target of rapomycin (mTOR) in the mTOR signalling 
pathway69-71. Insulin and amino acids activate mTOR within the mTOR 
pathway in mammalian cells to initiate translation of genes vital for cell 
growth and proliferation. The PPK within this pathway is thought to tag 
mTOR with polyP which activates mTOR. 
 
The third signal to target proteins in this case for disposal, is only found 
in prokaryotes and involves the co-translational tagging of the C-
terminus of a target polypeptide (Ssra), marking it for proteolysis72. The 
main proteases in E. coli, involved in the recognition of the Ssra tag are 
ClpXP and ClpAP, with ClpXP being responsible for the majority (90%) 
of the degradation of SsrA tagged proteins73. This occurs by a process 
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referred to as trans-translation. During translation a line of ribosomes 
move sequentially along the same mRNA, and if a ribosome stalls it 
needs to be released quickly or it would cause a major obstruction and 
consequently cessation of translation. The ribosome is rescued by a 
transfer messenger ribonucleic acid (tmRNA) which is a dual function 
RNA. This tmRNA is a tRNA charged with alanine (Ala), so is termed 
tmRNAala, and it carries a mRNA sequence coding for a 10 amino acid 
residue peptide (Ssra). The ribosome has two binding sites for tRNA 
molecules: the peptide site (P) for the tRNA bound to the stationary 
polypeptide-mRNA complex and the acceptor site (A) for incoming 
tRNA. Charged tmRNAala moves in to binding site A, providing alanine, 
which causes the mRNA to dissociate from the static polypeptide. The 
ribosome is then free to translate the sequence carried by the mRNA 
resulting in an SsrA tag at the C-terminus of the protein, labelling it for 
subsequent proteolysis. A ribosome can stall either because the mRNA 
lacks a stop codon due to damage, or when it reaches a rare codon 
within a complete mRNA74, 75. 
 
 
1.2.4 Ubiquitination of a target protein 
As shown previously the conjugation of ubiquitin to a target protein 
involves three and sometimes four different enzymes in three steps 
(Fig.1.5). In step 1, E1 catalyses two subsequent biochemical 
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reactions which eventually result in the hydroxyl group on the carbon 
of the D-carboxyl group of ubiquitin being replaced with a better 
leaving group, a thiol (SH). First, E1 activates the carbonyl carbon by 
offering ATP in order to undergo nucleophilic attack by the oxygen 
(reduced) from the hydroxyl group of the C-terminus of ubiquitin to 
form a phosphoryl ester. This eventually results in the covalent 
attachment of the D-carboxyl group of ubiquitin to a sulfhydryl group 
in the H-amino group of a cysteine residue in the active site of E1. In 
the second step ubiquitin is transferred to the active site of a second 
enzyme, E2 which is again bound via a sulfhydryl group of cysteine. 
In the third step ubiquitin, whilst covalently linked to E2 or E3, 
undergoes a nucleophilic attack by the H-amino group in a specific 
lysine residue of the target protein. Activation, conjugation and 
ligation reactions for UBLs occur in a comparable way with those 
involving ubiquitin using, E1-like, E2-like and E3-like enzymes. An E3 
ligase, PafA has been predicted to target proteins with Pup, in the 
eubacterium, Mycobacterium tuberculosis but no other protein 
tagging system has been found in eubacteria. Therefore it is of 
interest to note that homologues of E3 ligases have been found to be 
expressed by pathogenic eubacteria and their function was involved 
in overthrowing the host cell systems. This will be discussed in 
section 1.4. 
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Fig. 1.5 A cartoon to show the 3 steps in ubiquitinating a target protein (red 
oval) with ubiquitin (Ub) as a grey kite shape. In step 1, E1 first activates 
ubiquitin using ATP then the thiol group of cysteine in E1 carries out a 
nucleophilic attack on the carbonyl carbon of ubiquitin. In step 2, A thiol group 
of cysteine from an E2 then carries out a nucleophilic attack on ubiquitin. In step 
3 ubiquitin, whilst covalently attached to E3 or E2 undergoes nucleophilic 
attack, this time from a lysine residue within the H-amino group of the target 
protein. 
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Poly-ubiquitin chain formation sometimes involving a poly-ubiquitin 
chain conjugation factor (E4) can either be built by adding another 
ubiquitin protein (donor) to a lysine residue on a ubiquitin (acceptor) of 
the ubiquitin chain. This is a condensation reaction, shown in Fig.1.6 A. 
This could involve the D-amino group or the H-amino group from one of 
seven possible internal residues in the ubiquitin acceptor: K6, K11, K27, 
K29, K33, K48 and K63 demonstrated in vitro and in vivo76, 77. Fig.1.6 B 
shows ubiquitin as a sphere with all available 7 lysine resides and the 
D-amino group. Ubiquitin is also shown as a kite shape in Fig.1.6 C-F. If 
the D-amino group of the ubiquitin acceptor is used in poly-ubiquitin 
chain building this forms a linear poly-ubiquitin chain with an open 
conformation (Fig.1.6 F). A linear peptide bond exists between 
precursor ubiquitin proteins or is formed post translationally by an E3, 
linear ubiquitin chain assembly complex (LUBAC)78. When the H-amino 
group of the ubiquitin acceptor is used this can result in various poly-
ubiquitin chain isomers or even in chains with mixed linkages.  
 
Poly-ubiquitin chains connected using the same lysine residue on each 
subsequent ubiquitin molecule, for example all k48-linked, or all K63-
linked in poly-ubiquitin chains (Fig.1.5 D and E respectively) have 
different conformations from one another. A K63-linked poly-ubiquitin 
chain is more open compared with a K48-linked poly-ubiquitin chain. 
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However, recent findings have shown that K48-linked poly-ubiquitin 
chains vary with pH and adopts a fully closed conformation at a pH 7.5 
or greater and fully open when pH is 5.4 or less16. Ubiquitin chains can 
also be formed with mixed linkages, for example K48 and K29 can be 
used to form a forked poly-ubiquitin chain79. SUMO chains which have 
been ubiquitinated can also occur80, 81. 
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Fig.1.6 The formation of a peptide bond is a condensation reaction between two 
amino acid residues (1) and (2), with leaving groups shown in blue, to form a 
peptide bond (red) in the building peptide chain (3) and water (A). Ubiquitin is 
shown as a yellow sphere with all 7 lysine (K) residues (with H-amino groups) 
and the D-amino group, all of which can link up with another ubiquitin molecule 
(B). Ubiquitin is also shown as a kite shape which is closer to the ubiquitin 
structure and shows conformations of ubiquitin within different chain isomers 
(C). Ubiquitin chains that are K48-linked adopt a more closed conformation (D) 
when compared with K63-linked and linear ubiquitin chains (E and F 
respectively). 
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The lysine involved in the poly-ubiquitin linkage and the number of 
ubiquitin molecules attached, are critical in determining the resulting 
role of the target protein. A chain of four or more, K48-linked poly-
ubiquitin molecules will direct the target protein to the 26S proteasome 
for degradation82, 83. Alternatively, a K63-linked poly-ubiquitin chain may 
target the protein for involvement in DNA repair, signal transduction or 
endocytosis, for example by establishing new protein-protein 
interactions84. The biological significance of heteropolymeric ubiquitin 
chains has yet to be determined.  
 
 
1.2.5 Deubiquitination of a target protein 
1.2.5.1  The catalytic mechanisms of proteases 
Proteases are enzymes which cleave peptide bonds and are divided in 
to six main groups: serine proteases, threonine proteases, cysteine 
proteases, aspartate proteases, metalloproteases and glutamic acid 
proteases. In order to cleave peptide bonds the protease uses up to 
three reactive functional groups within the active site, including a 
functional group with proton withdrawing, or deproponating properties 
plus a nucleophilic group. If this process involves three (or two) amino 
acid residues then they are referred to as the catalytic triad (or diad). 
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These functional groups are in the side chains attached of the amino 
acids which form the DUB structure.  
 
Proteases are grouped according to the residue which serves as a 
nucleophile or the residue that generates the nucleophile from a water 
molecule. The catalytic triad of serine proteases is made up of 
aspartate (sometimes aspargine), histidine and serine. Aspartate 
deprotonates a nitrogen within a five membered ring of histidine, which 
leads to the other nitrogen within the ring to deprotonate oxygen from 
the hydroxyl group of serine, which generates an oxygen nucleophile 
(Fig.1.7.A)85, 86. Cysteine proteases are not as well understood as 
serine proteases but are known to have histidine and cysteine as key 
amino acid residues within the active site, with sulfur from the cysteine 
residue forming the nucleophile (Fig.1.7.B). Cysteine and histidine have 
been shown to be able to function without aspargine87. The aspartate 
proteases use a catalytic diad made up of two aspartate amino acid 
residues. The oxgyen from a hydroxyl group of aspartate is used to 
generate a nucleophile from a water molecule (Fig.1.7.C). 
Metalloproteases, zinc and an acid residue serve to make the oxygen of 
a water molecule nucleophilic (Fig.1.7.D). Reviewed by E. Erez et al 17. 
In 2004 the glutamic acid protease was discovered in which the amino 
group of glutamine stabilises the substrate whilst the oxygen of the 
hydroxyl group of glutamate deprotonates a water molecule to generate 
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a nucleophile (Fig.1.7.E)20, 88. Later, the threonine proteases were 
discovered, interestingly these proteases use only an D-amino group, 
threonine, to cleave proteins (Fig.1.7.F). Three E-subunits of the 
proteasome (E1,E2 and E5) are known to have threonine catalytic 
sites21, 89. Threonine has two key functional groups, a free amino group 
to serve as a general base with a water molecule and a side chain 
hydroxyl group to form a nucleophile. The main focus for this study is on 
DUBs and ULPs, proteases that form part of the eukaryotic ubiquitin-
mediated system, discussed in the next section.  
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A                                                                      B
C                                                                     D
E                                                                        F
Fig.1.7 Cartoon to show the key amino acid residues within active sites of the six subgroups 
of proteases and how these serve to initiate nucleophilic attack on DUB substrates. An amino 
acid residue within the active site is made nucleophilic (A, B and F), which then carries out a 
nucleophilic attack on the carbonyl carbon of the substrate. A: The mechanism of serine 
DUBs, using a catalytic triad, in which aspartate (sometimes asparagine) uses its oxygen to 
deprotonate a neighbouring nitrogen within the ring of histidine. This leads to the remaining 
nitrogen within the ring of histidine deprotonating oxygen on serine leaving oxygen to serve 
as the nucleophile. B: A cysteine DUB is thought to operate under a similar mechanism to 
that of a serine DUB with sulphur serving as a nucleophile. Threonine proteases use two 
functional groups within threonine plus a water molecule to generate an oxygen nucleophile 
from the hydroxyl functional group of threonine. Aspartate proteases (C), metalloproteases 
(D) and glutamic acid proteases (E) involve processes in which a water molecule is made 
nucleopKLOLF )LJXUHV µ$-'¶ IURP E. Erez etal17 µ(¶ IURP 0 )XMLQDJD et al20 DQG µ)¶ IURP
Orlowski et al21.  
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1.2.5.2 Tag removal as part of the Eukaryotic ubiquitin-mediated system 
As discussed below, DUBs and ULPs are mostly cysteine proteases 
and some DUBs are metalloproteases. DUBs and ULPs operate with a 
similar catalytic mechanism to one another90. During deubiquitination, 
ubiquitin whilst covalently attached to the target protein, undergoes a 
nucleophilic attack by the DUB which eventually leads to a free ubiquitin 
molecule and target protein. DUBs and ULPs are modular, usually 
containing ubiquitin binding domains (UBD). There are more than 
twenty families of UBDs which adds to the complexity of the enzymes 
structure and therefore their binding to substrates and other proteins91. 
 
Table 1.1 shows the seven classes of proteases encoded by 
eukaryotes and which remove protein tags in eukaryotes. Five of these 
classes are DUBs, the first of which is the ubiquitin C-terminal 
hydrolase (UCH), necessary to release ubiquitin from ubiquitin 
precursors92. The other four classes of DUBs are: ubiquitin specific 
proteases (USP) also known as ubiquitin processing proteases (UBP), 
DUBs carrying the ovarian tumour domain (OTU), metalloproteases 
(MM) and DUBs carrying the Josephin domain93-96. The Atg8 
conjugation system is essential for forming autophagosomes in 
autophagy97. Atg4 is the DUB-like enzyme in this system. There are two 
groups of ULPs, the first is SUMO small ubiquitin-like modifier specific 
proteases (SENPs) and the second group of ULP is specific for either 
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NEDD8 or ISG15. The structures of some members of DUB and ULP 
groups have been solved, reviewed98.  
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Protease 
family 
 
 
 
Classification of 
protease 
 
Substrate 
 
Example of DUBs/ULPs 
 
Monomer 
type 
 
Monomer / 
polymer 
 
Eukaryote encoded 
 
Pathogen encoded 
 
C12 
 
UCH 
 
Ubiquitin 
 
Ubiquitin 
precursor 
poly-
ubiquitin 
 
UCHL1, UCHL2 and 
UCHL3 deubiquitinate 
precursor ubiquitin99. 
 
No eubacteria 
encoded 
deubiquitinating 
enzymes have been 
reported of this DUB 
class. 
 
C19 
 
 
 
 
 
C54 
 
USP/UBP 
 
Ubiquitin  
 
 
 
 
 
Atg8 
Mono-
ubiquitin 
/K48-linked, 
K63-linked 
or K29-
linked poly-
ubiquitin 
 
 
Atg8 
monomer 
 
USPs are key DUBs in 
the UPS. CYLD inhibits 
the TNF-mediated NF-NB 
inflammatory response 
 
Atg4 is essential for 
normal formation of an 
autophagosome100. 
 
C64, C85, 
C87 and 
C88 
 
OTU 
 
Ubiquitin  
 
 
Mono-
ubiquitin 
/K48-linked, 
K63-linked 
or K29-
linked poly-
ubiquitin 
 
A20 and otubain1 OTU 
proteases both regulate 
the cell immune 
response101, 102. 
 
 
M67 
 
MPN+/JAMM  
 
Ubiquitin  
 
 
A subunit of the 
proteasome, 
Rpn11/POH1 is a 
JAMM/MPN+ protease. 
 
 
C86 
 
JD 
 
Ubiquitin  
 
 
Ataxin-3, a JD DUB was 
recently shown to edit 
ubiquitin chains of mixed 
linkage3. Ataxin-3 also 
associates with the 
proteasome and Rad23 
which leads to the 
degradation of 
ubiquitinated proteins103, 
104
. 
 
 
C48 
 
 
 
 
ULP 
 
 
NEDD8 / 
ISG15 
 
 
NEDD8 
monomer / 
ISG15 
monomer 
or polymer 
 
 
 
 
 
 
 
 
 
 
 
SGN5 (CSN5) thought to 
be part of CSN complex 
which deNEDdylates 
cullins as a control over 
NF-kB signalling105. 
 
UBP43 removes mono-
ISG15 or poly-ISG15, a 
ubiquitin homologue. 
Cleavage maintains the 
integrity of the blood-
brain barrier106.  
 
Only 3 reported 
eubacterial DUBs, all 
of which inhibit the NF-
NB inflammatory 
response: 
 
1. SseL and AvrA are 
DUBs (Salmonella 
enterica)7, 8. 
 
2. YopJ and YopP are 
DUBs and YopJ has 
also been shown to 
have deSUMOylating 
activity in plant hosts 
(Yersinia pestis and 
Yersinia 
enterocolitica)15, 107 9, 10 
 
3. ChlaDub1 and 
ChlaDub2 are DUBs 
which can also 
deNEDDylate 
(Chlamydia 
trachomatis)6, 108. 
 
ULP SENP 1-3 
 
SUMO 
 
Monomer 
or polymer 
 
ULP1 and ULP2 Cleave 
SUMO-1 from INBD and 
nuclear pore proteins 
(RanGAP1 and 
RANBP2)109. 
 
 
Table1.1 
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Table.1.1 shows the 7 classes of proteases, with examples, for the removal of 
protein tags. The first 5 classes are DUBs: ubiquitin C-terminal hydrolase (UCH), 
ubiquitin specific proteases (USP), DUBs carrying the ovarian tumour domain 
(OTU), metalloproteases (MM), DUBs carrying the Josephin domain. The 
remaining 2 classes are ubiquitin-like proteases (ULPs), small ubiquitin-like 
modifier (SUMO) specific proteases (SENPs) and neural precursor cell expressed 
developmentally down-regulated protein 8 (NEDD8). Some examples of ULPs 
which have DUB activity and are encoded by eubacteria have been included. 
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There is evidence to suggest that DUBs are likely to be closely 
associated with E3 protein complexes responsible for ubiquitination. 
The human genome encodes ninety five DUBs, seventy five of which 
were investigated using a global proteomics analysis of DUBs and their 
complexes, by M. E. Sowa et al110. Twenty six of the DUBs in the study 
were found to be associated with proteins with a role in ubiquitination, 
including HECT E3 and Cullin-based E3 ligases. The close proximity 
between enzymes responsible for such opposing roles, reveals the tight 
controls over the targeting of proteins. Additionally, it was shown that 
six of the DUBs in the study were likely to interact with an AAA ATPase, 
VCP/p97, an enzyme involved in ubiquitin binding and the delivery of 
proteins to the proteasome. 
  
It is clear that from the structures of some DUBs that certain domains 
can enable them to have additional roles to deubiquitinating. Not only 
can DUBs potentially deliver target proteins to the proteasome, one 
DUB, A20 has been shown to have E3 ligase activity. A20 uses its dual 
activities to edit K63-linked poly-ubiquitin chains to K48-linked poly-
ubiquitin chains to negatively regulate the TNF-mediated NF-NB 
pathway111. When stimulated by TNF the TNFR forms protein 
complexes which lead to the ubiquitination and proteolysis of INBD. This 
leaves NF-NB free to move to the nucleus and carry out transcription of 
genes associated with cell cycle arrest or apoptosis, as well as proteins 
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responsible for negative feed back on NF-NB signalling, INBD and A20. 
A20 has an N-terminal OTU domain for DUB activity and seven zinc 
finger structures in the C-terminal domain for E3 ligase activity112, 113. 
A20 binds to a protein receptor-interacting protein (RIP), within the 
TNFR protein complex. First A20 deubiquitinates RIP removing the 
K63-linked poly-ubiquitin chain. A20 then ubiquitinates RIP this time 
with a K48-linked poly-ubiquitin chain, targeting RIP for disposal by the 
proteasome, resulting in the inhibition of the transcription of genes 
associated with cell cycle arrest or apoptosis114-116. This dual function of 
A20 is an indication of the complexity of the roles of DUBs within the 
eukaryotic ubiquitin-mediated system. 
 
 
1.2.5.3 Tag removal for virulence 
As DUBs are often key enzymes within a signalling pathway, activating 
or deactivating key proteins within the pathway, this has lead to an 
interesting mode of virulence by pathogenic microbes. Over recent 
years there has been a steady increase in the number of reports of 
mimics of components of the eukaryotic ubiquitin-mediated system, 
including ULPs, encoded by eubacteria and viruses to take part in 
overriding the host cell systems for pathogenesis. However, viral 
proteins will not be considered here as the focus for this chapter is on 
eukaryotic ubiquitin-mediated systems and similar proteins of 
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eubacterial systems. There are six eubacteria encoded ULPs, AvrA, 
SseL, YopJ, YopP, ChlaDub1 and ChlaDub2 (Table 1.1). Despite being 
classed as ULPs they all primarily prefer ubiquitin as a substrate, 
although YopJ could possibly also act as a deSUMOylating enzyme and 
the ChlaDubs can deNEDDylate proteins. The subject of bacterial 
encoded DUBs for subverting host cell systems will be explored in 
Section 1.4 and revisited again in Chapter 6. 
 
 
1.2.5.4 Substrate specificity of DUBs or ULPs 
DUBs and ULP levels in cells are controlled by transcriptional 
regulation, for example CYLD, the negative regulator of NF-NB 
signalling is also one of the products of this signalling pathway. With the 
varied topologies of ubiquitin substrates there are also DUBs and ULPs 
which are specific to certain types of these topologies. For example, the 
ULP, NEDP1 is specific for NEDD8 and as discussed previously 
(1.2.5.2) A20 is specific for K63-linked poly-ubiquitin117. The activity of 
DUBs and ULPs is also controlled in different ways.  
 
Substrate-induced activity is a process which involves the binding of a 
substrate to an enzyme leading to allosteric changes taking place that 
realign key functional groups (discussed in 1.2.5.1) within the active 
site, to a conformation which favours catalysis. UCH-L3 is a DUB which 
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undergoes substrate-induced activity. The free structure for UCH-L3 
was solved by S.C. Johnston and UCH-L3 bound to a suicide inhibitor 
by a group lead by H.L. Ploegh118, 119. It was noted that a loop crossed 
over the active site of UCH-L3 in the free form but when bound, this 
loop had formed an D-helix and had moved to accommodate the 
VXEVWUDWH+/3ORHJK¶VJURXSWKHQFDUULHGRXWDQLQYHVWLJDWLRQWRVHHLI
the loop was vital for catalytic activity or if it served to restrict the size of 
substrates, as it appears that the substrate has to enter through the 
loop to access the active site120. This study involved the development of 
a new techniquHZKLFK+/3ORHJK¶VJURXSQDPHG µVRUWDJJLQJ¶ZKLFK
involved using an enzyme, sortase to partially digest points within the 
crossover loop which resulted in a loop that had slackened. After 
activation of this partially digested UCH-L3 with suicide inhibitors it was 
demonstrated that UCH-L3 maintained catalytic activity. In the same 
study, the loop was increased in length and it was found that the larger 
the loop the larger the substrate. These findings lead to the conclusion 
that the loop in UCH-L3 was mainly important for restriction on size of 
substrate.  
 
The crossover loop is now thought to be a characteristic of all the UCH 
family of DUBs, however, there are also examples of members of other 
DUB or ULP families that have a crossover loop. For example, a 
member of the USP DUB family, CYLD is known to have a crossover 
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loop and it has been suggested that this may be important for 
determining specificity for K63-linked poly-ubiquitin chains as they 
adopt a more open conformation than K48-linked poly-ubiquitin121. The 
OTU domain DUB family has two members, Otu1 and otubaine-2, 
which are thought to have a crossover loop which forms a E-structure 
when active93. The ULP family also has an example of a protein, 
NEDP1 which has the crossover loop, only in this case it forms a E-
structure in the active form117.  
 
A final example of a DUB which undergoes substrate induced activity is 
the USP, isopeptidase T (IsoT). IsoT recycles mono-ubiquitin from 
unanchored poly-ubiquitin. IsoT has a zinc finger (ZNF) domain, two 
ubiquitin associated (UBA) domains and a USP domain. The ZNF 
domain has a pocket that is specific for the empty C-terminus of 
ubiquitin and only when this is bound can a conformational change 
occur that correctly aligns the catalytic triad to enable catalysis to take 
place122, 123. 
 
DUBs have also been shown to become active when bound to a 
scaffolding protein or an adaptor protein. For example, the proteasome 
associated DUBs, Usp14, Uch37 and POH1 are only active when 
associated with the proteasome124, 125. DUBs have also been shown to 
become post-translationally modified which alters their active state. For 
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example, phosphorylation of A20 a USP which negatively modulates 
NF-NB signalling increases its activity, although it is not known if it is the 
ligase activity or the DUB activity is increased126. This contrasts with the 
phosphorylation of CYLD, another USP which negatively regulates NF-
NB signalling as phosphorylation renders CYLD inactive127. Just as all 
proteins can be ubiquitinated for their disposal, so can DUBs and ULPs. 
However, the Josephine domain carrying DUB, ataxin-3 (ATN3) 
increases in activity when ubiquitinaed128. 
 
Ubiquitin and UBLs often operate in opposing directions in pathways in 
eukaryotes, therefore the integrity of some proteases must be ensured. 
For example, the SUMOylation of p53 by Mdm2 (1.2.2) leads to the 
activation of p53 but the ubiquitination of p53 leads to p53 being 
inactive. Therefore to maintain integrity of each opposing signalling 
pathway there is a need for tag recognition to be distinct for each 
pathway. This is achieved using the protease active site cleft in DUBs 
or ULPs, to recognise motifs in the last five to seven residues of the C-
terminus of ubiquitin or the UBL respectively. The motif in ubiquitin is 
RLRGG, compared with NEDD8 which is RARLGG and the motif in 
SUMO is QQ/EQTGG109, 129. Many DUBs have also been shown to 
have ubiquitin binding domains to add to the specificity of the DUBs for 
ubiquitin, reviewed by D. Komander et al130. This will be discussed in 
more detail in the general discussion. 
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1.2.6 Disposal of a target protein 
Proteins targeted for disposal, from protein quality control systems or 
cell signalling are then delivered to a self-compartmentalised protease 
for proteolysis. Alternatively, proteins targeted as part of selective 
protein degradation via autophagy are transported in an 
autophagosome to undergo proteolysis in a lysosome100. Self-
compartmentalised proteases are found in eukaryotic and prokaryotic 
cells. In eukaryotes these chambered proteases are in the cytosol, 
nucleus or are connected with the endoplasmic reticulum or the 
endoskeleton. In prokaryotes these proteases are thought to be 
cytosolic and associated with the cell membrane.  
 
Typically, self-compartmentalised proteases have three main features: 
First, they are cylindrical; Second, they have a small pore restricting 
access to allow only unfolded proteins into the proteolytic chamber and 
third, Adenosine triphosphate (ATP) is hydrolysed by an ATPase-driven 
chaperone to unfold globular proteins and translocate the substrates 
into the proteolytic chamber. This produces peptide fragments of 10-15 
amino acids. The structures of prokaryotic and eukaryotic self-
compartmentalised proteases are compared in review articles131, 132. 
 
In eukaryotes and archaea the 26S proteasome breaks down ubiquitin 
tagged proteins and is composed of: a 20S catalytic core, the ATPase 
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enzyme, µATPase associated with various cellular activities¶ (AAA) and 
a lid and base at each end, reviewed recently25. The 20S catalytic core 
is formed from D-subunits which mainly form the structure of the 
proteasome and E-subunits which have active sites used in proteolysis. 
There are smaller self-compartmentalised proteases: ClpP, HsIUV, 
FtsH and Lon found in prokaryotes and in the chloroplasts and 
mitochondria of eukaryotes131.  
 
Proteases which are smaller than the eukaryotic 26S proteasome can 
form structures made up of one continuous protein as in the case of Lon 
or FtsH or composed of subunits. In E. coli these compartmentalised 
proteases are constructed of ClpP forming the proteolytic core and ClpX 
or ClpA as the ATPase or chaperone which work together to process 
SsrA-tagged proteins (Table 1.2)133. In these systems the proteins 
which attach the tags are SspB, RssB or the E3-like protein ClpS. ClpS 
has a putative type-2 binding site, normally found in the E3 ligase 
subgroup, N-recognins1, 2. B. Subtilis has ClpP as the catalytic core and 
ClpC as an ATPase or chaperone and the target proteins are tagged by 
MecAb. 
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Proteolytic core 
 
ATPase 
 
Protease 
family 
 
Location in 
cell 
 
Known tags or signals 
for proteolysis 
 
ClpP 
 
 
ClpX 
 
Serine 
 
Thought to be 
cytosolic. 
 
SsrA bound to SspB 
 
ClpP 
 
ClpA 
 
Serine 
 
Polyphosphate tags or 
SsrA bound to SspB. ClpS 
(yljA) regulates 
proteolysis. 
 
 
HSIV/ClpQ  
 
HSIU/ClpY 
 
Threonine 
 
Recognition signals within 
the target protein. 
 
 
Lon 
 
- 
 
Serine 
 
Cytosol 
 
Polyphosphate tags or 
proteins with exposed 
hydrophobic patches. 
 
 
FtsH 
 
- 
 
Metallo-
protease (zinc) 
 
Anchored to 
inner 
membrane 
 
Target proteins which are 
soluble and membrane 
associated and SsrA 
bound to SspB. Proteins 
targeted in response to 
heat shock / DNA 
damage. 
 
 
ClpP Eubacteria,  
B. subtilis 
 
 
ClpC 
 
Serine 
 
Cytosol 
  
Recognition signals within 
the target protein. 
 
20S Eubacteria,  
M. tuberculosis 
 
20S 
In archaea 
 
20S 
In eukaryotes 
 
Arc/Mpa  
 
 
PAN 
 
 
19S  
 
Threonine  
 
 
Threonine 
 
 
Threonine 
 
Cytosol  
 
 
Cytosol  
 
 
Nucleus or 
cytosol, 
associated 
with ER.  
 
 
Pup29  
 
 
Unknown  
 
 
Poly-ubiquitin 
Table.1.2 Self-compartmentalised proteases and associated tagging systems, 
found in eubacteria, Archaea and Eukaryotes1, 2. ClpP, HSIV/ClpQ, Lon and 
FtsH are all in E. coli and in the chloroplasts and mitochondria of eukaryotes. 
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1.3 Microbes which subvert host cell systems 
In Section 1.2 the ways in which proteins are targeted to change their 
activity or for their disposal have been discussed as part of the 
eukaryotic ubiquitin-mediated system in comparison with what is 
currently understood about similar systems in prokaryotes. The 
processes discussed in section 1.2 were those used as part of a 
signalling or protein quality control system important for cell survival. In 
this section it would be pertinent to change focus now to the proteins 
encoded by eubacteria as either virulence factors to subvert host cell 
systems, or to form a symbiotic relationship with the host. 
 
Virulence factors are proteins which are used by pathogenic eubacteria 
to over ride host cell systems. These virulence factors are released 
using needle-like structures so that the host cells can receive them. 
Virulence factors and the needle-like structures are coded for in genetic 
islands, which are either mobile in plasmids or as distinct islands on the 
chromosome. Although in a few cases bacteria have been reported to 
have these secretion systems, they are normally only found in 
pathogenic bacteria, in which the genomic island is referred to as a 
pathogenicity island. Only pathogenic E. coli have been reported to 
have these secretion systems.  
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There are seven main types of needle like structures called Type I ± 
Type VII secretory systems. Fig.1.7 shows these secretory systems, 
taken from a recent review by T. Tseng et al12. The Type II secretory 
system differs from Type I and Type III secretory systems as it modifies 
proteins within the periplasm on route. The pathogenic eubacteria which 
encode DUBs as virulence factors use the Type III secretory system, 
which has been shown to inject the host directly with the effector 
proteins134-136.  
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Fig.1.7 A schematic diagram of Type I, Type II, Type IV (A), Type III and Type, 
IV-VII (B) secretory systems in eubacteria taken from a recent review by T. 
Tseng et al12. Hydrolysis of ATP is used to secrete proteins across the 
membranes. Type I and Type III systems are similar as they involve the 
release of proteins in one step across the periplasm. HM: Host membrane; 
OM: outer membrane; IM: inner membrane; MM: mycomembrane; MFP: 
membrane fusion protein. ATPases and chaperones are shown in yellow. 
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Eubacteria have been shown to express mimics of the eukaryotic 
ubiquitin-mediated system which modulate the host ubiquitin-mediated 
processes as part of virulence. For example P. syringae pathover 
infects plants, using an E3 mimic, AvrPtoB, as a virulence factor to 
GLVDEOH WKH KRVW FHOO¶V VHOI-destruct signal to enter into an apoptotic 
state, therefore leaving the bacterium to replicate undisturbed137. As 
mentioned previously (1.2.5) some pathogenic eubacteria have been 
shown to express DUBs (with E3 mimics in some cases) which are also 
used for virulence.  
 
To date, there have been only 3 pathogenic eubacteria reported to 
express DUBs and do so as part of a Type III secretory system coded 
for on a pathogenicity island. These DUBs serve as virulence factors, 
inhibiting the activity of NF-NB in the eukaryotic interleukin-mediated 
NF-NB signalling pathway. The DUBs achieve this by deconjugating 
K63-linked or K48-linked poly-ubiquitin chains from key proteins 
activators within the NF-kB signalling pathway (Fig.1.2). This results in 
the inhibition of the inflammatory response.  
 
SseL and AvrA are DUBs encoded by Salmonella enterica7, 8. In some 
cases the target proteins for this DUB activity by the virulence factors 
have been established, shown in Fig.1.8. YopJ and YopP are DUBs 
expressed in Yersinia pestis and Yersinia enterocolitica respectively9, 15, 
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107
. YopJ and AvrA target INB, removing a K48-linked poly-ubiquitin 
chain so rescuing INB from disposal by the proteasome. YopJ also 
targets TRAF2 and TRAF6, removing K63-linked poly-ubiquitin chains 
which prevents the phosphorylation of INB and consequently maintains 
the NF-NB in an inactive state, preventing expression of inflammatory 
proteins15. YopP achieves the same result as YopJ but by removing 
K63-linked poly-ubiquitin chains from TRAF6 and NEMO including two 
other proteins in complex with NEMO, IKKD and IKKE9. ChlaDub1 and 
ChlaDub2 are DUBs which can also deNEDDylate and are expressed in 
Chlamydia trachomatis6, 108. ChlaDub1 has been shown to target INB 
removing a K48-linked poly-ubiquitin chain6. 
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Nucleus
YopJ
YopJ
YopP
Proteasome
AvrA
YopJ
ChlaDub1
Inflammatory 
proteins
E3-SCFETRCP
YopP
cell membrane
Fig.1.8 A simplified schematic view of the interleukin-mediated NF-NB signalling 
pathway to show key protein complexes targeted by pathogenic eubacteria 
using DUBs as virulence factors. The NF-NB signalling pathway is activated by 
pro-inflammatory cytokines released as part of the immune response. DUBs are 
shown in red and red dashed lines show deubiquitinating activity. AvrA, YopJ 
and YopP are DUBs expressed by Salmonella enterica, Yersinia 
pseudotuberculosis and Yersinia colitica, respectively15. The result of this 
inhibition of the NF-NB pathway is to inhibit the expression of inflammatory 
proteins which would normally attack bacteria as part of the immune response. 
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1.4 DUB activity observed in non pathogenic E. coli 
In the previous section the expression of mimics of the eukaryotic 
ubiquitin-mediated system, as virulence factors in eubacteria was 
discussed. In the current section the occurrence of a possible DUB 
activity in non-pathogenic E. coli will be considered. There have been a 
few observations in the literature of a possible DUB activity in E. coli as 
well as the discovery of a ULP with DUB activity in E. coli. It is therefore 
interesting to consider what functional role a DUB may have in a 
bacterium that lacks the secretory systems used by pathogenic 
eubacteria for virulence.  
 
There have been a few reports observing intrinsic, low level DUB 
activity in the eubacterium, E. coli. One group reported DUB activity in 
E. coli on two occasions, once when using bacteria to express penta-
ubiquitin, and immunoblotted for ubiquitin, which revealed the break 
down products from penta-ubiquitin: mono-, di-, tri- and tetra-ubiquitin3. 
The second time, a possible DUB activity was observed again, while 
developing a robust ubiquitin fusion protein expression system in E. 
coli138. DUB activity was also observed by A. M. Catanzariti and 
colleagues and demonstrated to be the result of a specific cleavage by 
sequencing4. Another group, A. Ciechanover and colleagues reported 
the eukaryotic elongation factor, EF-1D, a protein identical to their 
protein of interest, factor hedva (FH)139. The authors also mentioned a 
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DUB activity associated with a prokaryotic elongation factor, EF-Tu, a 
protein which co-migrated with the activity. The structure and function of 
elongation factors in the delivery of charged tRNA to ribosomes during 
translation has been fully described 140-142.  
 
Whilst our study was in progress, A. Catic reported the discovery of a 
ULP, elaD expressed in non-pathogenic E. coli, present in E. coli 
substrain K12 and intestinal pathogenic stains but absent from 
extraintestinal strains14. Bioinformatics analysis was used to search for 
new members of the clan containing ubiquitin and ubiquitin-like 
proteases (clan CE) in viruses, bacteria and eukaryotes, which revealed 
the protein, elaD as a potential protease. Two biochemical tests were 
then carried out in vitro, which showed that GST-elaD displayed 
protease activity associated with a DUB or ULP. The first biochemical 
test involved reacting GST-elaD with substrates termed suicide 
inhibitors, which were types of Michael acceptors, vinyl methyl ester 
(VME) or vinyl sulphone (VS). These Michael acceptors were attached 
C-terminal to: ubiquitin, Nedd8 or SUMO. GST-elaD formed an adduct 
with UbVME and to a small extent with Nedd8VS but not SUMOVS. The 
second biochemical test involved incubating GST-elaD with a 
fluorogenic substrate. GST-elaD deconjugated Ub-AMC but not 
SUMO1-AMC or Nedd8-AMC.  
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The discovery of a ULP in E. coli, together with the observations by 
three other groups, of a DUB activity in lab strains of E. coli lead one to 
speculate briefly upon the possible function for a DUB activity in non 
pathogenic strains of E. coli. Eubacteria may possess a ubiquitin-like 
system. However, as mentioned previously (1.2.1), eubacteria do not 
express ubiquitin and the only eubacterium so far, to be shown to 
express a ubiquitin homologue, Pup (6.9 kDa) is Mycobacterium 
tuberculosis29. It is also unlikely that a dePupylating enzyme would use 
the same mechanism as a DUB as Pup is attached to the targeting 
protein differently compared with ubiquitin. In E. coli however, it is still a 
possibility that a UBL and more ULPs have yet to be discovered. 
Alternatively, it is possible that as E. coli is a commensal bacterium 
found in the large intestine that the function of the DUB activity is 
associated with modifying the immune response in some way, to enable 
it to survive. As commensal (non-pathogenic) E. coli do not have 
genetic islands coding for secretion systems, this comes with the caveat 
that elaD must be a secreted effector and needs to enter the host cell in 
some way.  
 
 
1.5 The main aims for this study 
The work in this study started in response to the observation of a 
ubiquitin-fusion processing activity associated with an undocumented 
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DE3 substrain of E. coli, by other members of this group (H. Jefferey 
and I. Kerr) see section 3.2 for further details. This discovery and the 
observations made in the literature indicated that there may be an 
intrinsic DUB-like activity in E. coli or in some of its substrains. At that 
time, no DUB or ULP had been reported in E. coli. These findings 
initiated the current study, to characterise the ubiquitin-fusion 
processing activity in E. coli. 
 
There were four main aims of this study. The first two aims were to 
establish that the ubiquitin-fusion processing activity previously 
observed by H. Jefferey and I. Kerr was demonstrated with the E. coli 
substrain Rosetta2(DE3), then to determine the nature of the 
cleavage as specific DUB-like or non-specific. The third aim of this 
study was, once the type of cleavage was known, to investigate the 
specificity of the ubiquitin-fusion processing activity expressed in E. coli 
substrain Rosetta2(DE3). The final aim was to take a candidate 
approach to identify the enzyme or enzymes responsible for the DUB 
activity observed in E. coli substrain Rosetta2(DE3).  
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2 Materials and methods 
 
2.1 Cells, media and preparation of lysates 
2.1.1 Cells and media 
E. coli substrains used in this study were either XL10 Gold or DH5D (to 
generate clones) and Rosetta2(DE3) to express proteins. The strains 
were grown (37oC) with agitation in Luria-Bertani (LB) broth (1% 
tryptone, 0.5 % yeast extract, 1 % NaCl) (SIGMA-Aldrich) to an optical 
density = 0.6 ± 0.8. Where appropriate ampicillin (100 Pg/ml) was used 
to select for antibiotic resistance. IPTG (50 PM ± 200 PM) was used to 
induce protein expression. E. coli. strain, K12, MG1655, substrain, 
JIG182 was used initially to generate the elaD knockout and was grown 
(300C) with agitation in LB broth to an optical density = 0.6-0.8. Where 
appropriate ampicillin (100 Pg/ml) was used to select for antibiotic 
resistance. Apramycin (35Pg/ml) was used to select for the elaD 
knockout colony. Protein expression was induced by 0.2 % (w/v) 
arabinose. 
 
Lactococcus lactis strain, NZ9000 was used to express the (His)6-Ub-
LmrC construct (made by J. Dorrian) using pNZ8048 which carries a 
nisin promoter to control protein expression. Nisin is a protein which is 
also expressed in L. lactis (see below for the generation of nisin). L. 
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lactis was grown (30oC) without agitation in M17 medium (Merck, 
Darmstadt, Germany) supplemented with 0.5% (w/v) glucose to an 
optical density = 0.6. Chloramphenicol (5 Pg/ml) was used to select for 
antibiotic resistance. Protein expression was induced by addition of a 
culture supernatant from the nisin-expressing strain, nz9700 at a 
volumetric ratio of spent media : culture to be induced, 1: 8000. 
 
Enhanced nisin expression was obtained using plasmid, nz9700 in L. 
lactis. Cultures were grown as described above with no 
chloramphenicol until optical density = 0.9. A clarified lysate was 
prepared as described below and the resulting spent media was used 
for protein induction. Due to variations in concentration of nisin between 
clarified lysates it was necessary to find the volume of nisin to volume of 
culture required for optimum protein induction, which in this study was 
1/8000. 
 
2.1.2 Preparation of cell lysates 
Cell cultures were pelleted, resuspended in TBS (150 mM NaCl, 10 mM 
Tris) unless indicated otherwise and sonicated for 6 x 10s bursts (4oC) 
followed by centrifugation. The resulting supernatant was then used for 
the purposes described later.  
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2.2 Oligonucleotides used in the study and standard 
nucleic acid techniques 
2.2.1 Oligonucleotides used in this study  
See Table 2.1. 
 
2.2.2 Plasmid preparation  
DNA was extracted from the cell lysate supernatant, using plasmid 
preparation kit: QIAprepSpin (QIAGEN). 
 
2.2.3 Obtaining genomic DNA to use as a DNA template in PCR 
A sterile pipette tip was used to scrape a glycerol stock of the bacterial 
culture, in to 50 Pl sterile distilled water. The resulting cell solution was 
then mixed and left at 4oC for 20 min. 
 
2.2.4 Polymerase chain reaction (PCR) and site directed 
mutagenesis (SDM)  
2.2.4.1 PCR using Pfu DNA polymerase (Promega) 
PCRs were carried out using Pfu buffer (20 mM Tris-HCl (pH 8.8 at 
25oC), 10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1 % (v/v) Triton 
X-100 and 0.1 mg/ml nuclease-free BSA), the reactants shown in Table 
2.2.  The PCRs were carried out in a thermal cycler using cycling 
conditions described in Table 2.3.  
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2.2.4.2 PCR using GoTaq® DNA Polymerase (Promega) 
PCRs were carried out using 5X Colourless GoTaq® Reaction Buffer 
(Part# M792A, M792B): Proprietary formulation supplied at pH 8.5. This 
buffer contains 7.5 mM magnesium.  Buffer formula not specified. The 
PCRs were carried out in a thermal cycler using the reactants in Table 
2.2 and conditions described in Table 2.3. 
 
2.2.4.3 SDM  
2.2.4.3.1 SDM using Pfu DNA polymerase (Promega): 
PCR based SDM using the methods described in the QuickChange 
Instruction Manual, Revision A.01 (Stratagene), Pfu DNA polymerase 
(2.2.4.3.1) and the cycling parameters described in Table 2.4. 
 
2.2.5 Further treatment of amplified DNA products: 
2.2.5.1 PCR products for cloning:  
PCR products were either purified using QIAquick PCR Purification Kit 
(QIAGEN) or gel purified by elecrophoresing with DNA standards 200±
10000 bp, SmartLadder (Eurogentec) on a 1% (w/v) agarose gel, 70 V. 
Resulting bands were visualised using UV light and excised using 
sterile a razor blade and the DNA was isolated using QIAquick Gel 
Extraction kit (QIAGEN). 
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2.2.5.2 PCR products for SDM or to generate elaD knock-outs: 
PCR products were incubated with Dpn1 (10 u), 37oC for 1 hr to digest 
the parental DNA template and either introduced in to bacterial cells or 
was ethanol precipitated for creating elaD knock-outs (2.2.8). 
 
2.2.6 Screening for colonies using colony PCR 
Use of colony PCR to screen E. coli. Substrains, K12 and 
RosettaTM2(DE3) for the elaD knock-out. Colonies were purified and 
used to set up LB 1.5% (w/v) Agar Select either without antibiotic, with 
ampicillin (100 Pg/ml) or with apramycin (35 Pg/ml) as follows. A sterile 
pipette tip was used to touch a purified colony and then to inoculate the 
three types of LB Agar select plates above as well as to set up a 
template for colony PCR. The Ampicillin plates were used to check for 
successful curing of the pKD46 plasmid and the non selecting plates 
were used check cell viability in case there were no colonies on the 
other two types of plates. PCR was carried out using GoTaq® DNA 
polymerase, primers, ElaDCHF, ElaDCHR and method described in 
2.2.4.2. 
 
2.2.7 Restriction endonuclease digestion 
Purified DNA (400 ng) was digested with the appropriate pair of 
restriction enzymes (5 u of each), 1-2 hr, 37oC and run with DNA 
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standards 200±10000 bp, SmartLadder (Eurogentec) on an 1% (w/v) 
agarose gel, 70 V.  
 
2.2.8 DNA precipitation for use in generating elaD knock-out in K12 
Chilled ethanol was added to a mixture of sodium acetate (3 M pH 5.2) 
and DNA to volume ratio, 27.5:1:10, mixed then incubated (-20oC) 25 
min. The DNA solution was centrifuged (14,000g), 4oC for 30 min and 
the resulting pellet washed in 70% ethanol (chilled), air dried over night 
and resuspended in sterile water. 
 
 
2.2.9 Ligation 
Gel purified double digested inserts (I) and the appropriately digested 
vector (v) were usually ligated in volume ratios, I : v; 9:3, 6:3, 3:3, 3:9; 
The DNA was ligated in a 20 Pl reaction mix containing: ligase (1.5 u), 
30 mM Tris-HCl (pH 7.8), 10 mM MgCl2, 10 mM DTT and 1 mM ATP, 2 
hr at 20oC 
 
2.2.10 Phage 1 (P1) transduction 
The cell pellet from a 4 ml culture of the recipient strain, 
Rosetta2(DE3) was resuspended in 1 ml of MC Buffer (100 mM 
MgSO4.7H2O, 5 mM CaCl2.2H2O). The recipient cell solution (200 Pl) 
was incubated with Phage1 lysate, 370C for 30 min and the Phage1 
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infection of the recipient strain was stopped using 200 Pl sodium citrate 
(1 M). The infected recipient culture was then mixed with an overlay 
agar (1 % (w/v) Bactotryptone, 0.5 % (w/v) yeast extract, 171 mM NaCl, 
2 mM NaOH) and poured over a 1.5 % (w/v) LB Agar select plate 
containing apramycin (35 Pg/ml).  
 
2.2.11 DNA electrophoresis  
DNA was electrophoresed with DNA standards 200±10000 bp, 
SmartLadder (Eurogentec) on a 1% (w/v) agarose gel, 70 V. 
 
2.3 Transformation  
2.3.1 Transformation of chemically competent bacteria 
2.3.1.1 Preparation of chemically competent bacteria: 
Bacterial cells were grown (30oC) with agitation in LB broth to optical 
density = 0.5-0.8. The cells were pelleted down (4oC) by centrifugation 
(14,000 g) for 5 min, washed in 0.1 M MgCl2 and incubated in 0.1 M 
CaCl2 and incubated (4oC) for 20 min. After a further centrifugation 
(14,000 g) for 5 min the cells were resuspended in chilled 16% (v/v) 
glycerol in 0.1 M CaCl2. 
 
2.3.1.2. Transformation of competent bacteria 
Where appropriate, competent DH5D and Rosetta2(DE3) cells 
(100Pl) were incubated with plasmids (10 Pl), Dpn1 digested SDM 
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product (5 Pl) or ligated vector (10 Pl), as follows; 30 min (4oC); 30 s 
(42oC); 2 min (4oC). LB was added then incubated for 1hr with agitation 
(37oC). Controls included LB only to check for media infections and 
cells (- DNA) to check for cell infections. Cells were grown (37oC) on 1.5 
% (w/v) LB Agar Select. 
 
 
2.3.2 Transformation of bacteria using electroporation in 
generating the elaD gene knock-out JIG182'elaDApr used 
ultimately to make RosettaTM 2(DE3)'elaDApr 
The elaD gene knock-out was first created in E. coli substrain K12, 
MG1655 (JIG182) using homologous recombination to replace elaD 
with an apramycin resistance cassette (AprR). This AprR cassette 
(replacing elaD) was then transferred to RosettaTM2(DE3) using Phage1 
transduction. 
 
2.3.2.1 Preparation of bacteria for electroporation to generate 
JIG182'elaDApr: 
E. coli substrain K12, MG1655 (JIG182) was grown in a 40 ml culture 
(30oC) with agitation in SOB, ampicillin (100 Pg/ml) to optical density = 
0.6. JIG182 were then washed four times in 1 mM HEPES and 
resuspended in 100 Pl 1 mM HEPES. 
2.3.2.2 Electroporation of K12 to make JIG182'elaDApr: 
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Purified DNA (~2 Pg ) was added to 67 Pl of washed bacterial cells in a 
0.1 cm cuvette and the BIORAD Gene Pulser Xcell electroporation 
system supplied a V pulse, 1.7 KV. SOC was added to the cells 
immediately which were then grown on 1.5 % (w/v) LB Agar Select, with 
apramycin (35 Pg/ml), at 42oC to cure the pKD46 plasmid. 
2.3.2.3 Induction of ORed proteins involved in generating 
JIG182'elaDApr: 
E. coli substrain K12, MG1655 (JIG182), carrying pKD46 which codes 
for the ORed enzymes responsible for carrying out homologous 
recombination were used to generate JIG182'elaDApr. JIG182 was 
grown (30oC) in a 40 ml culture, including 0.2% (w/v) arabinose, to 
induce protein expression of the enzymes in the ORed system, with 
agitation in SOB, ampicillin (100 Pg/ml) to optical density = 0.6. 
 
 
2.4 Standard protein techniques 
2.4.1 Affinity purification of (His)6-tagged recombinant proteins  
A bacterial culture, typically 1 L, was grown up as described, 2.1.1 and 
lysates prepared (10 ml) detailed in 2.1.2, but using Wash and 
Equilibration (WE) buffer (50 mM sodium phosphate, 300 mM sodium 
chloride and 10 mM imidazole ACS reagent) in place of TBS (150 mM 
NaCl, 10 mM Tris). Protein purification by either Ni2+ or Co2+ affinity 
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chromatography: 10 ml lysate was then incubated (4oC) on a rotator 
with 1 ml slurry of either Ni2+ or Co2+ affinity resin (Sigma) for 30 min ± 
60 min. The specifically bound, immobilised proteins were washed in 
WE Buffer, then eluted in Elution buffer (50 mM sodium phosphate, 300 
mM sodium chloride and 250 mM imidazole). 
 
2.4.2 Affinity purification of GST-tagged recombinant proteins  
2.4.2.1 Capture of GST-tagged proteins on Glutathione-SepharoseTM4B 
beads 
A bacterial culture, typically 1 L, was grown up as described, 2.1.1 and 
lysates prepared detailed in 2.1.2. Lysate (10 ml) was then incubated 
(4oC) on a rotator with a slurry (1 ml) of Glutathione-SepharoseTM4B 
beads (Amersham) for 1 hr. The specifically bound, immobilised 
proteins were washed in TBS supplemented with Triton X-100 (TBST) 
(150 mM NaCl, 10 mM Tris 0.1% (v/v) Triton X-100 pH 7.5). Alternative 
buffer washes to TBST were also used in an attempt to wash off GroEL 
(Chapter 4): High salt (2 M NaCl, 50 mM Tris 0.1% (v/v) Triton X-100 
pH 7.5), B-PER (100%) and ATP buffer (2 mM ATP, 10 mM MgSO4, 50 
mM Tris-HCl pH 7.4). These buffers were not used for DUB assays as 
they were not appropriate for protein-protein interaction studies. 
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2.4.2.2 Eluting GST-tagged proteins from Glutathione-SepharoseTM4B 
beads 
The specifically bound, immobilised proteins on Glutathione-
SepharoseTM4B beads (captured as described in 2.4.2.2 using TBST 
washes) were incubated (4oC) 30 min rotating in 20 mM reduced 
glutathione in TBS (pH 7.5) (1 ml). 
2.4.2.3 Thrombin cleavage to remove the GST-tag from GST-tagged 
proteins 
The specifically bound, immobilised proteins on Glutathione-
SepharoseTM4B beads (captured as described in 2.4.2.2 using TBST 
washes) were washed in 10 ml thrombin cleavage buffer (TCB) (19.8 
mM Tris base, 149 mM NaCl and 2.5 mM CaCl.2H2O (pH 8.4)) then 
incubated (4oC) 30 min rotating in 1 ml thrombin (5u/500 Pl dry beads) 
in TCB. 
 
2.4.3 Dialysis of purified proteins 
Purified proteins were incubated in dialysis tubing (4oC), stirring over 
night in TBS with 0.1 mM DTT (pH 7.5) (2 L).  
 
2.4.4 Generation of ZNF-Sepharose 4B beads 
Cyanogen bromide activated Sepharose 4B beads were incubated with 
1 mM HCl solution for 15 minutes then washed with coupling buffer 
(100mM NaHCO3, 500mM NaCl, pH8.3 (HCl)). Thrombin cleaved 
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ZNF216 (wild type) was attached to the Sepharose beads by incubating 
rotating (4°C) for 2-3 hours then washed in 1M ethanolamine (pH8) and 
incubated (4°C) in 1 M ethanolamine overnight. This was then followed 
by 3 washes in coupling buffer, one wash with acetate buffer (100mM 
CH3COONa, 500mM NaCl, pH4), followed by three washes with Tris 
buffer (100mM Tris (hydroxymethyl) methylamine, 500mM NaCl, pH8), 
resulting in approximately 8-12mg protein/ml of Sepharose. 
 
2.4.4 Sodium dodecyl sulphate-polyacrylamide gel electrophoresis 
(SDS-PAGE) 
A gradient gel, 5-20% (w/v) acrylamide was made up using a gradient 
mixture; 5% (v/v) acrylamide (0.25 M Tris, and 0.1% (v/v) SDS); 20% 
(v/v) acrylamide (0.25 M Tris, 1.92 M glycine and 0.1% (v/v) SDS). 
Protein samples were incubated (95oC) for 7 min in gel loading buffer 
(GLB) (0.15 M Tris, 8 M urea, 2.5% (w/v) SDS, 20% (v/v) glycerol, 10% 
(v/v) 2-mercaptoethanol, 3% (w/v) DTT, 0.1% (w/v) bromophenol blue 
pH 6.8) and run in electrode buffer (25 mM Tris, 186 mM glycine and 
0.1% (w/v) SDS) at 40 mA.  
 
 
2.4.5 Coomassie staining and destaining 
Staining and destaining gels: Gels were stained by incubating (1 hr) in 
Coomassie Blue stain (50% (v/v) methanol, 20% (v/v) glacial acetic acid 
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and 0.12% (w/v) Coomassie brilliant blue R-250) and destained by 
incubating (over night) in Destain solution (10% (v/v)  methanol and 
10% (v/v) glacial acetic acid). 
 
2.4.6 Transfer of proteins to nitrocellulose membrane for N-
terminal sequencing and for Western blotting (WB) 
Proteins were transferred on to nitrocellulose membrane (NC) 
(Amersham), in transfer buffer (0.025 M Tris, 0.192 M glycine and 20% 
(v/v) methanol pH 8.3), at 40 mA over night, unless stated otherwise. 
The specifically labelled proteins were visualised by incubating the 
membrane (2 min) with Western Lightning® Plus±ECL, Enhanced 
Chemiluminescence Substrate (PerkinElmer), and was used to expose 
photographic film. 
 
 
2.4.6.1 Preparation of proteins for N-terminal sequencing (Edman 
degradation)  
Proteins were electrophoresed as described in (2.4.3) then the gel was 
incubated (15 min), rocking in transfer buffer (CAPs (10 mM) methanol 
(20%) (v/v) pH 11.0), to clear excess glycine. Proteins were then 
transferred on to Polyvinylidene fluoride (PVDF) from Amersham, in 
transfer buffer (CAPs (10 mM) methanol (20%) (v/v) pH 11.0) at 40 mA 
over night. The resulting membrane was washed in distilled water, 
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incubated (2 min) in Amido Black solution (16 mM Amido black, 7.5% 
(v/v), glacial acetic acid 20% (v/v) methanol), shaking, to reveal the 
proteins, then washed in distilled water. The resulting blot was then 
submitted for analysis (Protein and Nucleic Acid Chemistry Facility, 
University of Cambridge). 
 
2.4.6.2 WB for (His)6-tagged recombinant proteins 
The NC membrane was washed in TBST (25 mM TBS, Tween (1:1000 
v/v)) and blocked in 5% (w/v) Marvel in 0.25% (v/v) TBST. The NC 
membrane was washed in TBST before and after incubation with HRP-
labelled mouse anti-hexahistidine antibody (R&D Systems) in TBST 
(1:5000) for 1 hr. The HRP label on the primary antibody negated the 
secondary antibody step normally used in Western blotting. 
 
2.4.6.3 WB for ubiquitin 
The NC membrane was autoclaved (20 min) and blocked (1 hr) with 5% 
(w/v) Marvel in TBS before incubating in anti-ubiquitin primary 
polyclonal antibody from a rabbit, in 5% (w/v) Marvel (1:1000). After 
washing in TBS (10 mM Tris and 150 mM sodium chloride, pH 7.5) the 
NC membrane was incubated in anti-rabbit polyclonal antibody from 
swine in 5% (w/v) Marvel (1:2000), for 1 hr, then washed in TBS.  
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2.4.6.4 WB for GST-tagged recombinant proteins 
The NC membrane was washed in TBST (25 mM TBS, Tween (1:1000 
v/v)) and blocked in 5% (w/v) Marvel in TBST. The NC membrane was 
washed in TBST after incubation with the The HRP labelled mouse anti-
GST antibody (Universal Biologicals) (1:10 000) in 5% (w/v) Marvel in 
TBST for 1 hr. The HRP label on the primary antibody negated the 
secondary antibody step normally used in Western blotting. 
 
 
2.4.6.5 WB for SUMO1 
The NC membrane was washed in TBS and blocked in 5% (w/v) Marvel 
in TBS with 0.1% (v/v) Tween. The NC membrane was washed in TBS 
after incubation with the SUMO1 antibody (mouse anti-GMP-1, Zymed 
Laboratories) in 5% (w/v) Marvel in TBS with 0.1% (v/v) Tween 
(1:1000), 4oC, 15 hr.  
 
2.5 Deubiquitination assays 
(His)6-Ub-LmrC deconjugation assay 
E. coli substrain RosettaTM2(DE3) cell lysate, unpurified proteins: GST-
elaD, GST, PGP9.5 or purified proteins: USP2-core M231 were 
incubated (37oC) with either purified (2.4.1) or unpurified (2.1.2) (His)6-
Ub-LmrC protein (generated in Lactococcus lactis) in TBS with 0.5 mM 
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DTT (pH 7.5) for approximately 15 hr. PGP9.5 and M231 were included 
as positive controls for DUB activity. The reaction was stopped using 
gel loading buffer and the proteins were analysed by western blotting 
for ubiquitin. 
 
Poly-ubiquitin deconjugation assays 
GST-tagged proteins were purified using glutathione-Sepharose 4B 
beads and while still attached to beads were then incubated (37oC) with 
poly-ubiquitin substrates in TBS with 0.5 mM DTT (pH 7.5) for 
approximately 15 hr. Either USP2-core or M231 were included as a 
DUB to serve as a positive control for DUB activity. The reaction was 
stopped using gel loading buffer and the proteins were analysed by 
western blotting for ubiquitin. 
 
2.6 Cloning methods and generating mutants 
2.6.1 Cloning recombinant (His)6-NEDD8-LmrC, (His)6-SUMO1-
LmrC or (His)6-Ub-EGFP using a modified pHUE vector 
DNAs encoding human NEDD8 (GI:4738) and human SUMO1 
(GI:4507801) were supplied in a vector (pZHFN, Invitrogen) by S. 
Dawson; the (His)6-Ub-EGFP encoding human ubiquitin and synthetic 
EGFP were supplied in a vector (pDG268) by D. A. Gray143. PCR 
(2.2.4.1) was used to amplify DNA inserts to include restriction sites at 
WKH¶DQG¶HQGVRIWKHVHTXHQFHVXVLQJ3IX'1$SRO\PHUDVHDQGWKH
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following primers: Nedd8_LmrC_F, Nedd8_LmrC_R, Sumo1_LmrC_F, 
Sumo1_LmrC_R, EGFPinF and EGFPinR (Table 1). Inserts and vector 
were then digested using the appropriate restriction enzymes, NdeI and 
BamHI to make the NEDD8 and SUMOI constructs and NcoI with 
HindIII to make the EGFP construct (2.2.7). The purified (2.2.5.1) 
digested DNAs were then ligated (2.2.9) into the corresponding 
restriction sites of the modified pHUE vector (Fig.2.1).  
Screening for successful (His)6-NEDD8-LmrC, (His)6-SUMO1-LmrC and 
(His)6-Ub-EGFP constructs: DH5D were transformed (2.3.1), with 
ligated vector DNA. The resulting ampicillin resistant colonies were then 
used to inoculate a 10 ml culture (100 Pg/ml Ampicillin) grown over 
night and plasmid purified. The plasmid was double digested as 
described above and run on a 1% (w/v) agarose gel 70 V, to check for 
bands corresponding to inserts. Successful constructs were then 
sequenced. 
 
2.6.2 Cloning recombinant EF-Tu (GST-TufA and GST-TufB) and 
GST-elaD expression vectors 
2.6.2.1 Cloning TufA and TufB into pGEX4T1 
The E. coli elongation factor, EF-Tu is coded for by two genes, TufA 
(GI:147897, protein_id="AAA50993.1) and TufB (GI:297394, 
protein_id="CAA40370.1), both of the resulting proteins are identical 
apart from the final C-terminal amino acid, which is glycine (G) when 
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coded for by TufA and serine (S) when coded for by TufB. The cDNA 
for TufA was amplified by PCR using primers FA and RA (Table 1) to 
LQFOXGHD¶-BamHI VLWHDQGD¶-SalI site, respectively. The cDNA for 
TufB was amplified by PCR using primers FB and RB which again, 
LQFOXGH D ¶-BamHI VLWH DQG D ¶-SalI site, respectively. The DNA 
template used to amplify TufA and TufB was chromosomal DNA 
obtained from E. coli substrain XL10Gold (2.2.3) using PCR mix and 
cycling parameters (2.2.4.1). TufA, TufB and pGEX4T1 vector 
(Stratagene) were then digested using BamHI and SalI (2.2.7) and 
ligated (2.2.9) into the BamHI and SalI sites of pGEX4T1 (Fig.2.2).  
Ligated vector DNA was then used to transform DH5D and 
resulting ampicillin resistant colonies were screened for the generation 
of EF-Tu proteins. Successful constructs were then sequenced. 
 
2.6.2.2 Cloning elaD into pGEX4T1 
The cDNA for elaD was amplified by PCR using primers elaDIF and 
elaDIR (Table 2.1) WR LQFOXGH D ¶-BamHI site DQG D ¶-NotI site, 
respectively from chromosomal DNA obtained from E. coli substrain 
Rosetta2(DE3) (2.2.3) using PCR mix and cycling parameters 
(2.2.4.1). elaD and pGEX4T1 vector (Stratagene) were then digested 
using BamHI and NotI (2.2.7) and ligated (2.2.9) into the BamHI and 
NotI sites of pGEX4T1 (Fig.2.2). The ligated vector was then used to 
transform E. coli substrain XL10Gold and resulting ampicillin resistant 
  
 
82 
 
colonies were screened for the generation of GST-elaD proteins. 
Successful constructs were then sequenced. 
 
 
 
2.6.3 SDM to generate (His)6-Ub-LmrC mutants: GA, GP and GGP 
Mutants of the (His)6-Ub-LmrC construct: GA, GP and GGP were 
generated by carrying out PCR based SDM (2.2.4.1) using the methods 
described in the QuickChange Instruction Manual, Revision A.01 
(Stratagene). PCR was carried out using mutagenic primers designed 
to create mutations in the region linking ubiquitin with LmrC in (His)6-
Ub-LmrC within the pHUE vector (Fig.2.1). Screening for GA, GP and 
GGP carrying colonies was carried out first, by transforming DH5D 
(2.3.1) with DpnI digested (2.2.5.2) SDM DNA product. Two of the 
resulting ampicillin resistant colonies were then used to inoculate a 10 
ml culture (100 Pg/ml Ampicillin), grown over night and purified plasmid 
was sequenced. 
 
2.6.4 SDM to generate GST-elaD mutants: C313S, N227A, W232A, 
D169A 
Mutants of GST-elaD within the pGEX4T1 vector (Fig.2.2): C313S, 
N227A, W232A and D169A were generated by carrying out PCR based 
SDM using Pfu DNA polymerase (Promega) as described in 2.2.4.1 
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with the exception that a 7 min extension time was used followed by a 
final 7 min extension and 18 cycles were carried out. Methods 
described in the QuickChange Instruction Manual, Revision A.01 
(Stratagene) were used. PCR was carried out using mutagenic primers 
designed to create the mutations of elaD within the pHUE vector. 
Screening for mutant carrying colonies was carried out by transforming 
XL10Gold (2.3.1) with DpnI digested (2.2.5.2) SDM DNA product. 
Resulting ampicillin resistant colonies were then used to inoculate a 10 
ml culture (100 Pg/ml Ampicillin), grown over night and purified plasmid 
was sequenced. 
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Primer 
 
Primer sequence with restriction sites 
underlined 
 
Source 
 
Nedd8_LmrC_F 
¶-
GATGGGCAGCGGCCATATGCTAATTAAAG-¶
(NdeI)  
SIGMA-
ALDRICH 
 
Nedd8_LmrC_R 
¶-
CTGCCTAAGACCGGATCCTCCTCTAAGAG-¶
(BamHI) 
SIGMA-
ALDRICH 
 
Sumo1_LmrC_F 
¶-GATGGGCAGCGGCCATATGTCTGACCAG-
¶NdeI) 
SIGMA-
ALDRICH 
 
Sumo1_LmrC_R 
¶-
CTAAACTGTTGAGGATCCCCCCGTTTGTTCC
-¶BamHI) 
SIGMA-
ALDRICH 
 
EGFPinF 
¶-
GGCCGCCCATGGATGAGAGGCAGCCACCA
CCATCAC-¶NcoI) 
SIGMA-
ALDRICH 
 
EGFPinR 
¶-
TGTTGAAAGCTTACTTGTACAGCTCGTCCAT
GCCGAG-¶HindIII) 
SIGMA-
ALDRICH 
 
ElaD IF 
¶-
GCAACTAAAAGGGATCCATGATGGTTACAG-
¶%DP+, 
SIGMA-
ALDRICH 
 
ElaD IR 
¶-
CGAATTGATTGGGCGGCCGCTTAACTCACT
CTTTTGC-¶1RW, 
SIGMA-
ALDRICH 
 
FA 
¶-
GCACAATAGTAAGGAATGGATCCGTGTCTA
AAG-¶%DP+, 
 
µLQKRXVH¶ 
 
RA 
¶-
CTGACTAACGTGGTCGACGCCCAGAACTTT-
¶6DO,)) 
 
µLQKRXVH¶ 
 
FB 
¶-
TCTTAGAGGGAGGATCCATGTCTAAAGAAAA
GTTTG-¶%DP+, 
 
µLQKRXVH¶ 
 
RB 
¶-
AAATGTTATCGGGTCGACGCGCAGAACTTT-
¶6DO, 
 
µLQKRXVH¶ 
 
ElaDKOF 
¶-
ATGATGGTTACAGTTGTCAGCAATTATTGTT
CATGTGCAGCTCCATCAGCA-¶ 
SIGMA-
ALDRICH 
 
ElaDKOR2 
¶-
TTAACTCACTCTTTTGCCGGATGCTCTATTC
CGCCCAGATACAGAAAAGCC-¶ 
SIGMA-
ALDRICH 
 
ElaDCHF 
¶-
CAGCACAACCTTTGCAACTAAAAGGAGCCC-
¶ 
SIGMA-
ALDRICH 
 
ElaDCHR 
¶-
GCTGACTGGTCGAATTAATTAACAATGATG-
¶ 
 
SIGMA-
ALDRICH 
Table 2.1 Oligonucleotides used in this study with suppliers indicated in the table. 
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Table 2.3 PCR amplification conditions used to amplify DNA using either Pfu 
DNA polymerase (Promega) or GoTaq® DNA Polymerase (Promega). PCR 
mixes were then purified using QIAquick PCR Purification Kit (QIAGEN) or gel 
purified using QIAquick Gel Extraction kit (QIAGEN).  
*When amplifying apramycin resistant template to create the elaD knock-out in 
K12 the annealing temperature = 48oC. 
 
 
 
Cycle Step 
 
Temp. 
 
Time 
 
No. of Cycles 
 
Initial 
denaturation 
 
95 0C 
 
2.5 min 
 
1 
 
Denaturation 
 
Annealing 
 
Extension 
 
94 0C 
 
*55 0C 
 
72 0C 
 
 
1 min 
 
1 min 
 
2 min 
 
 
 
30-32 
 
Final extension 
 
72 0C 
 
5 min 
 
1 
 
 
Contents 
 
 
Final Conc. 
 
dNTPs (10 mM) 
 
200 PM of each 
 
¶ Primer (41.6 ng/Pl) 
 
2.5 ng/Pl 
 
¶Primer (41.6 ng/Pl) 
 
2.5 ng/Pl 
 
Template (15.28 ng/Pl)  
 
0.8 ± 2.0 ng/Pl 
 
Pfu DNA polymerase 
 
0.02 U/Pl 
Table 2.2 PCR mix using Pfu DNA polymerase (Promega) were carried out in 
the PCR components shown in the table, within Pfu buffer (20 mM Tris-HCl 
(pH 8.8 at 25oC), 10 mM KCl, 10 mM (NH4)2SO4, 2 mM MgSO4, 0.1 % (v/v) 
Triton X-100 and 0.1 mg/ml nuclease-free BSA). DNA was amplified in a 
thermal cycler. The PCR products were then purified up using QIAquick PCR 
Purification Kit (QIAGEN) or gel purified using QIAquick Gel Extraction kit 
(QIAGEN). The resulting cleaned up and purified DNA inserts were then 
ligated with the corresponding vector. 
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Cycle Step 
 
Temp. 
 
Time 
 
No. of Cycles 
 
Initial 
denaturation 
 
95 0C 
 
30 s 
 
1 
 
Denaturation 
 
Annealing 
 
Extension 
 
95 0C 
 
55 0C 
 
68 0C 
 
 
30 s 
 
1 min 
 
8 min 
 
 
 
14-22 
 
 
 
 
 
Table 2.4 The site directed mutagenesis (SDM) cycling parameters used to 
generate DNA mutants: GA, GP and GGP within the pHUE vector and elaD mutants 
within the pGEX4T1 vector. This PCR based SDM used Pfu DNA polymerase and 
methods described in the QuickChange Instruction Manual, Revision A.01 
(Stratagene).  
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NcoI NdeI                                        BamHI                                  HindIII
ataccATG...CATATGCAGATC...CGCGGTGGAtccgaatccATGGCTGAC....AAAGCTTAGatccggctg
Met      H     M    Q      I         R     G     G s    e   f     M     A    D         K     A   STOP
START 20     1     2      3        74   75    76                     1      2    3       585  586
ubiquitin(His)6 LmrC
PT7
fusion protein: 682 aa(75 kDa)
A
B
Fig.2.1. The pHue vector derived from pET15b (Novagen) was modified by 
Catanzariti A.M.4 to encode the T7 promotor in fusion with N-terminal 
hexahistidine (His)6 and human ubiquitin (Ub) UBA52, shown in (A). The vector 
had been further modified by Kerr I.D. (details not provided) to include lincomycin 
resistance C protein (LmrC) (from the bacterium, Streptomyces lincolnensis) 
which followed immediately after ubiquitin. Specificity of the DUB-like activity in E. 
coli for different fusion proteins was investigated by changing the ubiquitin like 
protein (UBL) for the UBLs, NEDD8 or SUMO1. Additionally the fusion partner, 
LmrC was replaced by enhanced green fluorescent protein. The generation of 
these three alternative fusion proteins was carried out using the region of the 
pHUE vector, shown in (B). This region of DNA was also used to compare the 
catalytic mechanism of the DUB-like activity in E. coli with those of eukaryotic 
DUBs, by introducing mutations at -UbG76-S- . 
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 Fig.2.2. The empty pGEX4T1 vector, 4969 bp (GE Healthcare) used to 
generate glutathione S-transferate (GST) tagged proteins with the 
cloning region available, as indicated. GST-tagged DUB candidates, 
TufA and TufB were cloned into the pGEX4T1 vector using restriction 
sites, 5¶ BamHI and 3¶ SalI and elaD was cloned in using 5¶ BamHI and 
3¶ NotI restriction sites. 
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3 Characterisation of a novel ubiquitin-fusion 
processing activity in the E. coli substrain 
Rosetta2(DE3) 
 
3.1 Introduction 
Ubiquitin or ubiquitin-like (UBL) tags have many roles including 
regulation of protein quality control, function and localisation. 
Knowledge of the systems for controlling the quality of proteins 
expressed in prokaryotes is limited and in bacteria, this does not involve 
ubiquitin. It is known that archaea express ubiquitin26, but bacteria 
(eubacteria) do not. However, there have been a limited number of 
reports observing intrinsic, low level DUB-like activity in E. coli 
expressing ubiquitin fusion proteins. It is common practice to express a 
protein as part of a fusion protein with a UBL (SUMO1 or ubiquitin) as 
the UBL improves folding of the nascent peptide and maintains 
solubility when expressed in bacteria. It is from studies using these 
fusion proteins that observations have been made which conflict with 
the assumption at the time of starting this project (2005), that as 
bacteria do not express ubiquitin, they would not express enzymes 
which specifically cleave a ubiquitin fusion protein.  
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One group has reported DUB-like activity in E. coli on two occasions. In 
1987 E. coli substrain AR58 was used to express linear, penta-ubiquitin 
equivalent to a ubiquitin precursor and immunoblotted for ubiquitin, 
which revealed the break down products from penta-ubiquitin: mono-, 
di-, tri- and tetra-ubiquitin3. Two years later, while developing a robust 
ubiquitin fusion protein expression system, again in E. coli substrain 
AR58, the group observed low level DUB-like activity 138.  
 
On another occasion DUB-like activity was not only observed in E. coli 
substrain BL21(DE3) but also demonstrated to result in specific 
cleavage of a substrate4. DUBs cleave immediately after glycine (G) of 
ubiquitin (Ub) of the C-terminus (UbG76). In this case the authors 
expressed ubiquitin, tagged with polyhistidine, (His)6 residues at the N-
terminus, fused to a broad range of proteins in differing sizes to develop 
a system for high level recombinant protein expression. These included 
two mutants of glutathione S-transferase with M or P at the N-terminus 
(M-GSTP1, P-GSTP1 respectively). Hence, the fusion proteins 
expressed were; (His)6Ub-SUMO; (His)6Ub-M-GSTP1 and (His)6Ub-P-
GSTP1. Interestingly, all the fusion proteins investigated, when 
expressed in E. coli substrain BL21(DE3) were cleaved, except for Ub-
P-GSTP1. The authors confirmed this was a specific activity by protein 
sequencing the cleavage products from (His)6Ub-SUMO and (His)6Ub-
M-GSTP1. The specific DUB-like activity, as well as the resistance of 
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Ub-P to cleave implicates UCH activity. However, two homologues of 
ubiquitin specific enzymes, Unp (mouse) and Unph (human) have been 
reported to cleave a Ub-P bond, verified by N-terminal sequencing, 
suggesting the existence of an alternative DUB mechanism 144. 
 
Further insights to DUB activity in E. coli were gleaned from in vitro 
work carried out by A. Ciechanover and colleagues139, while 
characterising a protein termed factor Hedva (FH). In this case the 
substrate was a core nucleosomal histone (H2A) conjugated to ubiquitin 
via an isopeptide bond, rather than a peptide bond, as in the cases 
mentioned above. The authors reported the inhibition of the DUB-like 
activity from E. coli substrain DH5D in the presence of a UCH inhibitor, 
ubiquitin aldehyde, suggesting that the enzyme is a UCH (one which 
can also cleave isopeptide bonds). Of particular note, this group also 
reported the co-migration of an unexpected candidate for this activity, 
the bacterial elongation factor, EF-Tu. The human elongation factor, 
EF-1Dwas also proposed to harbour the same activity. The structure 
and function of elongation factors in the delivery of charged tRNA to 
ribosomes during translation has been fully described 140-142.  
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3.2 Work leading up to this study 
The starting point for this work was initiated by the observation of a 
ubiquitin-fusion processing activity attributed to an undocumented 
expression strain of E. coli known to be a DE3 strain, by other members 
of this group (H. Jefferey and I. Kerr). Those members were 
investigating the mechanism of antibiotic-resistance-conferring ATP-
binding cassette (ABC) proteins. ABC proteins use the hydrolysis of 
bound ATP to undergo a conformational change which drives the 
transport of ions and macromolecules across the cell membrane. Some 
ABC proteins are associated with antibiotic resistance by pumping 
antibiotics out of the cell. ABC proteins are typically made up of 4 
domains: two transmembrane domains (TMD) which span the 
membrane bilayer and two ABCs also known as nucleotide binding 
domains (NBDs), placed in the cytoplasm145-147. The ABC protein under 
investigation was lincomycin resistance C (LmrC), a twin-NBD protein 
(60 kDa) which lacked TMDs. LmrC is involved in resistance to the 
antibiotic, lincomycin; both LmrC and lincomycin are expressed by the 
bacterium, Streptomyces lincolnensis.  
 
LmrC was over-expressed in a DE3 strain of E. coli as the fusion 
protein, (His)6-Ub-LmrC, with an N-terminal hexahistidine (His)6, by H. 
Jefferey and I. Kerr. The intention was to improve the recombinant 
protein expression level. The expressed (His)6-Ub-LmrC protein was 
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purified by Ni2+-affinity chromatography then resolved using 10 % (v/v) 
SDS-PAGE and stained with Coomassie blue (Fig.3.1). Just below the 
75 kDa band representing the intact fusion protein, a 64 kDa band was 
noted, which was presumed to represent LmrC. Although this cleaved 
LmrC would not have a (His)6 tag for capture during protein purification, 
it is possible that the intact (unprocessed) fusion protein can form a 
dimer with the LmrC cleavage product and so could be co-purified. The 
presence of a 64 kDa band posed the question as to whether it was 
specific DUB-like cleavage. This discovery and the observations of 
others in the literature indicated that there may be an inherent DUB-like 
activity in E. coli or in some of its substrains. Collectively it was these 
findings which initiated the current study, to characterise the ubiquitin-
fusion processing activity in E. coli initially using substrain 
Rosetta2(DE3). 
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 Fig.3.1 A substrain of E. coli, known to be a DE3 strain carrying a pHUE vector, 
sub-cloned with (His)6-Ub-LmrC was grown in LB plus ampicillin (100 Pg/ml) until 
optical density = 0.6-0.8. IPTG (50 PM) was used to induce protein expression. 
The resulting protein was purified using nickel affinity chromatography, 
electrophoresed on a 10% (w/v) acrylamide gel and stained using Coomassie 
Blue stain. A 76 kDa band for (His)6-Ub-LmrC and a lower band representing the 
64 kDa cleavage product, LmrC was noted, confirmed using N-terminal 
sequence analysis. This led to the proposal that the cleavage products resulted 
from DUB cleavage in the DE3 strain of E. coli (H. Jefferey and I. Kerr, 
unpublished). These observations, together with those in the literature led to the 
current study, to characterise the ubiquitin-fusion processing activity in E. coli 
substrain RosettaTM2(DE3).  
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3.3 The aims and objectives of the study 
The aims of this study were fourfold. The initial aim was to demonstrate 
the reproducibility of the observed cleavage of the (His)6-Ub-LmrC 
fusion protein when expressed in E. coli substrain Rosetta2(DE3). 
Then, the nature of the type of cleavage, specific DUB-like or non-
specific had to be determined. Thirdly, once the type of cleavage was 
known, the specificity of the ubiquitin-fusion processing activity 
expressed in E. coli substrain Rosetta2(DE3) was then investigated. 
Finally, a candidate approach was taken to identify the enzyme or 
enzymes responsible for cleaving the (His)6-Ub-LmrC fusion protein 
when expressed in E. coli substrain Rosetta2(DE3). In this chapter, 
the first two aims of the study are explored. The main thrust was to 
investigate specificity using Western blotting techniques, N-terminal 
sequencing analysis, mass spectrometry and site directed mutagenesis 
(SDM). 
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3.4 Results 
 
3.4.1 In vivo cleavage of the (His)6-Ub-LmrC fusion protein in E. 
coli substrain Rosetta'( 
In order to check the reproducibility of the original findings of other 
members of this group (H. Jefferey and I. Kerr), using the same 
procedures as carried out before, (His)6-Ub-LmrC was expressed in E. 
coli substrain Rosetta2(DE3), purified using cobalt affinity 
chromatography and analysed by SDS-PAGE on a gradient gel, 5-20% 
(w/v) acrylamide. Previously, an undocumented expression strain of E. 
coli known to be a DE3 strain, had been used for the expression of 
recombinant protein, therefore the DE3 strain of E. coli, 
Rosetta2(DE3) was chosen for this purpose in the current study. The 
Coomassie stained gel (Fig.3.2 A) has a similar banding pattern when 
compared with the Coomassie stained gel in Fig.3.1 (the findings of H. 
Jefferey and I. Kerr). In Fig.3.2 there is a 75 kDa band for intact (His)6-
Ub-LmrC and a 64 kDa band, presumed to represent LmrC. Therefore it 
is clear from these results that the original findings of ubiquitin-fusion 
processing activity in a DE3 strain in E. coli, were reproducible. In 
support of these results there was a 75 kDa, immunoreactive band 
representing the intact fusion protein when using the ubiquitin antibody, 
yet no immunoreactive band for LmrC (64 kDa) (Fig.3.2.B), which was 
to be expected given that (His)6-Ub would have been removed from 
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LmrC during cleavage. Additionally, these findings also show an 11 kDa 
band which was immunoreactive when probing for ubiquitin, so could 
SRVVLEO\UHSUHVHQWµIUHH¶+LV6-Ub.  
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 Fig.3.2 E. coli, Rosetta2(DE3) cells carrying a pHUE vector, sub-cloned with 
(His)6-Ub-LmrC were grown in LB plus ampicillin (100 Pg/ml) until optical density = 
0.6-0.8. IPTG (50 PM) was used to induce protein expression. The resulting 
protein was purified using cobalt affinity chromatography, electrophoresed on a 
gradient gel 5-20% (w/v) acrylamide and either stained using Coomassie Blue 
stain (A) or transferred on to nitrocellulose membrane and probed for ubiquitin (B). 
It is clear from these results that the original findings of a ubiquitin-fusion 
processing activity in a DE3 strain in E. coli were reproducible in Rosetta2(DE3). 
A 75 kDa band was evident in both the Coomassie stained gel (A) and the 
Western blot (B). The 64 kDa band presumed to represent LmrC was present in 
the Coomassie stained gel, but not when probed for ubiquitin, which was to be 
expected given that (His)6-Ub would have been removed from LmrC during 
cleavage. In addition to providing evidence that this cleavage in E. coli was 
reproducible, these results also show a smaller immunoreactive band (~11 kDa) 
which could represent the cleavage product, (His)6-Ub (B).  
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3.4.2 Investigating the nature of the cleavage of the (His)6-Ub-LmrC 
fusion protein 
To test the proposals in section 3.4.1, that the ubiquitin-fusion 
processing activity was a DUB activity, it was necessary to sequence 
the N-terminus of the 64 kDa protein observed in Fig.3.2.A to determine 
precisely where in the fusion protein cleavage had occurred. This would 
inform about the specificity of the enzyme responsible. This was done 
using a form of N-terminal sequence analysis, termed Edman 
degradation. Purified proteins were separated on a 5-20% (w/v) 
gradient gel and transferred on to Polyvinylidene fluoride (PVDF) 
membrane and stained with Amido Black solution (Fig.3.3). The 
preparation of purified proteins for N-terminal sequence analysis is 
detailed in 2.4.6.1. The circled band (~64 kDa), was submitted for N-
terminal sequence analysis. The N-terminal sequence analysis results 
show a specific DUB cleavage of the fusion protein had occurred, 
immediately after G76 of ubiquitin; the N-terminal sequence of the first 
five amino acids of the 64 kDa protein was found to be SEFMA, which 
is the linker sequence for LmrC that immediately follows G76 of 
ubiquitin. This indicated that a specific DUB cleavage had occurred in 
E. coli substrain Rosetta2(DE3).  
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Fig.3.3. Purified (His)6-Ub-LmrC fusion protein was separated on a 
gradient gel 5-20% (w/v) acrylamide, transferred on to nitrocellulose 
membrane and stained with Amido Black solution. The 64 kDa band 
submitted for N-terminal sequence analysis (Department of 
Biochemistry, University of Cambridge) is indicated (A). 
Chromatogram (B) shows retention times (min) of derivatised amino 
acid standards. (C-G) indicate the derivatised amino acids released 
from the 64 kDa protein to be SEFMA which is the linker sequence to 
LmrC that immediately follows G76 of ubiquitin within the fusion 
protein (H). This revealed that a specific DUB cleavage had occurred 
in E. coli. Substrain RosettaTM2(DE3) after G76 of ubiquitin. 
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3.4.3  Characterising the specificity of the DUB activity in E. coli 
substrain Rosetta2(DE3) by modifying residues around the 
cleavage site in the (His)6-Ub-LmrC substrate 
In order to determine if the DUB activity in E. coli displayed similar 
characteristics to those reported for eukaryotic DUBs, it was necessary 
to generate mutants of the cleavage site of ubiquitin, UbG76x within the 
(His)6-Ub-LmrC fusion protein. Proline (P) as a general rule, is known to 
render fusiRQSURWHLQVUHIUDFWRU\ WRFOHDYDJHLI LQSRVLWLRQ µ[¶RID'8%
site, when expressed in bacteria, yeast or mammals5. There is one 
exception, the Unp enzyme and homologue, Unph144 which is thought 
to operate under a different catalytic mechanism. Therefore, activity 
towards the Ub-P bond could shed light on the catalytic nature of the 
prokaryotic DUB activity. Proline has also been shown to prevent 
cleavage of fusion proteins in studies using a fusion protein containing a 
ubiquitin mutant, UbG76P. One such study, expressed (His)6-Ub fused 
with enhanced green fluorescent protein (EGFP), (His)6-UbG76P-EGFP 
in mammalian cells (D.A. Gray personal communication). A fusion 
protein containing a UbG76A mutant, (His)6-UbG76A-EGFP was also used 
in the same study and was shown to offer no resistance to cleavage in 
mammalian cells. In contrast however, a UbG76A mutant, when fused to 
metallothionein (MT) in the fusion protein, UbG76A-MT perturbed 
cleavage when expressed in yeast148.  
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In the current study the DNA coding for (His)6-Ub-LmrC was mutated in 
the region between ubiquitin and LmrC to determine how the catalytic 
mechanism of the ubiquitin-fusion processing activity in E. coli substrain 
Rosetta2(DE3) compared with mechanisms of eukaryotic DUBs. DUB 
cleavage of (His)6-Ub-LmrC would result in two cleavage products, 
(His)6-Ub and LmrC. The final residues (75 and 76) of ubiquitin are GG 
and the DUB site in (His)6-Ub-LmrC follows the last amino acid (76th) C-
terminal to ubiquitin (UbG76) prior to a serine (S) in a linker at the start of 
the LmrC protein (Fig.3.4). Therefore (His)6-Ub-LmrC can be denoted 
as follows, UbG76-S-LmrC. Two mutants were made by converting UbG76 
within (His)6-UbG76-S-LmrC to either alanine (A) or proline (P) to 
produce mutants, GA or GP respectively. A third mutant (mutant GGP) 
was made by converting the S in (His)6-UbG76-S-LmrC, immediately 
following UbG76, to P. These three (His)6-Ub-LmrC mutants will 
subsequently be referred to a GA, GP and GGP throughout the study 
(Fig.3.4). GA, GP and GGP were generated by carrying out PCR based 
SDM using Pfu DNA polymerase as described in 2.6.3.  
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 Fig.3.4 The fusion protein, (His)6-Ub-LmrC consists of 
hexahistidine (His)6, human ubiquitin (Ub) UBA52 and the full 
sequence for lincomycin resistance C protein (LmrC) from the 
bacterium, Streptomyces lincolnensis. The DNA coding for (His)6-
Ub-LmrC was mutated at the DUB cleavage site to compare 
catalytic mechanisms of the DUB-like activity in E. coli with 
mechanisms of eukaryotic DUBs. The cartoon shows three amino 
acids within (His)6-Ub-LmrC which were each mutated to produce 
three different mutants. The 76th residue of ubiquitin, glycine (G) 
was mutated to either alanine (A) to produce the first mutant, GA, 
or to proline (P) to create the second mutant, GP. The third 
mutant, GA was generated by mutating the serine (S) which 
immediately follows the 76th residue of ubiquitin to P. 
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Wild type (WT) (His)6-Ub-LmrC fusion protein and mutants, GA, GP and 
GGP were expressed in E. coli substrain Rosetta2(DE3), purified and 
analysed by SDS-PAGE on a gradient gel, 5-20% (w/v) acrylamide (Fig. 
3.5) and either stained using Coomassie Blue stain (Fig.3.5.A) or 
transferred on to nitrocellulose membrane and immuno-probed for 
ubiquitin (Fig.3.5.B). A 75 kDa band representing the intact fusion 
proteins was observed for WT and mutants on the Coomassie stained 
gel and the blot. The 64 kDa cleavage product observed in the WT 
sample was not seen in the mutants, however a similar band was 
evident for the mutants but less abundant, particularly for GA, with a 
larger, denatured molecular weight, evident for all three mutants. A 
band corresponding to the smaller DUB cleavage product was only 
present for the WT fusion protein, and a band with a slightly higher 
mass than this was present for all mutants. Without knowing the identity 
of these proteins it was not possible at this stage to know if they were 
DUB cleavage products showing aberrant migration, or if the proteins 
did have a higher mass and were therefore likely to be the products 
from an alternative, non-specific cleavage site. In order to determine the 
true nature of the cleavage of the mutant fusion proteins, N-terminal 
sequencing analysis was used to determine the specific N-terminal 
sequence of the larger bands produced by the mutants in the 65 kDa 
region. Additionally, it was necessary to use protein mass spectrometry 
  
 
105 
 
(MS) to determine the exact masses of the smaller cleavage products 
and by inference, sequences. 
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 Fig.3.5 E. coli, Rosetta2(DE3) cells carrying a pHUE vector, sub-cloned with WT 
(His)6-Ub-LmrC (WT) or one of three mutants GA, GP and GGP were grown in LB plus 
ampicillin (100 Pg/ml) until optical density = 0.6-0.8. IPTG (50 PM) was used to induce 
protein expression. The resulting protein was purified using cobalt affinity 
chromatography, electrophoresed on a gradient gel, 5-20% (w/v) acrylamide and either 
stained using Coomassie Blue stain (A)  or transferred on to nitrocellulose membrane 
and probed for ubiquitin (B). There was a band similar to the 64 kDa protein in the 
mutants compared with WT (with a lower intensity in the mutants). A DUB-like cleavage 
product (11 kDa) was present for WT and a protein band (*) of slightly larger mass than 
to be expected for DUB cleavage was also seen for all mutants.  
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3.4.4 Edman degradation to µSLQSRLQW¶WKHFOHDYDJHVLWHRI the GA,  
 
GP and GGP mutant fusion proteins: Purified GA, GP and GGP were 
separated on a 5-20% (w/v) gradient gel and transferred on to 
Polyvinylidene fluoride (PVDF) membrane and stained with Amido 
Black solution (Fig.3.6). The preparation of purified proteins for N-
terminal sequence analysis is detailed in 2.4.6.1. The circled bands, 
initially assumed to be processed LmrC (~64 kDa), previously detected 
in WT (His)6-Ub-LmrC was submitted for N-terminal sequence analysis. 
The chromatograms in Fig.3.6.B - Fig.3.6.F) indicate the first six amino 
acids of the band analysed from the GA lane, were AAKDVK which 
sequence alignments show is identical to that of the 60 kDa chaperone 
protein, GroEL (Cpn60). GroEL sequence was also present in bands 
from the GP and GGP lanes, data not shown. Therefore these results 
do not provided evidence of LmrC sequence in the ~64 kDa band for 
any of the mutants. It would clearly be informative to determine the 
molecular weights of the smaller bands of the WT, GA, GP and GGP 
cleavage product within the ~11 kDa region. 
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Fig.3.6 (A) Purified (His)6-Ub-LmrC mutant fusion proteins, GA, GP and GGP were 
separated on a gradient gel 5-20% (w/v) acrylamid and the gel was incubated in glycine 
free transfer buffer (2.4.6.1), rocking (15 min), transferred on to nitrocellulose membrane 
and stained with Amido Black. A higher protein load was used this time compared with 
the proteins loaded in Fig.3.5. The protein bands indicated in (A) were submitted for N-
terminal sequence analysis (Department of Biochemistry, University of Cambridge). The 
resulting chromatograms (B-F) show retention times (min) of derivatised amino acids 
released from the GA fusion product, which sequence alignments show is identical to 
that of the 60 kDa chaperone protein, GroEL (Cpn60). GroEL was also present in bands 
from the GP and GGP samples, data not shown. 
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3.4.5 Mass spectrometry to determine the precise mass of (His)6-
Ub and the proteins present in the ~11 kDa region 
MS MALDI-TOF analysis was used to find the exact masses of proteins 
in the ~11 kDa region in purified protein samples expressed by E. coli 
substrain RosettaTM2(DE3), carrying WT, GA, GP or GGP constructs. 
The resulting protein samples analysed will be referred to as WT, GA, 
GP and GGP samples, to indicate the construct that was used to 
generate the protein sample analysed. Fig.3.7A - Fig.3.7D) shows the 
spectra resulting from WT, GA, GP and GGP protein samples analysed, 
respectively, mass (Da) is shown on the x-axis and the percentage of 
maximum peak ion (%) is shown on the y-axis. There are two peaks 
shown for each sample analysed, data also included in Table 3.1. The 
estimated masses (Da) for the predicted (His)6-tagged DUB cleavage 
products for all four samples analysed (WT, GA, GP and GGP) are also 
included in Table 3.1. The masses for theoretical DUB cleavage 
products, after: UbG76, UbA76 and UbP76 in WT, GA or GP respectively, in 
the 11 kDa region (Table 3.2) were estimated for WT and all mutant 
fusion proteins using the onlLQH WRRO µ&RPSXWH S,0Z¶ ([3$6\. 
Masses were estimated using values corresponding to nitrogen as 
IRXQG LQ QDWXUH µQDWXUDO LVRWRSHV¶ These estimated values include 
proteins without an N-terminal methionine as proteins can also undergo 
N-terminal methionine (M) excision (NME), according to the N-End 
rule149. It is evident in Table 3.1 that only the WT sample, analysed had 
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an estimated value, 10596.98 Da (-M) close to an MS peak value, 
10597.6 Da (peak 1) for a DUB cleavage product. This evidence 
supports the findings from N-terminal sequence analysis, showing the 
WT fusion protein was cleaved specifically at the DUB site. However, 
µSeak 1¶ values for all the mutants are larger (by 1062 Da for GGP and 
1052 Da for GA and GP) indicating that these are likely to be products 
from a cleavage site to the C-terminal of the DUB site within the LmrC 
sequence.  
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Fig.3.7 E. coli, Rosetta2(DE3), transformed with (His)6-Ub-LmrC (WT) or 
one of three mutants GA, GP and GGP were grown in LB plus ampicillin (100 
Pg/ml) until optical density = 0.6-0.8. IPTG (50 PM) was used to induce protein 
expression. The protein was purified using cobalt affinity chromatography then 
submitted for analysis by MALDI-TOF mass spectrometry (S. Liddell, 
University of Nottingham) in the ~11 kDa region. The resulting spectra for 
proteins purified from WT, GA, GP and GGP bacterial cultures are shown in (A 
± D) respectively, with mass (Da) is shown on the x-axis and the percentage of 
maximum peak ion (%) is shown on the y-axis. Two peaks and therefore two 
proteins are shown for each of the four protein samples analysed. Table 3.1 
also summarises these results.  
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 Table 3.1 E. coli, Rosetta2(DE3), transformed with (His)6-Ub-LmrC (WT) or one 
of three mutants GA, GP and GGP were grown in LB plus ampicillin (100 Pg/ml) 
until optical density = 0.6-0.8. IPTG (50 PM) was used to induce protein 
expression. The protein was purified using cobalt affinity chromatography then 
submitted for analysis by MALDI-TOF mass spectrometry, in the ~11 kDa region. 
There were two peaks for each protein sample submitted for analysis, summarised 
in the table. 7KH RQOLQH WRRO µ&RPSXWH S,0Z¶ ([3$6\ was used to estimate 
molecular masses (MM) of proteins predicted to be generated by precise cleavage 
after G76, A76 or P76 of indicated proteins (Da). A post-translational modification 
of proteins, involving the N-terminal excision of methionine (M) can occur as part 
of the N-HQGUXOHVRYDOXHV IRU WKLV µPRGLILHG¶FOHDYDJHSURGXFW ± M) have also 
been estimated. Masses were estimated using values corresponding with nitrogen 
DV IRXQG LQ QDWXUH µQDWXUDO¶ LVRWRSHV 7KHVH HVWLPDWHG YDOXHV IRU WKH FOHDYDJH
product were then compared with those from the MS results (peak 1). It is evident 
from these data that the estimated mass, 10596.98 Da (-M) from the WT sample, 
is very close to the mass, 10597.6 Da, from the MS results (peak 1). This 
suggests accurate DUB cleavage occurred with the WT fusion protein, supporting 
the findings from N-terminal sequence analysis (Fig.3.3). However, none of the 
estimated masses are similar to masses from the MS results (peak 1) for either, 
GA, GP or GGP samples analysed, which would indicate that in this case the 
cleavage products did not result from specific DUB cleavage. 
 
 
 
Construct 
 
MM of proteins predicted to be 
generated by precise cleavage 
after G76, A76 or P76 of 
indicated proteins (Da) 
 
MS analysis of proteins in the 
~11 kDa region (Da) 
 
Unmodified 
(+ M) 
 
Modified  
(± M) 
 
Peak 1 
 
Peak 2 
 
WT 
 
10728.17 
 
10596.98 
 
10597.6 
 
10775.8 
 
GA 
 
10742.19 
 
10611.00 
 
11662.7 
 
11840.9 
 
GP 
 
10768.23 
 
10637.04 
 
11688.6 
 
11866.8 
 
GGP 
 
10728.17 
 
10596.98 
 
11658.8 
 
11836.8 
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In order to ascertain that the ~11 kDa bands seen in mutant proteins in 
Fig.3.5, resulted from an alternative cleavage site, the masses of 
proteins predicted from proteolysis at different positions within the LmrC 
sequence were calculated. This indicated an alternative cleavage site 
was located 10 aa C-terminal to the DUB site, in all mutants, (see 
cartoon in Fig.3.8). The MS data confirmed the WT fusion protein 
cleaved specifically at the DUB site when expressed in E. Coli substrain 
Rosetta2(DE3), which supports the evidence obtained by N-terminal 
sequencing. Therefore only the WT fusion protein was specifically 
cleaved by the prokaryotic DUB activity, suggesting that this activity 
XVHVDµFRQYHQWLRQDO¶FDWDO\WLFPHFKDQLVP7KHVHFRQGODUJer peak (by 
178 Da) observed in Fig. 3.7 for WT and mutant samples analysed by 
MS was likely to be a modified form of the cleavage product. When 
expressed in E. coli (His)6-tagged proteins have been shown to undergo 
D-N-6-phosphogluconoylation of hexahistidine which results in the extra 
mass of 178 Da150. At the time of writing, the Merops database was 
used to search for a peptidase that would recognised the second 
cleavage site and no peptisae was found. 
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DUB
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GGP
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LmrC
LmrC
LmrC
LmrC
Fig.3.8 A cartoon to show two cleavage sites within wild type 
(His)6-Ub-LmrC (WT), GA, GP and GGP fusion proteins, when 
expressed in E. coli substrain RosettaTM2(DE3). The first cleavage 
site is a DUB site immediately following UbG76 and the second 
cleavage site is 10 amino acids downstream of the DUB site, 
within LmrC. WT was shown by N-terminal sequence analysis as 
well as MS analysis to cleave specifically at the DUB site. In 
contrast, GA, GP and GGP were all demonstrated, using MS 
analysis to cleave non specifically, at the second site. The 
absence of DUB cleavage of GA, GP and GGP by the DUB 
activity in E. coli. substrain RosettaTM2(DE3) suggests that the 
'8% DFWLYLW\ XVHV D µFRQYHQWLRQDO¶ FDWDO\WLF PHFKDQLVP At the 
time of writing, the Merops database did not have a peptidase 
which recognised the second cleavage site. 
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3.4.6 Further characterising of the DUB activity in E. coli substrain 
Rosetta2(DE3) by replacing either one of the fusion proteins 
within the (His)6-Ub-LmrC fusion protein 
Having revealed a conventional catalytic mechanism in the DUB activity 
from E. coli substrain Rosetta2(DE3) the next step was to change the 
fusion partners within the fusion protein to investigate any preferences 
of the DUB activity for a particular fusion protein. This could potentially 
shed light on the type of substrate that this prokaryotic DUB activity 
normally targets. The UBLs, SUMO1 or NEDD8 were used to replace 
ubiquitin, and EGFP was used to replace LmrC (Fig. 3.9).  
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 Fig.3.9 Cartoon to show the changes made to (His)6-Ub-
LmrC (A) to construct three alternative fusion proteins (B-
D). The changes were made to the region of DNA encoding 
(His)6-Ub-LmrC in the pHUE vector. Ub was replaced with 
either SUMO1 (B) or with NEDD8 (C). To construct the third 
fusion protein (D), LmrC was replaced with enhanced green 
fluorescent protein (EGFP). This was performed to 
investigate any differences in specificity that the DUB 
activity in E. coli may have for these alternative fusion 
protein substrates. 
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3.4.6.1 Construction of (His)6-NEDD8-LmrC, (His)6-SUMO1-LmrC and 
(His)6-Ub-EGFP to investigate specificity of the DUB activity in E. coli 
substrain RosettaTM2(DE3) 
The ubiquitin cDNA sequence was exchanged for the UBLs, NEDD8 or 
SUMO1. Changing only the UBL within the (His)6-Ub-LmrC fusion 
protein could potentially reveal any possible high affinity the prokaryotic 
DUB activity could have for either of the UBLs. The change from 
ubiquitin to NEDD8 would be a subtle one regarding size and 3D 
characteristics, as NEDD8 has a high sequence identity (58%) to 
ubiquitin, is identical in size to ubiquitin and carries the same features 
as ubiquitin, the GG C-terminal and ubiquitin superfold. A preference for 
ubiquitin over NEDD8 may indicate that ubiquitin is the true substrate 
for this prokaryotic DUB enzyme or enzymes with a function related to 
subverting host cell systems.  The residue following NEDD8 and 
SUMO1 was S, just as it was in the fusion protein with ubiquitin and the 
residue following Ub in the (His)6-Ub-EGFP fusion protein was M. 
 
The constructs encoding (His)6-NEDD8-LmrC, (His)6-SUMO1-LmrC and 
(His)6-Ub-EGFP were made as follows (detailed in 2.6.1). NEDD8 (256 
bp), SUMO1 (322 bp) and (His)6-Ub-EGFP (990 bp) cDNAs were 
amplified to include appropriate restriction sites. The resulting DNA 
products and pHUE vector were separated by agarose gel 
electrophoresis, see Fig.3.10.A and double digested with the 
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appropriate enzymes (ODEHOOHG µCut¶ LQFig.3.10.B and Fig.3.10.C). Gel 
purified inserts were then ligated with the appropriately cut vector which 
was subsequently used to transform E. coli substrain DH5D with the 
ligation product. The purified plasmid from the resulting colonies was 
then screened for the presense of an insert using the appropriate 
restriction enzymes in a double digest (Fig.3.10.D). It was evident that 
all three constructs were coded for by the clones being screened, 
verified by sequencing. A very faint band was shown for double 
digested NEDD8 (227 bp) and SUMO1 (290 bp). A stronger band was 
seen for (His)6-Ub-EGFP (978 bp). Purified plasmid was then used to 
transform E. coli substrain Rosetta2(DE3) for induction of 
recombinant protein expression. 
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Fig.3.10 All figures (A ± D) show DNA electrophoresed on 1% (w/v) 
agarose gels. The three constructs generated for this study, (His)6-
NEDD8-LmrC, (His)6-SUMO1-LmrC and (His)6-Ub-EGFP were generated 
first, by amplifying NEDD8, SUMO1 and (His)6-Ub-EGFP with restriction 
sites, shown in (A). The PCR products and vector, pHUE containing 
(His)6-Ub-LmrC, shown in (B and C) were then double digested (cut) or left 
uncut. Double digested DNA products were ligated and used to transform 
E. coli DH5Dthen grown over night on LB agar plates + ampicillin (100 
Pg/ml) (37oC). Resulting colonies were grown over night in 10 ml cultures 
(37oC) and plasmid extracted using a kit, QIAprepSpin (QIAGEN). 
Successful clones were screened using a double digest to reveal the 
presence of the insert (size/bp) in the form of a second band (D). In this 
case the gels for NEDD8 and SUMO1 are the negative images in order to 
show the inserts which are feint bands. 
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3.4.6.2 Expression of fusion proteins, (His)6-SUMO1-LmrC, (His)6-
NEDD8-LmrC and (His)6-Ub-EGFP in E. coli substrain Rosetta2(DE3)  
Recombinant proteins, including (His)6-Ub-LmrC were expressed in E. 
coli substrain Rosetta2(DE3), purified and analysed by SDS-PAGE 
on a gradient gel, 5-20% (w/v) acrylamide and transferred on to 
nitrocellulose membrane and probed for either hexahistidine 
(Fig.3.11.A, B and D) or or SUMO1 (Fig.3.11.C). The (His)6-Ub-EGFP 
and (His)6-Ub-LmrC fusion proteins were shown to have undergone 
cleavage to produce a single band (11 kDa). There was no band for the 
expected DUB cleavage product for either (His)6-NEDD8-LmrC (11 
kDa) or (His)6-SUMO1-LmrC (13 kDa), however there were many bands 
noted below (His)6-SUMO1-LmrC which could be products of non-
specific proteolysis. The cleavage of the (His)6-Ub-EGFP as well as WT 
(His)6-Ub-LmrC could imply that ubiquitin is very similar to the natural 
substrate for the E. coli DUB activity. The UBL, NEDD8 is very close to 
ubiquitin in sequence (58% identity) and is the same size (76 aa), but 
curiously NEDD8 was not cleaved from its fusion partner, LmrC. The 
lack of cleavage of the (His)6-SUMO1-LmrC fusion protein would 
suggest that the DUB activity in E. coli substrain Rosetta2(DE3) does 
not normally target any protein analogous to SUMO1. These results 
provide evidence for a conservative DUB activity, expressed by E. coli 
substrain Rosetta2(DE3) which has a natural substrate close to 
ubiquitin. The next thing considered was the possibility that this DUB 
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activity was only observed in E. coli and not in other bacterial strains; to 
test this supposition Lactococcus lactis was included in the study. 
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(His)6-Ub-EGFP
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75 kDa
11 kDa
Anti-hexahistidine Anti-hexahistidine
(His)6-NEDD8-LmrC
75 kDa
11 kDa
Anti-hexahistidineAnti-SUMO1
Fig.3.11 E. coli, Rosetta2(DE3) cells carrying a pHUE vector, 
sub-cloned with either, (His)6-Ub-LmrC, (His)6-Ub-EGFP, (His)6-
SUMO1-LmrC or (His)6-NEDD8-LmrC were grown in LB plus 
ampicillin (100 Pg/ml) until optical density = 0.6-0.8. IPTG (50 PM 
for the NEDD8 and SUMO1 carrying clones and 100 PM for the 
EGFP clones) was used to induce protein expression. The 
resulting proteins were purified using cobalt affinity 
chromatography, electrophoresed on a 5-20% (w/v) gradient gel, 
transferred on to nitrocellulose membrane and probed for either 
hexahistidine (A, B and D) or SUMO1 (C). The (His)6-Ub-LmrC 
and (His)6-Ub-EGFP fusion proteins underwent DUB cleavage to 
produce a single band (11 kDa). There was no band for the 
expected cleavage products for either His)6-NEDD8-LmrC (11 
kDa) or (His)6-SUMO1-LmrC (13 kDa). It is evident that there are 
many bands in (C) which could be products of non-specific 
proteolysis. 
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3.4.7 Investigating the possibility that DUB activity in E. coli was 
species specific 
The observed DUB activity could be exclusive to the E. coli bacterial 
strain. To investigate this possibility the Lactococcus lactis substrain, 
NZ9000 a gram positive, lactic acid bacterium was also analysed. 
Recombinant protein expression of (His)6-Ub-LmrC sub cloned into the 
pNZ8048 vector (constructed by J. Dorrian, School of Biomedical 
Sciences) was induced in this strain using nisin (2.1.2) and purified 
using cobalt affinity chromatography. Purified proteins were then 
analysed by SDS-PAGE on a gradient gel, 5-20% (w/v) acrylamide, and 
transferred on to nitrocellulose membrane and probed for ubiquitin 
(Fig.3.12). The (His)6-Ub-LmrC fusion protein, when expressed in L. 
Lactis substrain NZ9000 was not cleaved at all (Fig.3.12.B) compared 
with when it was expressed in E. coli substrain RosettaTM2(DE3) 
(Fig.3.12.A). This indicates that the DUB activity is species specific. 
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Protein expressed 
in L. lactis 
substrain NZ9000
Protein 
expressed in 
E.coli substrain
RosettaTM2(DE3)
(His)6-Ub-LmrC (His)6-Ub-LmrC
(His)6-Ub
 Fig.3.12 The WT fusion protein, (His)6-Ub-LmrC was expressed in one of two 
different bacterial strains, E. coli substrain RosettaTM2(DE3) (A) or Lactococcus 
lactis substrain NZ9000 (B). The resulting protein was then purified using cobalt 
affinity chromatography, electrophoresed on a gradient gel 5-20% (w/v) 
acrylamide, transferred on to nitrocellulose membrane and probed for ubiquitin. 
An immunoreactive band (11 kDa) was evident in proteins generated in E. coli (A) 
but not from those generated in L. lactis, suggesting that this DUB activity was 
strain specific. 
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3.5 Discussion 
This work shows that the E. coli substrain Rosetta2(DE3) has an 
intrinsic, specific DUB activity similar to eukaryotic DUBs. The cleavage 
of (His)6-Ub-LmrC fusion protein by the DE3 strain of E. coli observed 
by other members of this group (H. Jeffery and I. Kerr) was shown to be 
reproducible in the present study when expressed in E. coli substrain 
Rosetta2(DE3) (Fig.3.2). The precision of this DUB cleavage was 
confirmed using N-terminal sequence analysis (Fig.3.3) and MS 
(Fig.3.7, Table 3.1). These findings agree with the observations of other 
workers and with Catanzariti et al. who also used N-terminal 
sequencing analysis to confirm specificity of intrinsic DUB cleavage in 
E. coli substrain AR58. In the present study, the use of (His)6-Ub-LmrC 
mutants, GA, GP and GGP, mutated at the DUB site to investigate 
VSHFLILFLW\XOWLPDWHO\VKRZHG WKHSURNDU\RWLF'8%DFWLYLW\KDGD µDUB 
activity similar to that of eukaryotic DUBs. However, there is a caveat 
associated with the use of this particular fusion protein. In addition to 
the DUB site within (His)6-Ub-LmrC we showed that there was also a 
second, non-specific cleavage site 10 aa, C-terminal to the DUB site in 
LmrC (see cartoon in Fig.3.8).  
 
A cleavage product, slightly higher in mass than the (His)6-Ub (~11 
kDa) was observed in the GA, GP and GGP samples analysed for MS 
MALDI-TOF in Fig.3.7. The resulting masses for proteins found in the 
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11 kDa region of all the samples analysed were compared with 
estimated masses for possible DUB cleavage products (Table 3.1). This 
clearly demonstrated that the bands observed in Fig.3.5, lanes 
indicated GA, GP and GGP, were not the products of DUB cleavage. 
Instead, these were products from a non-specific cleavage site 10 aa C-
terminal to the DUB site. It is interesting to note that there is no 
evidence in the data obtained from either N-terminal sequencing 
analysis or MS that WT (His)6-Ub-LmrC undergoes cleavage at the 
second site. This absence of cleavage of the second site within WT 
(His)6-Ub-LmrC could imply that for some reason the second site is only 
accessible while the DUB site is not being processed. It is likely that 
when the DUB site is not accessible that this drives the use of the 
second non-specific site by another bacterial enzyme. It is also possible 
that the second cleavage site is rendered unobtainable to the non-
specific enzyme due to steric hindrance from the DUB activity as the 
two sites are only 10 aa apart. It is also possible that the mechanism of 
proteolysis that takes place depends upon some signal for example the 
removal of an N-terminal residue by the N-end rule. For example the 
DUB activity may be favoured if it occurred co-translationally while the 
non-specific protease may have to have an additional signal for 
proteolysis in the form of the removal of the N-terminal M by the N-end 
rule. 
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The finding in the present study that the GG-P bond was not cleaved by 
the DUB activity in E. coli substrain, Rosetta2(DE3) implies that this 
prokaryotic DUB activity has an activity comparable to eukaryotic DUBs. 
The lack of cleavage of the GP mutant fusion protein by the DUB 
activity in Rosetta2(DE3) shows that the catalytic mechanism is 
similar to that of a mammalian DUB (D. A. Gray personal 
communication). Gray and co-workers expressed a UbG76P mutant 
within the fusion protein, (His)6-UbG76P-EGFP in mammalian cells and 
found it also resisted cleavage. Interestingly, in the present study, GA 
resisted cleavage in E. coli substrain Rosetta2(DE3) which is a 
characteristic more comparable with yeast DUBs. T. R. Butt reported 
the resistance of a fusion protein, UbG76A-metallothionein to cleave 
when expressed in yeast148. The (His)6-UbG76A-EGFP fusion protein 
offered no such challenge to the mammalian cell system (D. A. Gray) 
further highlighting differences between prokaryotic and eukaryotic 
cells.  
 
Characterisation of the DUB activity in E. coli substrain 
Rosetta2(DE3) was investigated by replacing either one of the fusion 
proteins within the (His)6-Ub-LmrC fusion protein. The DUB activity in E. 
coli substrain Rosetta2(DE3) did cleave (His)6-Ub-EGFP but not 
(His)6-NEDD8-LmrC or (His)6-SUMO1-LmrC (Fig.3.11). The amino acid 
which follows immediately after G76 of the UBL at the DUB site within 
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(His)6-NEDD8-LmrC  and (His)6-SUMO1-LmrC is S, the same as in WT 
(His)6-Ub-LmrC. The amino acid following the last G in the UBL at the 
DUB site within (His)6-Ub-EGFP was M. The ability of the DUB activity 
to cleave (His)6-Ub-EGFP as well as WT (His)6-Ub-LmrC would appear 
to denote a close similarity between ubiquitin and the natural substrate 
for this prokaryotic DUB activity. Nonetheless, neither of these fusion 
proteins underwent complete DUB processing, as was evident by the 
presence of the intact fusion proteins in both cases (Fig.3.11 & Fig.3.5 
A&C). The absence of cleavage of either of the fusion proteins 
containing UBLs, NEDD8 or SUMO1, (His)6-NEDD8-LmrC or (His)6-
SUMO1-LmrC respectively, could also signify a close relationship of 
ubiquitin to the natural substrate for the prokaryotic DUB activity. There 
is a high sequence identity when comparing NEDD8 with ubiquitin (58% 
identity) and both UBLs have the features associated with ubiquitin, a 
flexible diglycine C-terminus and the same three-dimensional structure 
with a E-grasp fold.  
 
A constraint over the complete processing of the fusion proteins could 
be due to a lack of specificity of the prokaryotic DUB activity for a 
pDUWLFXODU µVXE-W\SH¶ RI D SHSWLGH ERQG 'XULQJ WUDQVODWLRQ RI XELTXLWLQ
gene products (precursors) the D-carboxyl group of ubiquitin becomes 
condensed with the D-amino group of the neighbouring ubiquitin. 
Conversely when ubiquitin is attached post translationally to a protein, 
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the D-carboxyl group of ubiquitin is condensed the H-amino group of the 
target protein, forming an isopeptide bond. Some DUBs discriminate 
between the two types of bonds and it is possible that the DUB activity 
observed in E.coli substrain Rosetta2(DE3) prefers isopeptide bonds. 
Of course it is also possible that more than one type of DUB activity 
occurs in E. coli. Another possible restriction over the complete 
processing of (His)6-Ub-LmrC and (His)6-Ub-EGFP fusion proteins by 
the DUB activity could be explained by the ability of LmrC and EGFP to 
form homo-dimers. It is possible that the cleaved LmrC or EGFP can 
bind to intact fusion protein, preventing access by the DUB to the DUB 
site. In Fig.3.5 (A) it is clear that there is a near equal amount of intact 
and cut (His)6-Ub-LmrC protein and that this equal stoichiometry is 
evidence that of such a dimer. 
 
This study has revealed that the DUB activity observed in E. coli 
substrain Rosetta2(DE3) was strain specific. No DUB processing of 
WT (His)6-Ub-LmrC occurred when this protein was expressed in L. 
lactis (Fig.3.12). The second site was also not cleaved in L. lactis which 
shows a real difference between the strains of bacteria. However, the 
possibility that the DUB activity is also substrain specific has not been 
ruled out as DUB activity has only been observed in or associated with, 
the E. coli substrains; Rosetta2(DE3) in the current study and in 
DH5D, AR58 and BL21 during work carried out by other groups3, 4, 138. 
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This work has demonstrated that the E. coli substrain, Rosetta2(DE3) 
expressed a DUB or DUBs with a specific DUB mechanism similar in 
some ways to conventional eukaryotic DUBs, in not cleaving GG-P 
bonds. However, this bacterial DUB activity shares characteristics in its 
catalytic mechanism with both mammalian and yeast DUBs as it is 
unable to cleave either UbG76P or UbG76A, respectively when expressed 
within a fusion protein. Further work needs to be carried out to 
determine if the bacterial DUB activity shows discrimination between 
the two types of bond, peptide, or isopeptide. Additionally, a candidate 
approach may allow identification of the DUB enzyme or enzymes 
responsible for the DUB activity observed. 
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4 A candidate approach to identify the prokaryotic 
enzyme responsible for the DUB activity in E. coli 
substrain RosettaTM2(DE3)   
 
4.1 Introduction 
In Chapter 3, it was first established that the DUB activity in a DE3 
strain of E. coli was reproducible in E. coli substrain RosettaTM2(DE3) 
and occurred using specific DUB cleavage. The DUB activity was then 
shown to have an activity similar to eukaryotic DUBs, comparable to 
eukaryotic DUBs in addition to preferring ubiquitin as a substrate over 
SUMO1 and NEDD8. This having been achieved, the impetus was then 
to establish the identity of the DUB activity in E. coli substrain 
Rosetta2(DE3) using a candidate approach. 
 
The first DUB candidate considered was the E. coli elongation factor 
EF-Tu. This was a natural starting point following on from a report by A. 
Ciechanover and colleagues139. Their work concerned the 
characterisation of a protein, factor Hedva (FH) in which they also 
reported that the eukaryotic elongation factor, EF-1Dhad a DUB 
activity, in vitro which deubiquitinated a histone, H2A. Additionally, the 
authors noted that the prokaryotic elongation factor, EF-Tu, expressed 
by E. coli substrain DH5D, was also associated with this DUB activity, 
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as EF-Tu co-migrated with H2A. Therefore this DUB activity was 
associated with cleavage of an isopeptide bond rather than with the 
peptide bonds so far considered in the current study. In the present 
study, it was shown in Chapter 3 that not all of the substrate was 
cleaved by the DUB activity in E. coli substrain Rosetta2(DE3). This 
lead to the speculation that the DUB activity in E. coli substrain 
Rosetta2(DE3) may prefer an isopeptide bond rather than a peptide 
bond found in linear fusion proteins. The association of EF-Tu with a 
DUB activity made this a good candidate to investigate in the 
identification of the DUB activity observed in our E. coli substrain 
Rosetta2(DE3) study. Eukaryotic (rat) EF-1D Type 2 (EF1D2) was 
also included in this study, to compare both eukaryotic and prokaryotic 
elongation factors. 
 
Whilst this work was in progress the second DUB candidate considered 
was the E. coli protein, elaD. A group led by H. L. Ploegh, discovered a 
protein, elaD expressed in E. coli substrain K12, BL21 with DUB 
activity14. Bioinformatics was used to search for new members of the 
clan containing ubiquitin and ubiquitin-like proteases (clan CE) in 
viruses, bacteria and eukaryotes, which revealed the protein, elaD as a 
potential protease. Two subsequent biochemical tests, carried out in 
vitro, showed that GST-elaD displayed DUB activity with substrates 
termed suicide inhibitors as well as with the fluorogenic substrate Ub-
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AMC. The suicide inhibitors used were mouse UBLs, ubiquitin and 
SUMO-1 and Nedd8 which were modified to have a µdiverting¶ group for 
attack, a Michael acceptor, adjacent to the nucleophilic centre normally 
favoured by DUBs. The use of suicide inhibitors demonstrated that elaD 
favoured ubiquitin as a substrate over SUMO-1 and Nedd8. This 
particular preference for Ub as a substrate is a characteristic that elaD 
shares with the DUB activity investigated in the current study. As a 
result of these findings elaD was included as a candidate for the DUB 
activity in E. coli substrain Rosetta2(DE3).  
 
The work covered in this chapter discusses cloning of the two DUB 
candidates, EF-Tu and elaD, a gene knock-out of elaD and a ubiquitin-
Sepharose (ubiquitin-Sepharose) binding assay to select for candidates 
that bind to mammalian ubiquitin. 
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4.2 Results 
 
4.2.1 The cloning of GST-tagged candidates EF-Tu and elaD, for 
the DUB activity in E. coli substrain RosettaTM2(DE3)   
The aim of the work discussed in this chapter was to use a candidate 
approach in an attempt to identify the DUB activity in E coli. substrain 
Rosetta2(DE3) observed in Chapter 3. The initial objective was to 
create constructs for the over-expression of GST-tagged DUB 
candidates, EF-Tu and elaD in E coli. substrain XL10Gold. The next 
objective was to use the GST-tagged candidates in ubiquitin binding 
assays in vitro, to see if any candidate binds to ubiquitin (many DUBs 
have this property).  
 
Initially, the DNA sequence for elaD in E. coli substrain 
RosettaTM2(DE3) was sequenced then used in an alignment with the 
sequence for elaD (in E. coli substrain K12) reported by A. Catic14. This 
confirmed that the elaD sequences from RosettaTM2(DE3) and K12 
were identical. The cDNAs encoding EF-Tu (43 kDa) and elaD (45 kDa) 
proteins were cloned into pGEX4T1 in three main steps, detailed in 
2.6.2. In the first step, inserts were amplified by PCR. Two genes code 
for EF-Tu in E. coli µTufA and TufB¶ DQG WKH SURteins translated from 
them, TufA and TufB differ only in the last amino acid residue: TufA has 
G and TufB has S. The amplified TufA and TufB inserts are shown in 
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Fig.4.1.A and amplified elaD in 4.1.B. The resulting TufA and TufB PCR 
products were then used as a DNA template for a subsequent PCR 
Fig.4.1.B to increase product concentration. In the second step, purified 
PCR products and vectors were double digested using appropriate 
restriction enzymes and separated by electrophoresis Fig.4.1.C. In the 
third step, the purified, double digested DNA inserts and corresponding 
double digest vectors, were ligated and used to transform E. coli 
substrain XL10Gold. The purified vector from the resulting colonies was 
then screened using appropriate pairs of restriction enzymes in a 
digest. All three constructs coded for a candidate shown in Fig.4.1.D 
and were verified by DNA sequencing. The cDNAs encoding eukaryotic 
elongation factors, GST-EF-1D1 and GST-EF-1D2 proteins were cloned 
into pGEX4T1 by J. R. Cavey, University of Nottingham. 
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 Fig. 4.1 cDNAs encoding the candidates for the DUB activity, EF-Tu and elaD 
were inserted in to the pGEX4T1 vector to place a glutathione transferase 
(GST) tag at the N-terminal of the candidate. EF-Tu is coded for by two near 
identical coding regions, termed TufA and TufB. The TufA and TufB proteins 
differ only in the final amino acid, glycine in TufA and serine in TufB. (A ± D) 
show DNA electrophoresed on 1% (w/v) agarose gels. First, candidates were 
amplified with restriction sites (A), TufA PCR product was used as a template 
in a subsequent PCR to increase DNA concentration (B). The PCR products 
and veFWRU ZHUH WKHQ GRXEOH GLJHVWHG µCut¶ RU OHIW XQFXW (C) with sizes (bp) 
indicated. Double digested DNA products were ligated and used to transform 
E. coli substrain XL10Gold, then grown over night (37oC) on LB agar plates 
(100 Pg/ml ampicillin). Resulting colonies were grown over night in 10 ml 
cultures, with agitation (37oC) and plasmid extracted using a kit, Q1AprepSpin 
(QIAGEN). Successful clones were screened using a double digest to reveal 
the presence of the insert (of the same sizes indicated in C) in the form of a 
second band, see (D).  
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4.2.2 Over-expression of DUB Candidate proteins: GST-TufA, GST-
TufB, GST-elaD and eukaryotic elongation factors, GST-EF-1D1, 
GST-EF1-D2 
GST-tagged proteins were over-expressed (2.1) in E. coli substrain 
XL10Gold. Purified GST-tagged protein (2.4.2.1) was eluted in gel 
loading buffer and electrophoresed on a gradient gel, 5-20% (w/v) 
acrylamide gradient (2.4.4) and either stained with Coomassie blue 
stain (Fig.4.2.A and Fig.4.2.C.2) or transferred on to nitrocellulose 
membrane and probed for GST (Fig.4.2.B and Fig.4.2.C.1). GST-TufA 
and GST-TufB bands (68kDa) are shown on the Coomassie stained gel 
(Fig.4.2.A) and when probed for GST (Fig.4.2.B). Two weak bands (~68 
kDa) were seen on Coomassie stained gel (A), either could potentially 
be GST-elaD. Therefore the bands (i) and (ii), indicated in (Fig.4.2.B), 
were submitted for Peptide Mass Fingerprint analysis and resulting 
sequence matches showed that (i) represented GST-elaD and (ii) was a 
60 kDa chaperone protein, GroEL (Cpn60). It is interesting that GroEL 
did not co-purify with TufA or TufB proteins. The proteins in (Fig.4.2.A) 
and (Fig.4.2.B) were expressed from a 10 ml culture and the weak band 
for GST-elaD shows that this is expressed at low levels compared with 
GST-TufA and TufB. The product from a 50 ml culture was then 
electrophoresed as described above resulting in a stronger band (~69 
kDa) for GST-elaD on the Coomassie stained gel, which was also 
immunoreactive with the GST probe (Fig.4.2.C). There was a high level 
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of expression of GST-TufA and GST-TufB. This indicates a need to 
optimise GST-elaD expression and purification. 
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Fig. 4.2 DUB candidate proteins, GST-TufA, GST-TufB and GST-elaD were 
expressed in E. coli substrain XL10Gold and grown in LB plus ampicilin (100 
Pg/ml) until optical density = 0.6-0.8. IPTG (200 PM) was used to induce protein 
expression. The resulting protein was purified using glutathione-Sepharose 4B 
beads, eluted in gel loading buffer, electrophoresed on a gradient gel 5-20% (w/v) 
acrylamide and either stained using Coomassie Blue stain (A and C.2) or 
transferred on to nitrocellulose membrane and probed for GST (B and C.1). Bands 
(68 kDa) representing GST-TufA and GST-TufB are shown on the Coomassie 
stained gel (A) as well as when probed for GST (B). Two weak bands (~69 kDa) 
were seen on Coomassie stained gel (A), one of which was thought to be GST-
elaD. The bands indicated in (B), (i) and (ii) were submitted for Peptide Mass 
Fingerprint analysis and resulting sequences and subsequent sequence 
alignments showed (i) represented GST-elaD and (ii) was chain A of GroEL. The 
proteins in (A) and (B) were expressed from a 10 ml culture and the weak band for 
GST-elaD shows that this is expressed at low levels compared with GST-TufA and 
TufB. The recombinant protein from a 50 ml culture of XL10Gold was then purified 
and electrophoresed as described above resulting in a stronger band (~69 kDa) for 
GST-elaD on the Coomassie stained gel, which was also immunoreactive with the 
GST probe (C). It is evident that the antibody to GST cross-reacted with the GroEL 
protein (C). 
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4.2.3 Improving purification and yield of the DUB candidate, GST-
elaD protein 
It was evident, in Fig.4.2 (A and C) that GST-elaD protein expression 
was relatively low compared with that of GST-TufA and GST-TufB, thus 
it was necessary to increase elaD protein yield. An effort was also made 
to remove the 60 kDa protein, GroEL which co-purified with GST-elaD.  
 
4.2.3.1 Increasing the induced yield of DUB candidate, GST-elaD 
protein 
GST-elaD was expressed in E. coli substrain XL10Gold, grown in LB 
plus ampicillin (100 Pg/ml) until optical density = 0.6-0.8 (Fig. 4.3). A 
range of IPTG concentrations (50 PM - 200 PM) were used to induce 
protein expression at two different temperatures and times, 37oC, 3 hr 
or 20oC, over night. The resulting protein was purified using glutathione-
Sepharose 4B beads, washed in TBS, eluted in gel loading buffer, 
electrophoresed on a gradient gel 5-20% (w/v) acrylamide, transferred 
on to nitrocellulose membrane and probed for GST. There was a limited 
improvement in yield of GST-elaD protein when the culture was induced 
with 150 PM IPTG, over night at 20oC (Fig. 4.3 band B), compared with 
conditions used previously, 200 PM IPTG, 3 hr at 37oC (Fig. 4.3 band 
A). Therefore the new growth conditions were chosen for future use.  
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Fig. 4.3 To increase the yield of GST-elaD, protein expression was optimised 
by varying the concentration of IPTG and temperature. elaD protein was 
expressed in E. coli substrain XL10Gold, grown in LB plus ampicilin (100 
Pg/ml) until optical density = 0.6-0.8. A range of IPTG concentrations (50 PM - 
200 PM) were used to induce protein expression at two different temperatures, 
37oC, 3 hr or 20oC, over night. The resulting protein was purified using 
glutathione-Sepharose 4B beads, washed in TBS, eluted in gel loading buffer, 
electrophoresed on a gradient gel 5-20% (w/v) acrylamide, transferred on to 
nitrocellulose membrane and probed for GST. None of the conditions 
produced a significant increase in yield of elaD. However when comparing the 
band for maximal elaD protein (B) with the band of elaD induced in the 
conditions used previously, 200 PM IPTG, 37oC 3hr (A) there was a limited 
improvement in the induction of elaD protein. Therefore future inductions of 
GST-elaD were carried out at 150 PM IPTG, 20oC over night. The antibody to 
GST was also seen to cross-react with GroEL as it did in Fig.4.2. 
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4.2.3.2 Removing GroEL from purified GST-elaD protein with the aim to 
produce homogenous pure protein 
It was necessary to produce purified GST-elaD without GroEL as GroEL 
was present in the purified sample in relatively large amounts and the 
antibody to GST cross-reacts with GroEL. GST-elaD protein was 
expressed in E. coli substrain XL10Gold, grown in LB plus ampicillin 
(100 Pg/ml) until optical density = 0.6-0.8. IPTG (200 PM) was used to 
induce protein expression at 37oC for 3 hr. For protein purification, 
lysates were made up either as described in (2.1.3) or with 0.1% (v/v) 
Triton X-100 in TBS. Other washes (High salt, a mild non-ionic 
detergent: bacterial protein extraction reagent (BPER) 
(ThermoScientific) and ATP) were also tested, data not included 
(2.4.2.1) but they were not conducive to protein-protein interaction 
studies or enzyme studies. The resulting purified proteins were 
electrophoresed on a gradient gel 5-20% (w/v) acrylamide and stained 
with Coomassie blue stain (Fig. 4.4). Triton X-100 was sufficient in 
removing GroEL protein from the purified GST-elaD as can be seen 
when compared with TBS - Triton X-100 and therefore was chosen for 
subsequent elaD protein purification. 
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Fig. 4.4 Protein purification conditions were varied to remove GroEL, a 60 kDa 
protein which co-migrated with GST-elaD. GST-elaD protein was expressed in E. coli 
substrain XL10Gold, grown in LB plus ampicilin (100 Pg/ml) until optical density = 0.6-
0.8. IPTG (200 PM) was used to induce protein expression, 37oC, 3 hr. The resulting 
protein was purified using glutathione-Sepharose 4B beads in TBS, either in the 
presence, or absence of 0.1% (v/v) Triton X-100. Purified GST-elaD was 
electrophoresed on a gradient gel 5-20% (w/v) acrylamide and stained using 
Coomassie Blue stain. Triton X-100 was used in subsequent purifications of GST-
elaD as it succeeded in washing off GroEL. 
  
 
144 
 
4.2.4 An assay to screen the DUB candidates for the ability to bind 
with ubiquitin 
In Chapter 3, an in vivo DUB activity was observed when (His)6-Ub-
LmrC and  (His)6-Ub-EGFP substrates were expressed in RosettaTM 
2(DE3). This meant that the DUB activity could recognise and bind to 
ubiquitin in some way in order to cleave the ubiquitin fusion proteins. 
Therefore an initial assay was chosen to investigate and triage DUB 
candidates, TufA, TufB and elaD using a test for the ability to bind to 
ubiquitin in a pull-down assay. As well as the DUB candidates, 
eukaryotic EF-1D2 was also included in this study, to compare both 
eukaryotic and prokaryotic elongation factors and GST as a control. 
 
GST-tagged proteins were over-expressed as described in 2.1, with the 
exception that GST-elaD induction was carried out using 150 PM IPTG 
followed and incubated (20oC) for 15 hr. Lysates were prepared in 0.1% 
(v/v) Triton X-100 in TBS as described 2.1.2. Protein was captured 
using a bead slurry (100 Pl) of either, glutathione-Sepharose 4B beads 
(glutathione-Sepharose), ubiquitin-Sepharose or Sepharose and 
incubated (4oC) rotating for 1 hr, then washed with 0.1% (v/v) Triton X-
100 in TBS. Proteins were eluted off the beads using gel loading buffer, 
electrophoresed on a gradient gel 5-20% (w/v) acrylamide, transferred 
on to nitrocellulose membrane and probed for GST (Fig.4.5). A non-
specific protein indicated (*) which cross reacted with the GST antibody, 
  
 
145 
 
was present for all candidates as well as EF-1D2 and GST. All 
candidates were captured on glutathione-Sepharose 4B beads and it is 
evident that GST-elaD was the only DUB candidate to bind to ubiquitin-
Sepharose. None of the candidates, GST or EF-1D2 bound to 
Sepharose control beads. These results provide evidence for elaD 
being a candidate for the DUB activity observed in RosettaTM2(DE3). 
Therefore the next step was to create an elaD gene knock-out in E. coli 
substrain RosettaTM2(DE3) and to express (His)6-Ub-LmrC and (His)6-
Ub-EGFP in Rosetta2(DE3)'elaDapr to determine if the in vivo DUB 
activity ceased in the absence of elaD expression. 
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 Fig. 4.5 E. coli substrain XL10Gold, transformed with constructs coding for GST-tagged DUB 
candidates or GST as indicated were grown in LB plus ampicillin (100 Pg/ml) until optical 
density = 0.6-0.8. IPTG (150 PM) was used to induce GST-elaD protein expression, 200 PM 
IPTG was used to induce the other GST-tagged DUB candidates and GST. Cultures expressing 
GST-elaD were incubated (20
o
C) for 15 hr, other DUB candidate and GST expressing cultures 
were incubated (37
o
C) for 3 hr. Lysates were prepared in 0.1% (v/v) Triton X-100 in TBS as 
described 2.1.2. Protein was captured using either glutathione-Sepharose 4B beads (Glut-
Seph), Ub-Seph or Seph and incubated (4
o
C) rotating for 1 hr, then washed with 0.1% (v/v) 
Triton X-100 in TBS. Proteins were eluted off the beads using gel loading buffer, 
electrophoresed on a gradient gel 5-20% (w/v) acrylamide, transferred on to nitrocellulose 
membrane and probed for GST. A non-specific protein indicated (*) was present for all 
candidates including EF-1D2. All candidates were captured on glutathione-Sepharose beads 
and GST-elaD was the only DUB candidate to bind to ubiquitin-Sepharose. Non of the DUB 
candidates, GST or EF1D2 bound to Sepharose control beads. This provides evidence for elaD 
being a strong candidate for the DUB activity observed previously in Rosetta
TM
2(DE3). 
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4.2.2 Generation of the elaD knock-out, RosettaTM 2(DE3)'elaDApr 
to investigate further the possibility that elaD may be responsible 
for the DUB activity observed in this E. coli substrain  
In order to generate the elaD gene knock-out in E. coli substrain 
Rosetta2(DE3) a three step method was used. This method involved 
knocking out elaD in one strain of E. coli (K12) and then this gene 
knock-out characteristic was transferred to the desired strain of E. coli 
(Rosetta2(DE3)), developed by K. A. Datsenko and B. L. Wanner and 
subsequently adapted by E. Bolt (Fig. 4.6)151.  
 
First the antibiotic cassette, in this case coding for resistance to 
apramycin (AprR) was amplified using PCR to include the beginning and 
the end of elaD, the sequence to be knocked out (Fig.4.6.A). Within the 
second step, the E. coli substrain K12, MG1655 (JIG182) underwent 
two subsequent transformations, first with pKD46 then with AprR DNA. 
The vector, pKD46 codes for the ORed enzymes which carry out 
homologous recombination, essentially replacing DNA sequences, elaD 
with an AprR cassette (Fig.4.6.B) to generate JIG182'elaDApr. Colonies 
were screened for JIG182'elaDApr using colony PCR. In the final step, 
Phage 1 transduction (also involving homologous recombination) was 
used to transfer the elaD gene knock-out characteristic from 
JIG182'elaDApr to create RosettaTM 2(DE3)'elaDApr. Colony PCR was 
used to screen for RosettaTM 2(DE3)'elaDApr. 
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Fig. 4.6 There were three main steps, in knocking the elaD gene out from E. coli. 
substrain Rosetta2(DE3), which are briefly outlined above (A-C). The first step 
involved amplification of the apramycin resistance cassette (AprR), using PCR to 
LQFOXGHWKH¶DQG¶UHJLRQVRIWKe elaD gene to be knocked out (A). In the second 
step, homologous recombination was used, to replace elaD with an AprR cassette, a 
process carried out by O Red recombinase enzymes coded for by the PKD46 vector 
(B). This process involved carrying out two subsequent transformations of E. coli 
substrain, K12 MG1655, first using PKD46 vector DNA and secondly, using PCR 
product from (A). The resulting colonies were screened using colony PCR. In the 
final step (C), phage 1 transduction was used to convey the AprR characteristic in 
K12 to Rosetta2(DE3). This was done by incubating phage 1 viral lysate with the 
K12 carrying AprR, centrifuging (10 000 rpm) 20 min, incubating the resulting 
supernatant with Rosetta 2 (DE3) and finally screening for the elaD knock out using 
colony PCR. 
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Fig.4.7 shows the results from each of the 3 main steps used to 
ultimately develop RosettaTM 2(DE3)'elaDApr.  In step 1 (Fig.4.7), PCR 
was used to amplify the antibiotic resistance cassette, in this case the 
AprR sequence, using primers which also included regions homologous 
to the first and last 30 nucleotides of the elaD gene targeted for the 
knock-out. Two subsequent PCRs were carried out, PCR1 and PCR2, 
using the same conditions except PCR1 product was used as a 
template in PCR2 to increase DNA concentration. PCR primers, 
µ(OD'.2)¶ DQG µ(OD'.25¶ ZHUH XVHG to amplify the AprR sequence 
using Pfu DNA polymerase (2.2.4.1). Template DNA for PCR1 was 
prepared using E. coli substrain K12, MG1655 (JIG-515) carrying AprR 
sequence, as described in 2.2.3.1. There are strong bands for AprR 
DNA amplified in PCR2, compared with the weaker AprR DNA band 
amplified in PCR1. The bands from PCR2 were then DpnI digested 
(2.2.5.2) to remove the template and therefore any chance of 
transferring the AprR in the absence of generating JIG182'elaDapr. DpnI 
digested DNA was gel purified (2.2.5.1) and concentrated via ethanol 
precipitation (2.2.8) to give 2.6 Pg of gel purified amplified AprR DNA 
which was resuspended in 7 Pl sterile distilled water ready for step 2.  
 
In Step 2, elaD was knocked out in the E. coli substrain K12, MG1655 
(JIG-182) creating JIG182'elaDApr. To achieve this JIG-182 underwent 
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two subsequent transformations (by electroporation, 2.3.2.2). The first 
transformation was with pKD46 which codes for the ORed proteins 
responsible for homologous recombination. The newly transformed JIG-
182 cells were grown, induced to express ORed proteins, made 
competent, then transformed with DNA coding for the AprR cassette 
from Step 1 (details in 2.3.2). The resulting colonies were screened for 
JIG182'elaDApr using colony PCR (2.2.6) then positive colonies were 
subsequently screened using a XhoI test. The XhoI  test was carried out 
to eliminate the possibility that an error may have occurred during the 
homologous recombination step resulting in the insertion of the 
antibiotic cassette into a random region of the genomic DNA in K12. 
The AprR sequence is cut by XhoI and elaD is not.  
 
The resulting DNA from both screens was separated on a 1% (w/v) 
agarose gel (Fig.4.7 Step 2). Clones 1 - 6 showed positive for the AprR 
cassette as there was a 960 bp band. A parental RosettaTM2(DE3) 
colony was included with elaD (+) amplified for comparison, - template 
DNA (-T) and ±GoTaq (-Go). Clones 8 and 10 had a band closer to 
elaD (1272 bp) and there was no PCR product in clones 7 and 9. 
 
The same DNA, for clones 1 ± 6, amplified in colony PCR was then 
XhoI digest ed (2.2.6). XhoI digested (X) products and uncut AprR DNA 
(U) for clones 1 ± 6, as well as DNA carrying a XhoI site (+) and DNA 
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without a XhoI site (-) are shown in Fig.4.7 Step 2, as indicated. It is 
clear from the gel that clones 1 - 5 proved positive for the XhoI 
restriction sites, so amplified DNA from clones 1 and 2 were gel purified 
and submitted for sequencing. Both clones were JIG'elaDapr, verified 
by sequencing and clone 1 was used for the next step. 
 
The third step involved the transfer of the elaD knock-out characteristic 
from JIG'elaDapr to Rosetta2(DE3), to make 
Rosetta2(DE3)'elaDapr. This was done using P1 transduction to carry 
out the homologous recombination step instead of the ORed proteins 
(detailed in 2.2.10). A colony PCR was repeated to screen 
Rosetta2(DE3) for the AprR cassette and the resulting DNA was 
separated on a 1% (w/v) agarose gel and elaD was included for 
comparison (Fig.4.7 Step 3). Clones 4 - 2 showed positive for the AprR 
cassette and therefore were Rosetta2(DE3)'elaDapr, verified by 
sequencing.  
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Fig. 4.7 Shows the results from each of the 3 main steps in developing the elaD 
knock-out in E. coli substrain Rosetta2(DE3) (see text for details). Each step 
includes cartoons from Fig.4.6 to illustrate the procedure carried out. In Step 1 PCR 
was used to amplify the AprR sequence. Purified AprR DNA from Step 1 was then 
used for homologous recombination in Step 2. Resulting colonies were screened 
using colony PCR including elaD (+) to help with comparing the bands and two PCR 
controls, - template DNA (-T) and ±GoTaq (-Go). XhoI digestion (X) of clones 1 ± 6, 
as well as DNA carrying a XhoI site (+) and DNA without a XhoI site (-) identified as 
clones 1-4 being positive. Amplified DNA from clones 1 and 2 were gel purified and 
presence of the AprR cassette was verified by sequencing, as indicated. The AprR 
cassette was transferred to Rosetta2(DE3), using P1 transduction. A colony PCR 
was repeated to screen Rosetta2(DE3) for the AprR cassette, including a lane with 
elaD for comparison. Clones 4, 3 and 2 showed positive for the AprR cassette.  
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4.2.3 Expression of (His)6-Ub-LmrC and (His)6-Ub-EGFP 
recombinant proteins in Rosetta2(DE3)'elaDapr to serve as 
substrates for the DUB activity 
Rosetta2(DE3)'elaDapr was generated to determine if elaD may be 
responsible for the DUB activity already described in the parental 
substrain of E. coli, in chapter 3. To investigate this possibility the two 
fusion proteins, (His)6-Ub-LmrC and (His)6-Ub-EGFP, demonstrated 
previously to be cleaved by the DUB activity in the parental substrain 
were expressed in Rosetta2(DE3)'elaDapr. This could provide 
convincing evidence for elaD as the DUB activity if the removal of elaD 
was concomitant with the absence of DUB activity. Additionally, fusion 
proteins which previously proved resistant to DUB cleavage were also 
expressed in Rosetta2(DE3)'elaDapr. This was to investigate any 
differences in banding patterns of proteins analysed by SDS-PAGE, to 
see if elaD was responsible for any non-specific cleavage of fusion 
proteins. 
 
Rosetta2(DE3)'elaDapr and the parental substrains were transformed 
using the pHUE vector, sub-cloned with constructs to express the 
proteins: (His)6-Ub-EGFP (36 kDa), (His)6-SUMO1-LmrC (77 kDa), 
(His)6-NEDD8-LmrC (75 kDa) (A.I-III respectively) or the 75 kDa 
proteins, (His)6-Ub-LmrC (WT) and mutants, GA,GP and GGP (B). 
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Parental and Rosetta2(DE3)'elaDapr substrains were grown as 
described in 2.1.1 and protein purified (2.4.1) and electrophoresed on a 
5-20% (w/v) gradient gel and either Coomassie stained (Fig.4.8.B) or 
transferred on to nitrocellulose membrane and probed for either 
hexahistidine (Fig.4.8.A.I, III and C) as described in 2.4.6.2 or SUMO1 
(Fig.4.8.A.II) using methods described in 2.4.6.5. Intact fusion proteins 
are as indicated (]). Both (His)6-Ub-EGFP and (His)6-Ub-LmrC fusion 
proteins had an 11 kDa DUB cleavage product, (His)6-Ub in the parental 
substrain, however, as noted previously, this DUB cleavage product 
was not present in the Rosetta2(DE3)'elaDapr. This lack of DUB 
cleavage is clearly shown for (His)6-Ub-LmrC expressed in 
Rosetta2(DE3)'elaDapr, in the Coomassie stained gel, Fig.4.8.B. The 
absence of DUB activity in Rosetta2(DE3)'elaDapr provides the most 
convincing evidence so far, for elaD being responsible for the DUB 
activity observed in E. coli substrain Rosetta2(DE3). There was no 
change in the banding pattern for (His)6-NEDD8-LmrC and (His)6-
SUMO1-LmrC when comparing proteins expressed in 
Rosetta2(DE3)'elaDapr with those expressed in the parental 
substrain. Many smaller proteins still co-purified with (His)6-SUMO1-
LmrC when elaD had been knocked out which shows that elaD was not 
associated with this non-specific protease activity. Likewise, the 12 kDa 
band resulting from non-specific (NS) cleavage of GA, GP and GGP, 10 
residues C-terminal to ubiquitin was present in the parental substrain as 
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well as in Rosetta2(DE3)'elaDapr, which shows that in addition elaD 
was not associated with this non-specific protease activity. 
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Fig. 4.8 Rosetta2(DE3)'elaDApr (KO) and the parental (P) cell line which expressed 
elaD in the genome, were transformed using the pHUE vector, sub-cloned with constructs 
to express the proteins: (His)6-Ub-EGFP (36 kDa), (His)6-SUMO1-LmrC (77 kDa), (His)6-
NEDD8-LmrC (75 kDa) (A.I-III respectively) or the 75 kDa proteins, (His)6-Ub-LmrC (WT) 
and mutants, GA,GP and GGP (B and C). The resulting protein was purified using cobalt 
affinity chromatography, electrophoresed on a 5-20% (w/v) gradient gel and either 
Coomassie stained (B) or transferred on to nitrocellulose membrane and probed for either 
hexahistidine (A.I, III and B) or SUMO1 (A.II). Intact fusion proteins are as indicated (]). 
Both (His)6-Ub-EGFP and (His)6-Ub-LmrC fusion proteins had an 11 kDa DUB cleavage 
product, (His)6-Ub in the parental substrain, however, this DUB cleavage product was not 
present in the elaD knock-out substrain evident in both Coomassie stained gel (B) and the 
Western blot (C). This absence of DUB activity in Rosetta2(DE3)'elaDApr is convincing 
evidence for elaD being a strong candidate for the DUB activity observed in E. coli. 
substrain Rosetta2(DE3). There was no change in the banding pattern for (His)6-
NEDD8-LmrC and (His)6-SUMO1-LmrC when comparing proteins expressed in 
Rosetta2(DE3)'elaDApr with those expressed in parental E. coli. substrain 
Rosetta2(DE3) (as many, smaller proteins still co-purified with (His)6-SUMO1-LmrC 
when elaD had been knocked out this shows that elaD was not associated with this non-
specific protease activity). The 12 kDa band resulting from non-specific (NS) cleavage of 
GA, GP and GGP, 10 residues C-terminal to ubiquitin was present in the parental 
substrain as well as in the elaD knock-out, which shows that elaD was not associated with 
this non-specific protease activity.  
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4.3 Discussion 
The main aim of the work discussed in this chapter was to identify a 
candidate for the DUB activity observed in E. coli substrain 
Rosetta2(DE3), described in Chapter 3. DUB candidates, EF-Tu 
(TufA and TufB proteins) and elaD were chosen as likely candidates 
from the literature. These DUB candidates were then sub-cloned to 
eventually express GST-tagged DUB candidate proteins E. coli 
substrain XL10Gold. After optimising GST-elaD protein expression and 
purification, all candidates were then investigated to see if they could 
bind to ubiquitin.  
 
The specific DUB cleavage of (His)6-Ub-LmrC and  (His)6-Ub-EGFP by 
the DUB activity observed in Chapter 3 meant that the DUB activity 
could recognise and bind to ubiquitin in some way in order to cleave the 
ubiquitin fusion proteins. Therefore an assay was chosen to screen 
DUB candidates, TufA, TufB and elaD for the ability to bind ubiquitin. As 
well as the DUB candidates, eukaryotic EF-1D2 was also included in 
this study, to compare both eukaryotic and prokaryotic elongation 
factors and GST as a control. It is clear from the results of this ubiquitin-
Sepharose binding assay (Fig.4.5) that elaD was a good candidate for 
the DUB activity in E. coli substrain Rosetta2(DE3) compared with 
TufA and TufB, hence the subsequent focus on elaD.  
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It is interesting however, that neither, prokaryotic or eukaryotic 
elongation factors, EF-Tu µ7XI$¶ DQG µ7XI%¶ SURWHLQV or EF1D 
respectively bound to ubiquitin-Sepharose. A. Ciechanover and 
colleagues reported DUB activity, in vitro by EF1D and EF-Tu with a 
ubiquitinated histone, H2A as a substrate. Perhaps the DUB activity 
observed was actually due to elaD co-purifying with the elongation 
factors as they were purified using gel filtration. elaD and EF-Tu are 
close in mass, 45 kDa and 44 kDa respectively, and therefore it is 
plausible that elaD may have been the enzyme responsible for the DUB 
activity observed.  
 
These results provide evidence for elaD being a strong candidate for 
the DUB activity observed in E. coli substrain RosettaTM2(DE3). The 
next step was to ensure that elaD was responsible for the DUB activity 
observed initially with (His)6-Ub-LmrC and  (His)6-Ub-EGFP, using a 
gene knock-out technique. If elaD was knocked out in E. coli substrain 
RosettaTM2(DE3) and the DUB activity was lost, then this promised to 
provide the strongest evidence for elaD as the DUB activity. Of course, 
this approach made the assumption that the protein targeted to be 
knocked out (elaD) was responsible for the phenotype (DUB activity). It 
was also possible that the target protein could instead, be a protein 
which influenced the expression of a protein responsible for the 
phenotype. For example, elaD could have been a transcription factor 
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which once activated could have lead to the eventual translation of a 
gene coding for the true protein responsible for the DUB activity. If this 
was the case, then knocking out elaD would also abolish DUB activity. 
However, in this case, as it is known that elaD has DUB activity, then it 
is safe to assume that if no DUB activity occurred when elaD was 
knocked out, then elaD must be the protein responsible for the DUB 
activity14.  
 
In an attempt to demonstrate elaD was responsible for the DUB activity 
observed in E. coli substrain RosettaTM2(DE3), first, an elaD gene 
knock-out in E. coli substrain RosettaTM2(DE3) was created. Second, 
this Rosetta2(DE3)'elaDapr was then used to express all fusion 
proteins that were investigated in Chapter 3, in comparison with the 
parental strain. (His)6-Ub-EGFP, (His)6-SUMO1-LmrC, (His)6-NEDD8-
LmrC, (His)6-Ub-LmrC and mutants were analysed by SDS-PAGE and 
Western blotted (Fig.4.8). When (His)6-Ub-EGFP (Fig.4.8.A) and (His)6-
Ub-LmrC (Fig.4.8.B) were expressed in Rosetta2(DE3)'elaDapr 
compared with the parental substrain the band for the cleavage product, 
(His)6-Ub, was absent. This provides the most robust evidence, so far 
for elaD being responsible for the DUB activity that we have observed in 
E. coli substrain RosettaTM2(DE3). Additionally, it was demonstrated 
that elaD was not responsible for non-specific protease activity 
observed with (His)6-SUMO1-LmrC and at the second, non-specific site 
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10aa C-terminal to the DUB site within GA, GP and GGP proteins. The 
banding patterns for proteins purified from cells expressing (His)6-
SUMO1-LmrC, GA, GP and GGP were the same when expressed in 
Rosetta2(DE3)'elaDapr compared with the parental substrain 
(Fig.4.8.A), confirming that this resulted from non-specific cleavage as 
expected. 
 
In Chapter 3, it was demonstrated that the DUB activity observed in E. 
coli substrain RosettaTM2(DE3) cleaved (His)6-Ub-LmrC and  (His)6-Ub-
EGFP, specifically in a way comparable to eukaryotic DUBs. The work 
discussed in the current chapter has taken a candidate approach, using 
ubiquitin binding and gene knock-out techniques to successfully identify 
elaD as the DUB activity which we have observed in E. coli substrain 
RosettaTM2(DE3). Next, having identified the DUB activity as elaD it was 
possible to build upon the work in Chapter 3, in further characterising 
elaD function. 
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5 Further characterisation of elaD DUB activity 
 
5.1 Introduction 
The work for this study began by confirming that a DUB activity 
observed by other members of our group, in an E. coli DE3 strain was 
reproducible in the E. coli substrain RosettaTM2(DE3). This is described 
in Chapter 3. Once this activity was confirmed an initial characterision of 
the DUB activity in E. coli substrain RosettaTM2(DE3) was carried out. 
By expressing (His)6-Ub-LmrC fusion proteins, GA, GP and GGP 
mutated around the DUB site it was revealed that the prokaryotic DUB 
was very similar to both yeast and mammalian DUBs in that it did not 
cleave GP, i.e. post proline at position 76 of ubiquitin. However the 
catalytic mechanism of the prokaryotic DUB was more similar to yeast 
DUBs than mammalian DUBs in that it could cleave GA. It was further 
demonstrated, using fusion proteins expressed in E. coli substrain 
RosettaTM2(DE3) that the DUB activity showed a preference for 
ubiquitin as it cleaved (His)6-Ub-LmrC and (His)6-Ub-EGFP, yet it did 
not cleave (His)6-SUMO1-LmrC or (His)6-NEDD8-LmrC, in vivo.  
 
In work discussed in Chapter 4 the main focus was to identify the 
enzyme responsible for the DUB activity in E. coli substrain 
RosettaTM2(DE3) using a candidate approach. Out of the two 
candidates considered for the DUB activity, the E. coli elongation factor, 
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GST-EF-Tu and GST-elaD, a ubiquitin-Sepharose pull down assay 
succeeded in demonstrating that only GST-elaD bound to ubiquitin. 
Subsequently, when elaD was knocked out of E. coli substrain 
RosettaTM2(DE3) this was also seen to abolish DUB activity with (His)6-
Ub-LmrC and (His)6-Ub-EGFP as substrates. Therefore this work 
successfully identified elaD as the enzyme responsible for the DUB 
activity against these substrates in E. coli substrain RosettaTM2(DE3).  
 
The preference shown by GST-elaD for ubiquitin as a substrate is 
interesting as E. coli do not express ubiquitin or a ubiquitin homologue 
which functions as a protein tag. E. coli does have ubiquitin 
homologues, molybdopterin converting factor, subunit 1 (MoaD) and 
thiamine biosynthesis protein S (ThiS), involved in Molybdenum 
cofactor biosynthesis and the biosynthesis of thiamine, respectively152, 
153
. Although MoaD and ThiS are both activated by E1 like enzymes, 
MoeB and ThiF (respectively), once activated instead of functioning as 
protein tags, MoaD and ThiS provide a sulphur obtained during 
activation for incorporation into molybdopterin and thiazole, 
respectively154, 155. It is possible that elaD may function to subvert the 
host cell system by targeting the eukaryotic ubiquitin system. 
Alternatively elaD may form part of a eukaryotic ubiquitin-like system in 
E. coli, yet to be discovered.  In this Chapter the aim was to investigate 
further the specificity of GST-elaD for different types of ubiquitin 
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substrates. The work using deubiquitinating assays, described so far in 
this study has focussed on DUB activity of GST-elaD, in vivo with fusion 
proteins. The work in the current Chapter uses a variety of ubiquitin 
substrates to build a more detailed picture of the catalytic mechanism 
and specificity of GST-elaD. 
 
In eukaryotic cells a large variety of ubiquitin ligated proteins form 
substrates for eukaryotic DUBs within the eukaryotic ubiquitin system. 
There are seven possible lysine (K) residues in ubiquitin available for 
another ubiquitin molecule to become covalently attached: K6, K11, 
K27, K29, K33 K48 and K63 (Fig.5.1.A) and are used in vivo. Ubiquitin 
links to its interaction partners which can either be a target protein 
(Fig.5.1.B) or another ubiquitin molecule, leading to the formation of 
poly-ubiquitin chains (Fig.5.1.C). 
 
There are two main types of bond between ubiquitin proteins or 
between ubiquitin or another protein; the first is a linear linkage (peptide 
bond) and the second is an isopeptide bond. The linear linkage exists 
between the D-amino group of the first amino acid residue of ubiquitin, 
methionine (M1), with the D-carboxyl group (G76) on another ubiquitin 
(as occurs in ubiquitin precursors) or another protein (as in artificial 
fusion proteins) (Fig.5.1.C.II-III). The linear fusion proteins, (His)6-Ub-
LmrC and (His)6-Ub-EGFP, used as substrates for GST-elaD in 
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previous chapters are shown, with orange spheres representing (His)6. 
The linear linkage can occur between ubiquitin precursors during 
translation or as was recently discovered, there is an E3 ligase 
complex, the linear ubiquitin chain assembly complex (LUBAC) which 
assembles linear ubiquitin chains on target proteins78 (Fig.5.1.CI).  
 
Isopeptide bonds are found between ubiquitin and target proteins, 
ubiquitin dimers or ubiquitin polymers. Isopeptide bonds occur post 
translationally using the H-amino group of lysine on one ubiquitin and 
the D-carboxyl group of G76 of ubiquitin. An isopeptide bond can occur 
using many lysine residues within the target protein to produce a 
multiply ubiquitinated protein (Fig.5.1.D) or poly-ubiquitin chains. 
Ubiquitin chains can form a single isomer (Fig.5.1.E), or a mixed chain 
with different lysine residues used which can form a fork. A forked chain 
is shown in (Fig.5.1.F) in which a K29-linked ubiquitin chain forms a 
bond with two other ubiquitins using K29 and K48, causing a fork. 
Additionally it is possible for heterologous chains to form, for example, 
SUMO2 chains (blue spheres) have been shown to become 
ubiquitinated with a ubiquitin chain (Fig.5.1.G). 
 
The work discussed in this Chapter, concentrates on building a clearer 
picture of the nature of the catalytic activity of GST-elaD using a wider 
range of ubiquitin substrates. Linear linkages between two ubiquitin 
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molecules, isopeptide bonds between ubiquitin of two to four units long, 
in mixed length poly-ubiquitin chains, in single poly-ubiquitin chains 
exclusively using one of all seven possible lysine linkages were used. 
Finally possible binding mutants were made and used in a ubiquitin-
Sepharose pull-down assay to ascertain the regions within GST-elaD 
responsible for binding to ubiquitin (seen previously 4.2.4).  
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Fig. 5.1 Ubiquitin is shown as a yellow sphere with the carboxyl group of the C-terminus and 
the D-amino group of the N-terminus. The ubiquitin D-amino group and 7 lysine residues (K) 
which have an H-amino group, are available to form linkages with other ubiquitin proteins (A). 
Ubiquitin forms a bond with a second protein which can either be a target protein (B) or 
another ubiquitin molecule which can also form ubiquitin chains shown in (C). This bond can 
occur using the D-carbonyl carbon on ubiquitin and nitrogen from either the D-amino group 
or the H-amino group of the second protein. If ubiquitin is connected to the D-amino group of 
another protein then this is a peptide bond, known as linear linkage and occurs both during 
translation (C.II-III), or post translationally. The linear fusion proteins, (His)6-Ub-LmrC and 
(His)6-Ub-EGFP, used as substrates for elaD in previous chapters are shown, with orange 
spheres representing (His)6. The ubiquitin E3 ligase, linear ubiquitin chain assembly complex 
(LUBAC) builds chains post translationally (C.,). Alternatively, if ubiquitin is connected to the 
H-amino group of another protein then this is an isopeptide bond which is only formed post 
translationally. An isopeptide bond can occur using many lysines within the target protein to 
produce a multiply ubiquitinated protein (D) or ubiquitin chains. Ubiquitin chains can form a 
single isomer (E), or a mixed chain with different lysine residues used which can form a fork. 
Just one example of a forked chain is shown in (F) in which a K29 linked ubiquitin chain 
forms a bond with two other ubiquitins using K29 and K48, causing a fork. Additionally it is 
possible for heterologous chains to form, for example, SUMO2 chains (blue spheres) have 
been shown to become ubiquitinated with a ubiquitin chain (G). 
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5.2 Results 
5.2.1 An in vitro DUB assay using (His)6-Ub-LmrC as a substrate 
for GST-elaD  
The fusion protein (His)6-Ub-LmrC 
(Fig.5.2) was used as a substrate for 
GST-elaD. (His)6-Ub-LmrC was 
demonstrated to be cleaved, in vivo by 
elaD in previous chapters was not 
completely processed by elaD (see 
Fig.3.2). This led to the speculation that as LmrC is thought to form 
homo-dimers, perhaps cleaved LmrC and intact fusion proteins formed 
dimers which prevented further DUB activity156.  
 
To test this idea intact fusion protein was used as a substrate for GST-
elaD. The intact (His)6-Ub-LmrC substrate was induced in L. Lactis, a 
bacterial strain which does not express elaD and only produces the 
intact form of the fusion protein. The intact (His)6-Ub-LmrC used in the 
assay was either purified (P) protein or used as a lysate containing 
unpurified recombinant (His)6-Ub-LmrC protein (L). Two DUBs were 
included as positive controls for DUB activity, a eukaryotic DUB, protein 
gene product 9.5 (PGP9.5) and a viral DUB, M231. Cell lysate 
containing unpurified recombinant proteins: GST-elaD, GST, GST-
PGP9.5 and purified M231 protein were used in the DUB assay. A cell 
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lysate from RosettaTM2(DE3) with no pHUE vector was also included, to 
control for any background DUB activity by intrinsically expressed elaD. 
This would allow a comparison to be made between the DUB activity of 
unpurified GST-elaD (which was in a cell lysate) with any DUB activity 
of intrinsically expressed elaD in the same volume of cell lysate. The 
amounts of enzyme or substrate used in each DUB assay reaction were 
produced by a 10 ml culture. The reactants were incubated (37oC) in 
TBS with 0.5 mM DTT (pH 7.5) for approximately 15 hr. The reaction 
was stopped using gel loading buffer, electrophoresed on a 5-20% (w/v) 
acrylamide gradient gel, transferred on to nitrocellulose membrane and 
probed for the hexahistidine-tag (Fig.5.3). 
 
There was no evidence of DUB activity by any of the DUBs using the 
(His)6-Ub-LmrC as a substrate, in vitro, evident from the absence of 
cleavage product, (His)6-Ub (Fig.5.3). The lack of DUB activity by 
PGP9.5 and M231 as well as GST-elaD would seem to indicate that 
there may be an alternative block to DUB activity against this substrate 
post translationally; perhaps when (His)6-Ub-LmrC is expressed in L. 
Lactis, strong dimerisation occurs between LmrC intact fusion proteins 
precluding subsequent proteolysis by DUBs. This could also be the 
reason for the lack of background DUB activity by constitutively 
expressed elaD (RosettaTM2(DE3) with no pHUE vector) (Fig.5.3). 
Alternatively, unlike all DUB assays carried out previously, this DUB 
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assay was carried out in vitro, rather than an in vivo. Therefore as the 
protein expression (of elaD and substrate (His)6-Ub-LmrC) and DUB 
activity did not occur within E. coli, the lack of any DUB activity 
(including background DUB activity) by elaD may have been due to the 
lack of an enzyme co-factor or a key protein binding partner. 
Additionally, the absence of background DUB activity (by intrinsically 
expressed elaD) may have been due to the level of elaD being so low 
that DUB activity was undetectable. The reason for including 
RosettaTM2(DE3) with no pHUE vector was to compare the DUB activity 
of unpurified GST-elaD (in lysate) with any background DUB activity, by 
intrinsically expressed elaD in the same amount of cell lysate taken 
from a 10 ml culture. 
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Fig. 5.3 The fusion protein, (His)6-Ub-LmrC containing linear peptide linkages between 
ubiquitin and LmrC was used as a substrate for GST-elaD. The DUB assay using (His)6-Ub-
LmrC, expressed by L. lactis  as a substrate for elaD was set up as follows. E. coli substrain 
RosettaTM2(DE3) cell lysate, containing unpurified proteins: GST-elaD, GST, PGP9.5 or 
purified proteins: USP2-core M231 were incubated (37oC) with either purified (P) or 
unpurified (L) (His)6-Ub-LmrC protein in TBS with 0.5 mM DTT (pH 7.5) for approximately 15 
hr. PGP9.5 and M231 were included as positive controls for DUB activity. The reaction was 
stopped using gel loading buffer, electrophoresed on a 5-20% (w/v) acrylamide, gradient gel 
transferred on to nitrocellulose membrane and probed for the hexahistidine-tag. There was 
no evidence of DUB activity by any of the DUBs using the (His)6-Ub-LmrC as a substrate, in 
vitro. (His)6-Ub-LmrC was expressed by L. lactis and therefore intact and available for DUB 
cleavage. However there was no DUB activity with (His)6-Ub-LmrC by PGP9.5 and M231 as 
well as elaD which indicates a block to DUB activity. There is cross reactivity of the 
hexahistidine-tag antibody with M231 enzyme. 
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5.2.2 An in vitro DUB assay using unanchored linear di-ubiquitin 
as a substrate for GST-elaD  
Linear di-ubiquitin was used as a substrate for 
GST-elaD, as an alternative linear peptide-linked 
protein to use in vitro, without complication of 
possible substrate dimerisation. GST-elaD (~15 
Pg) and GST (~15 Pg) were purified using 
glutathione-Sepharose 4B beads and while still attached to beads were 
then incubated (37oC) with 0.9 Pg linear di-ubiquitin (Ub2) in TBS with 
0.5 mM DTT (pH 7.5) for approximately 15 hr. USP2-core (0.4 Pg) was 
included as a DUB to serve as a positive control. The reaction was 
again stopped using gel loading buffer, electrophoresed on a 5-20% 
(w/v) acrylamide gradient gel, transferred on to nitrocellulose membrane 
and probed for ubiquitin (Fig.5.5). 
 
Interestingly, linear di-ubiquitin was not deconjugated by immobilised 
GST-elaD, but was deconjugated by USP2-core, in vitro. The absence 
of DUB activity by GST-elaD with Ub2 was surprising as the bonds 
between ubiquitin and LmrC or another ubiquitin, in this case were both 
linear, i.e. peptide linkages.  
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Fig.5.5 Linear di-ubiquitin was used as a substrate for GST-elaD. Immobilised 
GST-elaD (15 Pg) and GST were incubated (37oC) with 0.9 Pg linear di-
ubiquitin (Ub2) in TBS with 0.5 mM DTT (pH 7.5) for approximately 15 hr. 
USP2-core (0.4 Pg) was included as a DUB to serve as a positive control for 
DUB activity. The reaction was stopped using gel loading buffer, 
electrophoresed on a 5-20% (w/v) acrylamide gradient gel, transferred on to 
nitrocellulose membrane and probed for ubiquitin (B). Linear di-ubiquitin (Ub2) 
was not cleaved by elaD but was cleaved by USP2-core.  
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The next substrates considered for GST-elaD were anchored K63-
linked and K48-linked tetra-ubiquitin. However, first, this would be good 
point to consider the different conformations of the different isomers of 
poly-ubiquitin chains. Fig.5.6 shows cartoons of ubiquitin as either the 
spherical shape introduced earlier (Fig.5.6.A), or as a kite shape which 
allows the conformation of ubiquitin chains to be shown. At the time of 
writing, there was only information in the literature about the 
conformation structure of K48, K63 and linear ubiquitin dimers, which 
can be extrapolated to poly-ubiquitin chains. It has been shown that 
K48-linked poly-ubiquitin chains adopt a closed conformation with 
increasing pH, being fully closed when pH is greater than 7.5, and is 
fully open when pH is lower than 5.4 (Fig.5.6.D)16. The K63-linked 
ubiquitin chain has been demonstrated to form a more open 
conformation than the relaxed form of K48-linked ubiquitin chain, with a 
strong similarity to linear ubiquitin (Fig.5.6.F)19. 
 
Knowing that GST-elaD cleaves a linear fusion protein which contains 
ubiquitin (His6-Ub-LmrC) would lead one to speculate that GST-elaD 
might show a preference for ubiquitin polymers with an open 
conformation, such as a linear linkage or possibly a K63-linked ubiquitin 
chains. As there was no evidence for deconjugation of linear di-ubiquitin 
by GST-elaD so next, the K48 and K63 linked tetra-ubiquitin were 
evaluated as substrates for GST-elaD. 
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Fig. 5.6 A cartoon to show the different conformations of some of the 
ubiquitin chain isomers. Ubiquitin can be shown simplistically as a yellow 
sphere (A) as well as a kite shape which is closer to the ubiquitin structure 
and is useful for showing conformations of ubiquitin within different chain 
isomers. At the time of writing, there is only information in the literature about 
the conformation of K48, K63 and linear ubiquitin dimers, which can be 
extrapolated to poly-ubiquitin chains. K48-linked ubiquitin chains are able to 
adopt a closed conformation and with increasing pH the conformation opens 
(D)16. The K63-linked ubiquitin chain forms a more open conformation than 
the open form of K48-linked ubiquitin chain, with a strong similarity to linear 
ubiquitin (F)19. 
 
 
A B 
C                                   D
E
F                      
Fully closed: pH > 7.5 Fully open: pH < 5.4
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5.2.3 K63 and K48 isopeptide bonds within unanchored tetra-
ubiquitin as substrates for GST-elaD 
The K63 and K48 isomers of tetra-ubiquitin were investigated next as 
substrates for GST-elaD in vitro. GST-elaD and GST were purified 
using Glutathione-Sepharose 4B beads and after washing in TBS, 
whilst still immobilised on the beads GST-elaD (~15 Pg) and GST (~15 
Pg) were incubated with 0.25 Pg tetra-ubiquitin in TBS (1 mM DTT), 
37oC for 15 hr. The reaction was stopped using gel loading buffer and 
the samples were electrophoresed on a 5-20% (w/v) acrylamide gel, 
transferred to nitrocellulose membrane and probed for ubiquitin 
(Fig.5.7). There is evidence that GST-elaD deconjugated tetra-ubiquitin 
to tri-ubiquitin but there were no bands representing di-ubiquitin or 
mono-ubiquitin on the blot so it was not complete deconjugation as with 
the control USP2-core. It should be noted that the K63-linked tetra-
ubiquitin was not pure as traces of tri-ubiquitin were present in the 
control sample (lane 1 of Fig.5.7.A). However, more tri-ubiquitin is 
present in the reaction containing GST-elaD (lane 3 of Fig.5.7.A) than in 
the control sample.    
 
There was no deconjugation by GST-elaD of K48-linked tetra-ubiquitin 
which would indicate that GST-elaD shows a preference for a K63-
linked tetra-ubiquitin under comparable conditions. The lack of 
deconjugation of K48-linked tetra-ubiquitin by GST-elaD may be due to 
  
 
179 
 
the closed conformation assumed by this poly-ubiquitin chain isomer at 
the pH at which the assay was carried out (pH 7.5)16. As GST-elaD 
cleaves ubiquitin containing substrates with linear linkages presumably 
indicating a requirement by GST-elaD for the ubiquitin containing 
VXEVWUDWH WRDGRSWDQ µRSHQ¶FRQIRUPDWLRQ WR UHYHDOQHFHVVDU\ELQGLQg 
epitopes. 
 
The discovery that GST-elaD deconjugated K63-linked tetra-ubiquitin 
but not K48-linked tetra-ubiquitin was an interesting finding as it 
appeared that GST-elaD preferred the open conformation of K63. elaD 
is a bacterial enzyme which is now known from previous work in this 
study to prefer ubiquitin as a substrate over NEDD8 or SUMO1, yet E. 
coli does not express a homologue of ubiquitin. Now this evidence 
shows that GST-elaD not only deconjugates isopeptide bonds between 
ubiquitin but apparently prefers the K63-linked tetra-ubiquitin isomer 
over K48. K63-linked isomers of ubiquitin chains are associated with 
signalling pathways in eukaryotic cell systems. This leads to the 
speculation that GST-elaD may have a function to overthrow, or 
manipulate a host cell signalling system, assuming it is a secreted 
bacterial effector see discussion.  
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Having demonstrated catalytic activity by GST-elaD in vitro, the next 
step in this investigation was to make a GST-elaD catalytic mutant in 
order to confirm specificity of activity. 
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Fig. 5.7 GST-elaD (15 Pg) and GST, whilst still attached to glutathione-
Sepharose 4B beads and USP2-core (0.4 Pg) used as a DUB to serve as a 
positive control for DUB activity, were incubated (37oC) with 0.25 Pg tetra-
ubiquitin (Ub4 ), K63 (A) and K48 (B) for approximately 15 hr. The reaction 
was stopped using gel loading buffer, electrophoresed on a 5-20% (w/v) 
acrylamide gradient gel, transferred on to nitrocellulose membrane and 
probed for ubiquitin. Only K63-linked Ub4 was deconjugated to Ub3 by elaD 
as indicated. 
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5.2.4 Construction of a GST-elaD catalytic mutant, GST-C313S for 
comparison with GST-elaD in in vitro DUB assays 
 
5.2.4.1 Designing the GST-elaD catalytic mutant, GST-C313S 
Previously (4.2.1), when planning the GST-elaD construct, the 
sequence for genomic elaD from E. coli substrain RosettaTM2(DE3) was 
sequenced, then aligned with the elaD sequence in E. coli substrain 
K12. Both elaD sequences were found to be identical for both 
substrains of E. coli. A GST-elaD mutant was designed to remove the 
catalytic ability of GST-elaD by targeting the cysteine of the catalytic 
triad. Fig.5.8 shows the catalytic triad in SENP8 (Human GI: 33942066) 
compared with the elaD homologue, from two lab strains of commensal 
bacteria (E. coli RosettaTM2(DE3) sequenced in this study) and E. coli 
K12 (GI: 16130204), as well as elaD from pathogenic bacteria, (E. 
coli_O157 GI: 15832411). The catalytic triad and oxyanion stabilising 
groups for SENP8, elaD in O157 and elaD in K12 were highlighted by 
A. Catic14.  The elaD sequence in RosettaTM2(DE3), established earlier 
in this study (4.2.1) as identical to elaD in K12, thus has the same 
highlighted regions in Fig.5.8. 
 
The catalytic triad for these cysteine proteases, shown in red, is formed 
by: cysteine (C), histidine (H) and asparginine (N) or aspartate (D), in 
elaD asparagine is used. Glutamine (Q), shown in aqua, provides the 
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oxyanion stabilising group, of which there are two in elaD. The cysteine 
targeted for mutation in elaD from RosettaTM2(DE3), the 313th residue, 
was converted to serine (S) and therefore the catalytic mutant for GST-
elaD is known as GST-C313S onwards. This strategy was also used by 
A. Catic to create a catalytic mutant of GST-elaD from E. coli substrain 
K1214. The GST-C313S mutant was generated by carrying out PCR 
based SDM using Pfu DNA polymerase as described in 2.6.4.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
  
 
184 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fig. 5.8 An alignment using full length protein sequences between SENP8 (Human GI: 
33942066) and: elaD in two lab strains of commensal bacteria (E. coli RosettaTM2(DE3 
sequenced in this study) and E. coli K12 (GI: 16130204), including an elaD homologue 
found in bacteria which are pathogenic to humans (E. coli_O157 GI: 15832411). The 
alignment was carried out using EMBL-EBI Clustal W online alignment tool. The predicted 
catalytic triad: histidine (H), aspartate (D) or asparagine (N) and cysteine (C) are all shown in 
red. The glutamine residues (Q) shown in aqua form part of the oxyanion-stabilising group 
with cysteine. A mutation was introduced in elaD (RosettaTM2(DE3)) to remove the ability to 
carry out catalytic activity. A good target for mutation in cysteine proteases is the cysteine of 
the catalytic triad. Therefore the elaD catalytic mutant was made by converting cysteine, the 
313th residue in elaD to serine (S) generating mutant, C313S. The catalytic mutant could 
then be used to compare with wild type elaD within DUB assays to be able to demonstrate 
that any activity observed in vitro would be as a result of DUB activity by elaD. 
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5.2.5 K63 and K48 linked unanchored poly-ubiquitin mixed length 
chains as substrates for immobilised GST-elaD including GST-
C313S  
In section 5.2.2 GST-elaD showed a preference for K63-linked tetra-
ubiquitin chains over K48-linked tetra-ubiquitin so the next step was to 
test GST-elaD for DUB activity with longer chains of ubiquitin of the 
same linkages. GST (~15 Pg), GST-elaD (~15 Pg) and the GST-tagged, 
newly generated catalytic mutant, GST-C313S (~15 Pg)  were captured 
on glutathione-Sepharose 4B beads, washed with 0.1% (v/v) Triton X-
100 in TBS and incubated (37oC) in parallel with M231, a positive 
control DUB with 0.45 Pg poly-ubiquitin chain mixtures for 
approximately 15 hr. The reaction was stopped using gel loading buffer, 
electrophoresed on a 5-20% (w/v) acrylamide gradient gel, transferred 
on to nitrocellulose membrane and probed for ubiquitin (Fig.5.9).  
 
The same preference by GST-elaD for K63-linked poly-ubiquitin chains 
over K48-linked poly-ubiquitin chains was shown compared with tetra-
ubiquitin. However, in this case a stronger DUB activity was observed. 
This suggests that elaD does prefer open conformations of ubiquitin 
such as K63-linked poly-ubiquitin chains. The GST-elaD catalytic 
mutant, however did not deconjugate the poly-ubiquitin chains 
confirming that activity by GST-elaD is a specific DUB activity. K63-
linked poly-ubiquitin chains were deconjugated by GST-elaD, evident 
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from the absence of Ub6 and a barely visible band for Ub5. This was not 
complete deconjugation as weak bands for Ub4 and Ub3 were 
noticeable. Indeed strong bands for Ub2 could indicate that GST-elaD 
prefers longer poly-ubiquitin chains. 
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Fig. 5.9 Poly-ubiquitin chain mixtures containing either K63-linked ubiquitin or K48-
linked ubiquitin were used as a substrate for GST-elaD. This was to determine if the 
same preference for the K63-linked form was seen with longer chains than tetra-
ubiquitin. GST, GST-elaD (15 Pg) and the GST-tagged, catalytic mutant (C313S) (15 
Pg) were captured on glutathione-Sepharose 4B beads, washed with 0.1% (v/v) Triton 
X-100 in TBS and incubated in parallel with M231, a positive control DUB with 0.45 Pg 
poly-ubiquitin chain mixtures for approximately 15 hr. The reaction was stopped using 
gel loading buffer, electrophoresed on a 5-20% (w/v) acrylamide gradient gel, 
transferred on to nitrocellulose membrane and probed for ubiquitin. C313S showed not 
DUB activity with either isomer of poly-ubiquitin chain mixtures. The same preference by 
elaD for K63-linked poly-ubiquitin chains over K48-linked poly-ubiquitin chains as was 
shown with tetra-ubiquitin was observed. K63-linked poly-ubiquitin chains were 
deconjugated, evident from the absence of Ub6 and a barely visible band for Ub5. This 
was not complete deconjugation as weak bands for Ub4 and Ub3 were noticeable. 
Strong bands for Ub2 would indicate that elaD has a preference for longer poly-ubiquitin 
chains. 
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5.2.6 K63 and K48 linked unanchored poly-ubiquitin mixed length 
chains as substrates for GST-elaD in solution 
The DUB assays using linear di-ubiquitin and K48 or K63 linked poly-
ubiquitin as substrates for GST-elaD were carried out previously with 
GST-elaD attached to glutathione-Sepharose 4B beads. To check that 
the attachment of GST-elaD to beads did not alter DUB activity in any 
way, GST-tagged proteins were next eluted from glutathione-Sepharose 
4B beads using 20 mM reduced glutathione then dialysed in 0.1% (v/v) 
Triton X-100 in TBS. GST (~15 Pg), ~15 Pg GST-elaD and ~15 Pg GST-
tagged, catalytic mutant (GST-C313S) were incubated (37oC) with 0.45 
Pg poly-ubiquitin chain mixtures for approximately 15 hr. The reaction 
was stopped using gel loading buffer, electrophoresed on a 5-20% (w/v) 
acrylamide gradient gel, transferred on to nitrocellulose membrane and 
probed for ubiquitin (Fig.5.10). It is evident from the Western blot that 
the same preference is shown by GST-elaD for the K63-linked poly-
ubiquitin chain mixture when free from the glutathione-Sepharose 4B 
beads and therefore in solution, compared with when it was 
immobilised. Again, the longer poly-ubiquitin chains seem to be 
preferred by GST-elaD. Additionally the free GST-elaD appeared to 
show a limited deconjugation of K48-linked chains. GST-C313S and 
GST were not associated with any deconjugation of either chain 
isomers. USP2-core was included in the DUB assay as a positive 
control DUB fully deconjugated both poly-ubiquitin chain forms. 
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Fig. 5.10 Poly-ubiquitin chain mixtures containing either the K63-linked ubiquitin or 
K48-linked ubiquitin were used as a substrate for GST-elaD, this time eluted from 
glutathione-Sepharose 4B beads. This assay was used to check that elaD activity 
was not altered by being attached to the glutathione-Sepharose 4B beads. GST, 
GST-elaD (15 Pg) and the GST-tagged, 15 Pg catalytic mutant (C313S) were 
incubated (37oC) in parallel with 0.4 Pg USP2-core, a positive control DUB with 
0.45 Pg poly-ubiquitin chain mixtures for approximately 15 hr. The reaction was 
stopped using gel loading buffer, electrophoresed on a 5-20% (w/v) acrylamide 
gradient gel, transferred on to nitrocellulose membrane and probed for ubiquitin. 
The C313S mutant showed no DUB activity with either isomer of poly-ubiquitin 
chain mixtures. The same preference by eluted elaD was shown for K63-linked 
poly-ubiquitin chains over K48-linked poly-ubiquitin chains compared with when 
elaD was attached to glutathione-Sepharose 4B beads. K63-linked poly-ubiquitin 
chains were only deconjugated to Ub3 this time compared with being deconjugated 
to Ub2 in Fig.5.9. The eluted elaD showed weak DUB activity with K48-linked poly-
ubiquitin by deconjugating Ub6 to Ub4. 
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5.2.7 Analysis of elongation factors, both prokaryotic (EF-Tu) and 
eukaryotic (EF-1D for DUB activity using unanchored K63/K48-
linked mixed length poly-ubiquitin as substrates 
In Chapter 4 the candidates for the DUB activity in E. coli 
RosettaTM2(DE3); the E. coli elongation factors EF-Tu (GST-TufA and 
GST-TufB) and GST-elaD, including the eukaryotic elongation factor 
(GST-EF-1D1 and GST-EF-1D2) were triaged using a ubiquitin-
Sepharose pull down assay. This was following the hypothesis that a 
DUB activity would also be associated with the ability to bind ubiquitin 
as many DUBs contain ubiquitin binding domains (UBDs), some may 
not157. This theory was verified in this particular case, later through the 
use of gene knock-out techniques to knock-out elaD. It is possible that 
as well as elaD, there may be other DUBs in E. coli so it would be an 
interesting exercise to use poly-ubiquitin DUB assays to test TufA and 
TufB for any DUB activity.  
 
A DUB assay was carried out using K63 and K48 linked poly-ubiquitin 
chain mixtures. GST (~15 Pg) and GST-tagged  DUB candidate 
proteins (~15 Pg) were captured on glutathione-Sepharose 4B beads, 
then incubated (37oC) with 0.45 Pg either K63 (Fig.5.9.A) or K48 
(Fig.5.9.B) linked poly-ubiquitin chain mixtures for approximately 15 hr. 
The reaction was stopped using gel loading buffer, electrophoresed on 
a 5-20% (w/v) acrylamide gradient gel, transferred on to nitrocellulose 
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membrane and probed for ubiquitin. Fig.5.11.A and Fig.5.11.B show 
GST-elaD was the only DUB candidate to deconjugate poly-ubiquitin 
chains (preferring K63-linked poly-ubiquitin). This confirms the choice of 
GST-elaD, during the triage of DUB candidates in Chapter 4. 
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Fig. 5.11 GST and GST-tagged DUB candidate proteins were purified using 
glutathione-Sepharose 4B beads, and whilst still attached to glutathione-
Sepharose 4B beads were then incubated (37oC) with either K63 (A) or K48 (B) 
linked poly-ubiquitin chain mixtures for approximately 15 hr. The reaction was 
stopped using gel loading buffer, electrophoresed on a 5-20% (w/v) acrylamide 
gradient gel, transferred on to nitrocellulose membrane and probed for ubiquitin. It 
is evident that GST-elaD was the only DUB candidate to demonstrate DUB activity 
as Ub5 was deconjugated to Ub2 although not completely as a feint band for Ub3 
remained. This verifies the choice of elaD as the likely DUB candidate chosen 
during the triage discussed in Chapter 4.  
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5.2.8 Anchored poly-ubiquitin chains as substrates for GST-elaD, 
including exclusive K6, K11, K27, K29, K33, K48, K63 linkages 
The poly-ubiquitin chains used as substrates for GST-elaD so far in this 
study have been unanchored K63-linked or K48-linked forms. Some 
eukaryotic DUBs, for example isopeptidase T (IsoT), have been known 
to demonstrate a preference for unanchored poly-ubiquitin chains over 
anchored poly-ubiquitin chains158. Therefore to investigate any 
preference for anchored poly-ubiquitin chains by GST-elaD, anchored 
chains were used. As only K63 and K48-linked unanchored poly-
ubiquitin chains have been used previously in this study, all possible 
isomers of the anchored poly-ubiquitin chains were also included. 
These anchored poly-ubiquitin chains are GST-tagged, N-terminal to 
the polyubiquitin chain and were kindly supplied by BIOMOL- Enzo Life 
Sciences as they were not yet commercially available at the time that 
this work was carried out. These unanchored chains were first used by 
H. Wang et al in order to develop a specific antibody for K63-linked 
poly-ubiquitin159. 
 
Eluted GST-tagged proteins (prepared as described in 5.2.6) were 
incubated (37oC) with 0.45 Pg poly-ubiquitin chains (anchored) for 
approximately 15 hr. The reaction was stopped using gel loading buffer, 
electrophoresed on a 5-20% (w/v) acrylamide gradient gel, transferred 
on to nitrocellulose membrane and probed for ubiquitin (Fig.5.12). It is 
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clear from Fig.5.12.B that GST-elaD did not deconjugate the anchored 
K63-linked poly-ubiquitin chains. Having demonstrated previously 
(5.2.4) that GST-elaD does deconjugate unanchored K63-linked poly-
ubiquitin chains, this would indicate a preference by GST-elaD for 
unanchored poly-ubiquitin chains. GST-elaD did not deconjugate any of 
the other possible linkages of the unanchored poly-ubiquitin chains but 
the positive control did. 
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Fig. 5.12 Anchored poly-ubiquitin chains containing one of either possible lysine-
linkage: K6, K11, K27, K29, K33, K48 and K63, were used as a substrate for GST-elaD 
eluted from glutathione-Sepharose 4B beads. GST-elaD (5 Pg) and 5 Pg GST-tagged, 
catalytic mutant (C313S) were incubated (37oC) in parallel with 0.4 Pg USP2-core, a 
positive control DUB with 0.45 Pg poly-ubiquitin chain mixtures for approximately 15 hr. 
The reaction was stopped using gel loading buffer, electrophoresed on a 5-20% (w/v) 
acrylamide gradient gel, transferred on to nitrocellulose membrane and probed for 
ubiquitin. GST-elaD did not deconjugate any of the forms of anchored poly-ubiquitin 
chains.  
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5.2.9 A mixture of target proteins, poly-ubiquitinated and mono-
ubiquitinated, including unanchored poly-ubiquitin from rat 
muscle as substrates for GST-elaD 
First the ubiquitin binding protein, ZNF216 (expressed in E. coli) was 
attached to Sepharose 4B beads to generate ZNF216-Sepharose 
beads (2.4.2.4)160. Next, the hind leg muscle (35g) from a sacrificed 
adult male Lister-hooded rat (Charles River, UK) was homogenised in 
Tris-DTT (50mM Tris, 1mM DTT, pH7.5), including protease inhibitor 
cocktail on ice. Then, clarified rat muscle lysate containing a mixture of 
ubiquitinated proteins, was incubated with immobilised ZNF216-
Sepharose beads (2.4.2.1). Eluted GST (~5 Pg) or ~5 Pg GST-tagged 
proteins (prepared as described in 5.2.6) were incubated (37oC) with 
immobilised rat muscle ubiquitinated proteins for approximately 15 hr. 
The reaction was stopped using gel loading buffer, electrophoresed on 
a 5-20% (w/v) acrylamide gradient gel, transferred on to nitrocellulose 
membrane and probed for ubiquitin (Fig.5.13). There is evidence in 
Fig.5.13 that GST-elaD did deubiquitinate some of the ubiquitinated 
proteins, as there is a feint band for mono-ubiquitin. Unanchored poly-
ubiquitin was also likely to have been present as a substrate for elaD. It 
is possible that the weak band for mono-ubiquitin corresponds with the 
amount of unanchored chains rather than a weak DUB activity of GST-
elaD.  
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Fig. 5.13 A mixture of ubiquitinated proteins, captured from a rat muscle 
lysate, were used as substrates for GST-elaD. Eluted GST (5 Pg), GST-
elaD (5 Pg) and the GST-tagged, 5 Pg catalytic mutant (C313S) were 
incubated (37oC) in parallel with USP2-core, a positive control DUB with 
immobilised ubiquitinated proteins on glutathione-Sepharose 4B beads 
for approximately 15 hr. The reaction was stopped using gel loading 
buffer, electrophoresed on a 5-20% (w/v) acrylamide gradient gel, 
transferred on to nitrocellulose membrane and probed for ubiquitin. GST-
elaD showed limited deubiquitinating activity as is evident from a feint 
band for mono-ubiquitin (circled). 
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5.2.10 Characterising GST-elaD DUB activity using unanchored 
K63-linked mixed length poly-ubiquitin 
The final analysis was to vary DUB assay conditions to investigate 
further the catalytic activity of GST-elaD, using K63-linked poly-ubiquitin 
as a preferred substrate. When carrying out assays involving DUB 
enzymes the reducing agent, dithiothreitol (DTT) was included to 
reduce disulphide bonds and therefore prevents unwanted 
intramolecular and intermolecular disulphide bonds from forming 
between cysteine residues. The concentration of DTT was varied (1 
mM, 0.5 mM and 2 mM) to see how this affected the catalytic activity of 
GST-elaD.  
 
Buffers differ in their ability to buffer pH, which in turn affects the 
optimum pH for the catalytic activity of an enzyme, therefore three 
buffers were used. The buffers used for the DUB assays were TBS (150 
mM NaCl, 10 mM Tris), Tris buffer (50 mM Tris, 1 mM EDTA pH 7.5) 
and HEPES buffer (50 mM HEPES, 0.5 mM EDTA). The Tris buffer had 
been shown to provide optimal conditions for USP2-core, the positive 
control DUB used in this assay161. The HEPES buffer is a standard 
buffer used for DUB assays by ENZO Life Sciences UK (P. Sheppard, 
personal communication). Buffers were used in a range of pH values 
(7.1 ± 7.6) measured at 37oC to find the optimum pH for the catalytic 
activity of GST-elaD. The assay was carried out using GST-elaD (15 
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Pg) captured on Glutathione-Sepharose beads as described previously, 
then incubated with 0.45 Pg unanchored K63-linked poly-ubiquitin and 
the proteins were analysed by probing for ubiquitin (Fig.5.14).  
 
None of the assay conditions shown in Fig.5.14 were conducive to a 
complete deconjugation of K63-linked poly-ubiquitin chains by GST-
elaD, showing that this enzyme has limited deubiquitinating activity. 
Previous DUB assays were carried out in TBS (0.5 mM DTT) at pH 7.5-
7.6 (37 oC) which appear to be within the optimum range of pH for GST-
elaD and as shown on previous occasions, for USP2-core activity for all 
buffers used in Fig.5.14. The USP2-core used in Fig.5.14.A and 
Fig.5.14.B were from an old stock so DUB activity was poor. 
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Fig. 5.14 The DUB assay conditions were varied to investigate the ability of elaD 
to deconjugate K63 poly-ubiquitin chains over a range of pH 7.1 - 7.6 (37oC) and 
in different buffers. GST-elaD (15 Pg) was purified using glutathione-Sepharose 
4B beads, and whilst still attached to glutathione-Sepharose 4B beads, incubated 
(37oC) with 0.45 Pg K63-linked poly-ubiquitin, 0.4 Pg USP2-core was included as 
a positive control DUB. DUB assay samples were incubated (37oC) for 15 hr, for 
all 4 conditions, with TBS 0.5 mM DTT (A), TBS 2 mM DTT (B), HEPES buffer, 1 
mM DTT (C) and Tris buffer, 1 mM DTT (D). The reaction was stopped using gel 
loading buffer, electrophoresed on a 5-20% (w/v) acrylamide gradient gel, 
transferred on to nitrocellulose membrane and probed for ubiquitin. None of the 
assay conditions improved the ability of elaD to deconjugate chains shorter than 
Ub3, however elaD was more sensitive to pH when using TBS 0.5 mM DTT. 
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5.2.11 Construction of mutations within GST-elaD designed to 
impair binding of GST-elaD to ubiquitin: GST-N227A, GST-W232A 
and GST-D169A  
Section 5.2.3 describes generating the GST-elaD catalytic mutant, 
GST-C313S, to compare with wild type GST-elaD in DUB assays and 
demonstrate that GST-elaD was responsible for the observed 
deconjugation of K63-linked poly-ubiquitin chains. The focus of this 
section now changes from the catalytic activity of GST-elaD to the 
binding of GST-elaD to ubiquitin, i.e. ubiquitin recognition by GST-elaD, 
previously observed in 4.2.4. This is of particular interest as this 
represents an interaction between a prokaryotic (elaD) and highly 
conserved eukaryotic (ubiquitin) protein. 
 
A homology model of the structure of elaD was used to predict amino 
acid residues which may be responsible for catalysis and substrate 
binding. The homology model was based on the closest structural 
neighbour to elaD, Xanthomonas outer protein D (XopD), (personal 
communication by I. Dreveny, University of Nottingham) (Fig.5.15). 
XopD is a SUMO specific, deSUMOylating enzyme, a virulence factor 
secreted using Type III secretory system by Xanthomonas campestris 
pv. Vesicatoria. Results from homology modelling revealed six amino 
acid residues within elaD potentially important for binding or catalysis. 
Three of those amino acid residues (aspartate (D) 169, asparagine (N) 
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227 and tryptophan (W) 232) mutated in this study are shown in red in 
Fig.5.15 (the active site residues have been excluded).  
 
The first of the three amino acid residues in elaD, chosen for mutation 
in an effort to disrupt binding or catalysis in this study was D169. D169 
in elaD (conserved in XopD, all SENPs and SseL) and like NEDP1 
could form a salt bridge with a conserved arginine residue at P35 
position in its substrate. When the aspartate in NEDP1 (D29), 
corresponding with elaD D169, was mutated to D29A or D29N, NEDP1 
activity was abolished. Therefore in this study, D169 in elaD was 
chosen for mutation to interfere elaD binding to ubiquitin117.  
 
The second of the three amino acid residues in elaD, chosen for 
mutation to disrupt binding or catalysis, was N227. N227 in elaD 
(conserved in XopD, NEDP1, SENP6, SENP7, Ulp1 and SseL) may be 
important in forming a hydrogen bond with arginine in ubiquitin, as the 
conserved asparagine residue in NEDP1 (N91) can form a hydrogen 
bond with arginine residue 74, at the P3 position in NEDD8. The 
NEDP1 mutant, N91A was shown by L. Shen et al to be inactive, thus in 
this study N227 in elaD was chosen for mutation as it may potentially 
interfere with elaD binding to ubiquitin117. 
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The third of the three amino acid residues in elaD, chosen for mutation 
to disrupt binding or catalysis, was W232. W232 in elaD (conserved in 
XopD, all SENPs and SseL) can form Van der Waals interactions with 
glycine at P1 position in ubiquitin in the same way that NEDP1 does 
with NEDD8. A considerable loss of activity was reported by L. Shen et 
al when this conserved tryptophan in NEDP1 (W103) was mutated to 
W103A117. Therefore in this study, in an attempt to hinder elaD binding 
to ubiquitin, W232 was mutated.  
 
Each of the three amino acid residues in elaD, D169, N227 and W232 
were mutated to alanine, as the alanine side chain (-CH3) can not form 
a salt bridge, hydrogen bond or have Van der Waals interactions with 
ubiquitin. The three GST-elaD mutants, developed in an attempt to 
abrogate the ability of GST-elaD to bind ubiquitin were, GST-N227A, 
GST-W232A and GST-D169A. Wild type GST-elaD and the three 
mutants were then tested for their ability to bind ubiquitin using a 
ubiquitin-Sepharose pull-down assay. The three mutants, GST-N227S, 
GST-W232A and GST-D169A were generated by carrying out PCR 
based SDM using Pfu DNA polymerase as described in 2.6.4.  
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Fig. 5.15 A homology model of the structure of the elaD peptidase domain based 
on the closest structural neighbour to elaD, Xanthomonas outer protein D (XopD), 
personal communication by I. Dreveny, University of Nottingham. XopD is specific 
for SUMO and is a virulence factor secreted using Type III secretory system by 
Xanthomonas campestris pv. Vesicatoria. The residues (excluding active site 
residues), are as indicated, and are predicted to be important for catalytic activity 
or substrate binding or for both functions. Mutants of elaD were generated by 
converting some of the residues (W232, D169 and N227) shown in red to alanine. 
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5.2.12 Using mutants of GST-elaD (N227A, W232A and D169A) to 
investigate recognition of ubiquitin 
Ubiquitin-Sepharose was used to test GST-tagged wild type (WT) elaD 
and elaD binding mutants, GST-N227A, GST-W232A and GST-D169A 
for their ability to bind ubiquitin. Protein was captured from a clarified 
lysate generated from a 10 ml culture, using a bead slurry (100 Pl) of 
either, glutathione-Sepharose 4B beads (glutathione-Sepharose), 
ubiquitin-Sepharose or Sepharose (control) and incubated (4oC) rotating 
for 1 hr, then washed with 0.1% (v/v) Triton X-100 in TBS. Proteins 
were eluted off the beads using gel loading buffer, electrophoresed on a 
5-20% (w/v) acrylamide gradient gel and stained with Coomassie blue 
stain (Fig.5.16). When this assay was carried out previously the 
proteins were transferred on to a nitrocellulose membrane and probed 
for GST (4.2.4). However there was a large amount of non-specific 
protein which cross reacted with the GST antibody. Therefore to reduce 
sensitivity, this time a Coomassie stained gel was preferred. 
 
When using Coomassie stain, ~1/10th of wild type (WT) GST-elaD 
bound to glutathione-Sepharose was shown to bind to ubiquitin-
Sepharose (Fig.5.16). This assumes that the glutathione-Sepharose 
reveals the total amount of GST-fusion available for binding. The 
predicted binding mutants, GST-W232A and GST-N227A showed 
reduced binding to ubiquitin-Sepharose, more so for GST-W232A 
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compared with WT GST-elaD. Interestingly, GST-D169A and to some 
extent GST-C313S appeared to show an increased ability to bind 
ubiquitin-Sepharose. The lack of binding by GST confirms the specificity 
of elaD for immobilised ubiquitin. 
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Fig. 5.16 A ubiquitin-Sepharose pull-down assay to investigate any effects of 
mutating predicted ubiquitin binding residues may have over GST-elaD 
binding to ubiquitin. The three GST-tagged ubiquitin binding mutants tested 
were: D169A, W232A and N227A. The GST-elaD catalytic mutant, C313S 
was included to investigate any changes in binding ubiquitin as a result of 
changing a residue in the catalytic site. E. coli substrain XL10 Gold lysates 
were prepared in 0.1% (v/v) Triton X-100 in TBS as described 2.1.2. Protein 
was captured using either glutathione-Sepharose 4B beads (Glut-Seph), Ub-
Seph or Seph and incubated (4oC) rotating for 1 hr, then washed with 0.1% 
(v/v) Triton X-100 in TBS. Proteins were eluted off the beads using gel 
loading buffer, electrophoresed on a 5-20% (w/v) acrylamide gradient gel, 
and Coomassie stained. W232A and N227A showed a reduced binding to 
ubiquitin, more so for W232A compared with WT. Interestingly, D169A and 
to some extent C313S showed an improved ability to bind ubiquitin. 
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5.3 Conclusions 
The work discussed in this chapter was aimed at developing a better 
understanding of the preference by GST-elaD for the topology of 
ubiquitin substrates and the mechanism of how GST-elaD binds to 
ubiquitin for catalysis. In this study (Chapter 3) it has already been 
demonstrated (in vivo) that GST-elaD is capable of cleaving linear 
peptide bonds in fusion proteins containing ubiquitin. The work in this 
chapter clearly shows that GST-elaD also has the ability to deconjugate 
isopeptide bonds within unanchored poly-ubiquitin chains and in 
particular, showed a preference for unanchored K63-linked poly-
ubiquitin over K48-linked poly-ubiquitin chains.  
 
The ability of GST-elaD to deconjugate K63-linked poly-ubiquitin is 
perhaps not surprising as the topology of linear ubiquitin is very similar 
to that of K63-linked poly-ubiquitin19. However, this preference for the 
K63-linked chains could indicate a possible function for GST-elaD. 
Eukaryotic DUBs targeting this poly-ubiquitin linkage are often involved 
in inhibiting the NF-NB signalling pathway, therefore preventing the 
expression of genes involved in the immune response6, 9, 15, 107, 108. 
Interestingly, both commensal and pathogenic E. coli (excluding 
extraintestinal strains) express elaD. Therefore these findings 
strengthen the argument that elaD is involved in some way in 
subverting host cell systems. However non-pathogenic E. coli lack the 
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specialised secretory structures found in pathogenic bacteria, for 
example the Type III secretory system which injects the host cell with 
virulence effectors. Non-pathogenic E. coli do have ABC transporters, 
as well as a general secretion (Sec) and two-arginine (Tat) translocation 
pathways, which could potentially be used for the export of elaD12, 162. 
Proteins secreted through the Sec and Tat pathways do need an N-
terminal leader sequence for recognition by the systems. Assuming 
elaD has been translocated across the cytoplasmic membrane and cell 
wall of E. coli it would then need to be delivered in to the host cell. A 
novel form of contact-dependent signalling used by pathogens is also 
theoretically a possible way to transfer elaD directly into epithelial cell 
membranes163. This method would have to use novel transfer proteins 
as those known to be involved in this mode of transport have only been 
found in pathogenic bacteria164.More work needs to be done in that 
area. 
 
The structure of elaD has yet to be determined, however fold 
recognition predictions of the peptidase domain show the closest 
structural neighbour to elaD to be XopD (Xanthomonas outer protein D) 
and SENP proteins, Ulp1 (yeast) and SENP2 (human) are also quite 
close. Therefore a paradox exists between the structure of elaD and its 
substrate, as the structural neighbours for elaD are deSUMOylating 
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enzymes and GST-elaD does not deSUMOylate but prefers ubiquitin. 
These findings were confirmed by A. Catic14. 
 
There is evidence for a limited deubiquitinating activity with a mixture of 
ubiquitinated substrates from rat muscle (Fig.5.13), when used as a 
substrate for GST-elaD. However, this appears to be a weak DUB 
activity as it is less active than the positive control DUB, USP2-core. It 
is possible that the low level of mono-ubiquitin is related to the 
restriction of GST-elaD to unanchored K63-linked poly-ubiquitin than to 
a weak DUB activity in this case. When poly-ubiquitin was the substrate 
for GST-elaD only a weak DUB activity was observed. It is likely that 
there are some constraints over poly-ubiquitin recognition by GST-elaD, 
clear from the lack of deconjugation of poly-ubiquitin chains to below 
Ub2 (Fig.5.10). However, there were still feint bands for Ub4 and Ub5, 
which had not been deconjugated after 15 hr. The low level of catalytic 
activity by elaD in the current study was not observed by A. Catic et al 
when using ubiquitin-AMC as a substrate14. The low level activity of 
elaD seen in this study may be due to elaD having a higher affinity for 
ubiquitin-AMC than for the ubiquitin substrates used in the current 
study. Alternatively, one might suggest that this was an µapparent¶ low 
level activity resulting from a low concentration of elaD in DUB assays. 
However if this was the case, one might expect that an active enzyme 
would have completed a reaction within a fifteen hour incubation time. 
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The most likely reason for the low level activity of GST-elaD observed in 
this study is due to the absence of a co-factor or another protein, 
necessary for GST-elaD to be fully active.  GST-elaD was not a very 
active DUB when compared with the activities of other DUBs, reported 
by D. Komander et al19. In the study by Komander et al, nine DUBs, all 
selected from different groups of DUBs were incubated with either K48-
linked, K63-linked or linear tetra-ubiquitin at a molar ratio (DUB : 
substrate), 4 : 1, for a range of times (0 min ± 60 min). Isopeptidase T 
(IsoT) completely deconjugated K63-linked or K48-linked tetra-ubiquitin 
to within 10 minutes, compared with GST-elaD which had a molar ratio, 
0.4 : 1 and incompletely deconjugated K63-linked poly-ubiquitin in 15 
hr. The incomplete processing of poly-ubiquitin by GST-elaD is a 
feature of other enzymes for example, UCH-L1 and A20, had 
deconjugated tetra-ubiquitin to Ub3 in an hour. 
 
The weak binding of GST-elaD to ubiquitin (Fig.5.16) also shows that 
GST-elaD has a low affinity for mono-ubiquitin which probably 
contributes to the weak DUB activity. Limited information was obtained 
about the residues in GST-elaD important for binding to ubiquitin. 
Creating single point mutations in GST-elaD, predicted to perturb GST-
elaD binding to immobilised ubiquitin revealed that W232 possibly 
contributes to GST-elaD binding to immobilised ubiquitin whereas N227 
does not.  
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The absence of DUB activity by GST-elaD with some of the ubiquitin 
substrates was perhaps just as informative as the DUB activity 
observed. The lack of deconjugation of a linear peptide bond in di-
ubiquitin was initially unexpected as GST-elaD has been shown to 
cleave the linear peptide bond in fusion proteins containing ubiquitin. 
However, GST-elaD did only deconjugate unanchored K63-linked poly-
ubiquitin to tri-ubiquitin, so perhaps GST-elaD lacks necessary 
recognition sites for binding to di-ubiquitin, regardless of the bond type 
between the ubiquitin molecules. It is particularly interesting that GST-
elaD did not deconjugate anchored K63-linked poly-ubiquitin chains yet 
did deconjugate unanchored poly-ubiquitin of the same isomer. This 
preference for unanchored poly-ubiquitin is associated with IsoT, a 
DUB which deconjugates ubiquitin chains in the cell to recycle 
ubiquitin165. IsoT requires the C-terminus of the proximal ubiquitin in the 
poly-ubiquitin chain to be free for binding. These findings lead to the 
suggestion that when poly-ubiquitin is the substrate, GST-elaD needs 
the C-terminus of the proximal ubiquitin in the chain in order to bind and 
deconjugate the chain. A slightly different mechanism must operate 
when GST-elaD deubiquitinates a linear fusion protein as ubiquitin is 
connected to a fusion partner and therefore there is no exposed 
ubiquitin C-terminus for recognition. 
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From the work discussed in this chapter, more has been learned about 
the preference GST-elaD has for ubiquitin isomers as substrates. GST-
elaD prefers unanchored chains, and specifically prefers K63-linked 
poly-ubiquitin. elaD is only expressed in commensal and pathogenic E. 
coli associated with the intestines. This and the preference for K63-
linked poly-ubiquitin could indicate that elaD plays a role in modulating 
the inflammatory response in the intestines to retain a symbiotic 
relationship with host cells. More work needs to be carried out to 
investigate if this is the case and to ascertain how this occurs. 
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6 Discussion 
 
6.1. Key findings of this study 
 
6.1.1 E. coli substrain RosettaTM2(DE3) expresses a specific DUB 
with a conventional mechanism 
The work in this study has clearly demonstrated that E. coli substrain 
RosettaTM2(DE3) has a specific, intrinsic DUB activity. Work leading up 
to this project involved the observation of a novel ubiquitin-fusion 
processing activity in a DE3 strain of E. coli by other members of this 
group (H. Jefferey and I. Kerr, unpublished). The processing activity 
occurred in vivo, against an N-terminal hexahistidine tagged ubiquitin-
lincomycin resistance C fusion protein, (His)6-Ub-LmrC expressed in the 
DE3 strain of E. coli. The initial work in this study was aimed at 
characterising the novel ubiquitin-fusion processing activity, initially in E. 
coli substrain RosettaTM2(DE3). The DUB activity was specific (i.e. 
cleaved post Gly76 of ubiquitin), confirmed by N-terminal sequence 
analysis (Chapter 3). A main focus of this study was to investigate the 
specificity of the DUB activity in E. coli substrain RosettaTM2(DE3) as 
well as to identify this prokaryotic DUB. The initial work showed that the 
DUB in E. coli substrain RosettaTM2(DE3) had a conventional catalytic 
activity. The use of (His)6-Ub-LmrC mutants with point mutations around 
the DUB cleavage site (GA, GP and GGP), designed to perturb 
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cleavage showed that the prokaryotic DUB, like most mammalian DUBs 
(D. A. Gray, personal communication) did not cleave bonds when 
proline forms part of the DUB cleavage site. The inability of the 
prokaryotic DUB to cleave GA (i.e. G76A mutation at the C-terminus of 
ubiquitin) was similar to the findings of Butt and co-workers who 
previously characterised the specificity of DUBs expressed in yeast148. 
In this study it was demonstrated that GST-elaD has a conventional 
catalytic mechanism, one which requires cysteine within its catalytic 
triad. This is shown by the lack of activity by the GST-elaD catalytic 
mutant C313S compared with the activity of wild type GST-elaD in DUB 
assays (in vitro). The lack of catalytic activity by C313S was not simply 
the result of poor binding to substrate, as C313S was better at binding 
with ubiquitin (in ubiquitin-Sepharose) than wild type GST-elaD.  
 
 
6.1.2 The DUB in E. coli substrain RosettaTM2(DE3) was shown to 
prefer ubiquitin over SUMO1 or NEDD8 as substrates in vivo 
The work in this study was aimed at investigating any preference that 
the DUB in E. coli substrain RosettaTM2(DE3) may have for ubiquitin or 
the ubiquitin-like proteins (UBLs) small ubiquitin-related modifier 1 
(SUMO1) or neural precursor cell expressed developmentally down-
regulated protein 8 (NEDD8). If a preference was shown by the DUB in 
E. coli substrain RosettaTM2(DE3) then this could give more information 
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about its catalytic site/mechanism in comparison with known DUBs or 
ubiquitin-like proteases (ULPs) and may even indicate a possible 
function. Some DUBs or ULPs are exclusive to their substrates, whilst 
others are less specific. For example the deNEDDylating ULP, NEDP1 
(human) is specific for NEDD8 only, whereas the DUB, USP21 (human) 
can cleave ubiquitin and NEDD8 but not SUMO1109, 166. The 
deSUMOylating ULPs (all human), SENP1, SENP2 and SENP3 are all 
specific for SUMO. The specificity of DUBs or ULPs for their substrates 
is still not fully understood, however, functional studies and structural 
information have helped us to understand some structural controls over 
specificity. 
 
Shen et al. determined the crystal structures of NEDP1 bound to 
NEDD8 or in isolation and compared those findings with the structure 
for, Yuh1 (yeast) covalently linked to ubiquitin aldehyde determined by 
Johnston et al. and the structure for Ulp1 (yeast) in complex with SUMO 
determined by Mossessova et al.117, 167, 168. Shen et al. highlighted the 
importance of the 72nd amino acid residue in NEDD8 and ubiquitin in 
determining the specificity of NEDP1 for NEDD8 over ubiquitin. The 
72nd amino acid residue of ubiquitin is arginine (R) UbR72 and NEDD8 is 
alanine (A) NEDD8A72. The specificities of NEDP1 and Ulp1 for their 
substrates, NEDD8 and SUMO1, respectively, are explained by Shen et 
al. as being due to two structural characteristics of the proteases. The 
  
 
217 
 
surfaces on each protease have very different charges, which ensure 
specificity for the substrate. Additionally, each protease has a loop 
which moves over the C-terminus of each protease in complex with the 
substrate and in NEDP1 this loop is much longer than in Ulp1 limiting 
binding partners for each protease and ensuring strict specificity. The 
findings of our study have demonstrated that the DUB activity in E. coli 
substrain RosettaTM2(DE3) preferred ubiquitin over SUMO1 or NEDD8. 
These initial investigations compared the ability of fusion proteins 
containing either ubiquitin, NEDD8 or SUMO1 to be cleaved, in vivo 
when expressed in E. coli substrain RosettaTM2(DE3). Only the fusion 
protein containing ubiquitin was cleaved in vivo. Therefore, this would 
indicate that the DUB in E. coli substrain RosettaTM2(DE3) has a 
catalytic site and a binding surface more comparable to Yuh1.  The 
finding in our study that the DUB in E. coli substrain RosettaTM2(DE3) 
shows a preference for ubiquitin over NEDD8 or SUMO1 is significant. 
E. coli do not have a system like the eukaryotic ubiquitin-mediated 
system and therefore have no ubiquitin homologue to function as a 
protein tag. It is possible that the two ubiquitin homologues, ThiS and 
MoaD which take part in the biosynthesis of thiamin and Molybdenum 
cofactor (respectively) in E. coli are substrates for elaD. The possible 
implications for a prokaryotic DUB having a specificity for ubiquitin will 
be discussed later in section 6.1.6. 
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6.1.3 The DUB in E. coli substrain RosettaTM2(DE3) was identified 
as elaD 
At the start of this study there were no reports of DUB expression in E. 
coli. It was known however from the literature that some prokaryotic 
DUBs were expressed by pathogenic eubacteria other than E. coli, and 
that these DUBs were involved in subversion of host cell systems for 
virulence6-8, 15, 107 9, 10, 108. During the progression of this study a ULP, 
elaD, expressed by E. coli, was discovered by Catic in a group lead by 
Ploegh14. Using a bioinformatics search for new members of a clan 
containing UBPs and ULPs Catic et al. identified elaD and subsequently 
showed that GST-elaD had DUB activity, using suicide inhibitors and 
ubiquitin-AMC as substrates for elaD. Therefore the work in our study 
aimed at identifying the identity of the DUB activity in E. coli substrain 
RosettaTM2(DE3) included elaD as a candidate. The prokaryotic 
elongation factor, EF-Tu, shown by Ciechanover and colleagues to be 
associated with an ubiquitin protease activity, was also included as a 
candidate for the activity139. The identity of the DUB activity in E. coli 
substrain RosettaTM2(DE3) was established as elaD, using a gene 
knock-out technique to knock-out elaD, creating 
RosettaTM2(DE3)'elaDapr. When fusion proteins shown to cleave in the 
parental E. coli, (His)-Ub-LmrC or (His)6-Ub-enhanced green 
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fluorescence protein (EGFP), were expressed in 
RosettaTM2(DE3)'elaDapr, DUB activity was abolished (4.2.3).  
 
The findings in our study (6.1.2) of the preference for ubiquitin over 
NEDD8 or SUMO1 by the prokaryotic DUB, now known to be elaD, are 
supported by the biochemical tests carried out by Catic et al.14. The 
authors found that GST-elaD cleaved ubiquitin-AMC but not SUMO-
AMC or NEDD8-AMC. However, the use of suicide inhibitors showed 
that GST-elaD became covalently attached to ubiquitin-vinyl 
methylester but not SUMO-vinylsulphone (SUMOVS) and to a limited 
extent GST-elaD also became covalently linked to NEDD8VS. The 
findings by Catic et al. suggest a weak DUB activity by elaD for NEDD8. 
In our study we observed no cleavage of NEDD8 in (His)6-NEDD8-
LmrC; perhaps these different findings relate to the differences in 
NEDD8 substrates. It is possible that the binding of GST-elaD to 
NEDD8 is an artefact due to the use of suicide inhibitors. The 
NEDD8VS suicide inhibitor is slightly different from NEDD8.  The 
suicide inhibitors developed by Catic et al. have an alternative 
electrophilic region neighbouring the electrophilic carbonyl carbon 
(which normally undergoes nucleophillic attack by the DUB). 
Additionally, the electrophilic region has to be stabilised by an electron 
withdrawing group, therefore the chemical environment in NEDD8 is 
different from that of NEDD8VS. The positioning of NEDP1 by 
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NEDD8A72 was found to be a critical factor in conferring specificity to 
NEDP1 for NEDD8117. Therefore, the slight difference in peptide bond 
location and in the chemical environments of NEDD8VS compared with 
NEDD8 may be enough of a change to favour a binding that would not 
normally occur with NEDD8. 
 
6.1.4 GST-elaD prefers unanchored Lysine 63-linked poly-ubiquitin 
as a substrate in vitro 
In this study work carried out (discussed in Chapter 5) using different 
types of ubiquitin substrates for GST-elaD was aimed at building a 
picture of the specificity that GST-elaD has for ubiquitin. In a recent 
review, Komander et al. describe the five different types of specificities 
displayed by DUBs for poly-ubiquitin chains130. DUBs can be linkage-
specific, for example to prefer Lysine 48-linked (K48) poly-ubiquitin; 
regionally-specific, for example either endo-specific or exo-specific; 
substrate-specific; mono-ubiquitin-specific or specific for unanchored 
ubiquitin. 
 
The findings of our study have demonstrated that GST-elaD showed a 
clear preference for Lysine 63-linked (K63) poly-ubiquitin chains over 
K48-linked poly-ubiquitin chains. Interestingly, as well as being linkage 
specific for K63-linked poly-ubiquitin, GST-elaD also demonstrated a 
specificity for unanchored poly-ubiquitin as GST-elaD was unable to 
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deconjugate anchored K63-linked poly-ubiquitin (5.2.8). This could 
mean that GST-elaD is either specific for unanchored chains, or GST-
elaD is substrate-specific with the added ability in being able to 
deconjugate unanchored K63-linked poly-ubiquitin. If GST-elaD simply 
has a preference for unanchored poly-ubiquitin this would suggest that, 
with poly-ubiquitin elaD must have a ubiquitin recognition site similar to 
that in the eukaryotic DUB, isopeptidase T (IsoT)158, 165. The lack of 
specificity of IsoT for unanchored poly-ubiquitin, i.e. it is not linkage-
specific, makes it ideal for recycling K63-linked poly-ubiquitin (and 
possibly linear poly-ubiquitin) from poly-ubiquitin chains. However, if 
elaD is substrate-specific it is possible that elaD deubiquitinates a 
protein in a eukaryotic signalling pathway. 
 
The differences between the observations in this study of GST-elaD 
DUB activity and what is known about catalytic mechanism of IsoT, 
leads to the conclusion that, if elaD is specific for unanchored poly-
ubiquitin then elaD has a slightly different DUB mechanism to IsoT. 
GST-elaD was able to cleave ubiquitin fusion proteins, (His)6-Ub-LmrC 
and (His)6-Ub-EGFP (in vivo). There is no exposed GG of the C-
terminus of ubiquitin in either of the fusion proteins for GST-elaD to 
recognise, so this leads one to suggest that elaD has an alternative site 
for the recognition of ubiquitin. The cleavage of the fusion proteins in 
this study (in vivo) may be restricted to fusion proteins as nascent poly-
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peptides, so in an unfolded state, therefore revealing extra recognition 
sites necessary for elaD. However, elaD could be substrate-specific and 
therefore does not have the strict requirement for a C-terminus on 
ubiquitin.  
 
The findings of our study also showed that GST-elaD does not appear 
to recognise di-ubiquitin as GST-elaD did not deconjugate linear di-
ubiquitin and only deconjugated unanchored K63-linked poly-ubiquitin 
to di-ubiquitin. Although the bonds between ubiquitin molecules are 
different in linear di-ubiquitin compared with those in K63-linked poly-
ubiquitin, the peptide bond and K63-linked isopeptide bonds are 
structurally similar19. Therefore it is possible that GST-elaD may 
deconjugate linear poly-ubiquitin chains longer than n=2. However, this 
was not tested in this study. Constraints over time prevented the 
generation of linear ubiquitin substrates using an in vitro system that 
included the E3, the linear ubiquitin assembly complex (LUBAC) and 
linear poly-ubiquitin is not yet commercially available.  
 
 
6.1.5 GST-elaD-ubiquitin binding and elaD structural neighbours 
Limited information was obtained about the amino acid residues 
responsible for binding of GST-elaD to ubiquitin. GST-elaD mutants 
N227A, W232A and D169A were generated to perturb the ability of 
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GST-elaD to bind ubiquitin. A ubiquitin-Sepharose pull-down was used 
to compare the abilities of GST-tagged WT and mutant elaD to bind 
immobilised ubiquitin. Only residues W232 and N227 were 
demonstrated to be important for binding, but not vital as limited binding 
still occurred. More work needs to be carried out in this way to test other 
amino acid residues predicted to be important for binding elaD to 
ubiquitin.  
 
As part of this work a homology model of the structure of elaD was 
drawn based upon Xanthomonas outer protein D (XopD), the closest 
structural neighbour to elaD, (personal communication by I. Dreveny, 
University of Nottingham). Interestingly, XopD is a deSUMOylating 
enzyme which is specific for SUMO. This contrasts with elaD as 
although it is structurally similar to XopD, elaD does not cleave SUMO1 
and is specific for ubiquitin. This mismatch between structure and 
function of proteases is not unusual, for example, Avp is an adenoviral 
protease, structurally similar to the deSUMOylating protease, ULP1, yet 
Avp does not cleave SUMO, it cleaves a ubiquitin homologue precursor 
protein, ISG15169.  
 
6.1.6 Implications and outcomes 
The preference of elaD for ubiquitin, a eukaryotic protein, is significant, 
as it indicates that elaD may have a function associated with ubiquitin in 
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eukaryotic cells. E. coli do not have a system like the eukaryotic 
ubiquitin-mediated systems, and do not express ubiquitin or a ubiquitin 
homologue used as a protein tag. Therefore it is unlikely that this 
preference by GST-elaD for ubiquitin is related to a function within 
bacteria. Under standard growth conditions elaD did not appear to be 
essential for E. coli survival, as there was no evidence of impaired 
growth of the E. coli strain with elaD knocked out 
(RosettaTM2(DE3)'elaDapr), compared with wild type E. coli 
RosettaTM2(DE3).  
 
This, together with the observation that elaD is only expressed in 
commensal E. coli or pathogenic E. coli associated only with the 
intestines are indicators of elaD having a function which benefits the 
existence of a commensal bacterium. This could be to evade an 
immune response by dampening host cell signalling systems14. If this is 
the case, elaD could potentially benefit both commensal and pathogenic 
intestinal E. coli, but a secretion system and delivery mechanism would 
be needed.  
 
Commensal E. coli do have secretion systems and they certainly have 
been shown to dampen NF-NB signalling in intestinal epithelial cells, 
dendritic cells and B cells. The precise details of how these effects are 
achieved, however, are not known. The commensal bacterium, 
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Bacteriodes thetaiotamicron was shown to induce the export of RelA, 
one of the subunits of the transcription factor, NF-NB from the nucleus, 
preventing transcription of inflammatory genes170. B. thetaiotamicron 
was grown in a co-culture with an immortalised intestinal epithelial cell 
line, human epithelial colorectal adenocarcinoma (Caco-2) cells. It was 
demonstrated that B. thetaiotamicron induced the transcription of 
PPAR-J and the movement of peroxisome proliferator activated 
receptor-J (PPAR-J) in to the nucleus of Caco-2 cells followed by their 
exit from the nucleus with RelA. Another commensal bacterium, 
Lactobaccillus casei has been reported to prevent proteolysis of INB by 
the proteasome by an unidentified mechanism171.  
 
These examples demonstrate that commensal bacteria are capable of 
secreting effectors to modulate host cell systems, though more work is 
needed to identify the bacterial effectors and how they are delivered to 
the host. If elaD has a dampening effect over NF-NB signalling in host 
cells more needs to be learned of how commensal bacteria achieve this 
to understand any role elaD may have in E. coli.  
 
In contrast to the limited knowledge of how commensal bacteria 
dampen NF-NB signalling in host cells, more is known of how 
pathogenic bacteria of the gut achieve this. However, if elaD is simply 
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specific for unanchored K63-linked poly-ubiquitin it is unlikely that elaD 
would use the same mechanisms as known pathogens.  
 
Yersinia pseudotuberculosis (described in Chapter 1) expresses a DUB, 
YopJ which deubiquitinates K63-linked poly-ubiquitin chains from 
TRAF2 and TRAF6 and K48-linked poly-ubiquitin chain from INB 
therefore inhibiting production of inflammatory proteins15. Therefore 
YopJ is a DUB with dual specificity for K63-linked and K48-linked poly-
ubiquitin isomers and cleaves anchored chains. The findings of our 
study showed that elaD prefers unanchored K63-linked poly-ubiquitin 
over anchored K63-linked poly-ubiquitin. Therefore it would be unlikely 
that elaD could deubiquitinate TRAF 2, TRAF 6 or INB as the chains 
would be anchored. The preference for unanchored poly-ubiquitin by 
elaD would suggest that elaD has a similar role to that of IsoT, which 
recycles ubiquitin from poly-ubiquitin chains158. elaD could recycle K63-
linked poly-ubiquitin and linear unanchored chains. The lack of 
availability of linear chains longer than di-ubiquitin has precluded the 
use of linear poly-ubiquitin as a substrate for elaD in this study. It is 
likely that elaD could also process ubiquitin precursor proteins as GST-
elaD has been demonstrated in this study to cleave ubiquitin fusion 
proteins. IsoT does have a preference for K63-linked and K48-linked 
unanchored poly-ubiquitin over unanchored linear poly-ubiquitin, so 
elaD could potentially improve the recycling of unanchored K63-linked 
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and unanchored linear poly-ubiquitin ubiqitin19. However, this potential 
improvement in the availability of ubiquitin by elaD is unlikely to have 
any real benefit in dampening NF-NB signalling.  
 
Alternatively, if elaD is substrate-specific, rather than simply specific for 
unanchored K63-linked poly-ubiquitin, it is feasible that elaD could 
target NEMO, TRAF2, TRAF3 or TRAF6, or all three TRAF proteins 
depending on the degree of specificity that elaD may have for the 
substrate. NEMO has been shown to be ubiquitinated by an E3, the 
linear ubiquitin assembly complex (LUBAC) which builds linear poly-
ubiquitin chains with the same effects as K63-linked poly-ubiquitin, 
recently reviewed172. elaD could also potentially deconjugate linear 
poly-ubiquitin in this context. 
 
It is intriguing that a DUB expressed in both enteropathogenic E. coli 
and commensal E. coli, has an affinity for eukaryotic ubiquitin and 
neither E. coli strain expresses a ubiquitin homologue. elaD could be a 
key enzyme in modulating host cell systems and further work promises 
to improve our understanding of the relationship between commensal 
and enteropathogenic E. coli and host cells. 
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6.2. Future work 
More work needs to be done to explore the possible role for elaD and 
whether this is beneficial to commensal E. coli, enteropathogenic E. coli 
or both. The catalytic mechanism of elaD needs further investigation, as 
well as to search for possible binding partners for elaD. 
 
6.2.1 Investigating the possible role or roles of elaD 
An investigation could be carried out to test the hypothesis that elaD 
may be important for dampening NF-NB signalling in both 
enteropathogenic and commensal E. coli. Therefore elaD could be 
knocked out of an enteropathogenic strain of E. coli, for example O157 
and this strain could be compared with parental O157 in their abilities to 
invade eukaryotic cells. The work could include assays used to 
measure changes in localised actin polymerisation within eukaryotic 
cells and the appearance of pedestal structures in epithelial tissue.  
 
To discover how elaD may be delivered to host cells an antibody 
against elaD and fluorescent microscopy could be used to detect any 
secretion of elaD. Assays could also be developed to test for contact-
dependent transfer of elaD. 
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The importance of individual domains in elaD in determining 
pathogenicity of E. coli could be investigated. elaD is thought to have 
two domains (K. Hoffman, personal communication), a ULP-like 
domain, ~128th ± 407th residue of elaD and the first 120 residues 
probably form a separate domain which could be important for the 
catalytic domain or may be important for recognising interaction 
partners or associating with type III secretion systems. It would be 
interesting to test the hypothesis that the first 120 residues of elaD 
might play a key role in determining the pathogenic state of E. coli. It 
may be possible that in enteropathogenic E. coli the first 120 residues 
of elaD carry a mutation or are truncated, favouring an interaction with a 
different protein and enabling virulence. A bioinformatics study could be 
carried out, starting with a BLAST search for elaD and comparing the 
first 120 residues. Immobilised wild type elaD could be used in a pull-
down from eukaryotic lysate and E. coli lysate to search for interacting 
proteins If this is successful, constructs of elaD, from various 
pathogenic E. coli could be generated and used in similar pull-downs to 
see if this changes binding partners.  
 
elaD could be more important for commensal E. coli than for 
enteropathogenic E. coli which would have the added advantage of 
many virulence effectors and secretory systems. This would require 
initial work looking in to the effects of wild type commensal E. coli over, 
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NF-NB signalling, PPAR-J induction and RelA export from the nucleus, 
in intestinal epithelial cells. This could then be followed by similar work 
comparing the effects of E. coli with elaD knocked out with WT 
commensal E. coli.    
 
6.2.2 Further investigations in to the catalytic activity and 
interaction partners for elaD 
When available, unanchored linear poly-ubiquitin could be used as a 
substrate for elaD to see if there is a greater preference for unanchored 
linear chains over unanchored K63-linked poly-ubiquitin. To investigate 
if elaD is substrate-specific, elaD-Sepharose could be generated and 
used to search for substrates in eukaryotic lysates. NEMO, TRAF2, 
TRAF3 and TRAF6 could be ubiquitinated with K63-linked poly-ubiquitin 
(including linear poly-ubiquitinated NEMO), in vitro and used as 
substrates for elaD. This use of immobilised elaD could also potentially 
identify any other interaction partners for elaD in eukaryotic and in E. 
coli lysates.  
 
elaD could be truncated or mutated and used in DUB assays to see if 
the first 120 residues of elaD are important for catalysis. If wild type 
immobilised elaD succeeded in pulling down interaction proteins then 
immobilised, truncated or mutated elaD could be used in a pull-down 
compared with immobilised wild type elaD. DUB assays using 
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pathogenic elaD constructs could be compared with wild type elaD to 
test for different DUB activities. 
 
Investigation in to the possible effects that pH may have over specificity 
of elaD for K48-linked poly-ubiquitin may also be relevant. K48-linked 
poly-ubiquitin adopts a fully closed conformation at pH 7.5 and is fully 
open at pH 4.516.  The DUB assays carried out in this study were at pH 
7.6 (37oC), therefore the K48-linked poly-ubiquitin chains would have 
been in a closed conformation. A report by Karagiannis and Young 
found the pH of yeast to be maintained at pH 7.3 throughout the cycle. 
However minor stresses can lower pH to 5.75173. If these values are 
extrapolated to intestinal epithelial cells then K48-linked poly-ubiquitin 
would be partially open and more so in cases of cell stress, due to for 
example, a challenge by pathogenic bacteria. Therefore, it is possible 
that, some DUBs which appear to be linkage-specific in vitro may not be 
linkage-specific in vivo. 
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